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1 Introduction 
Recently plant type III-polyketide synthases (PKSs) became the target of numerous 
mutational studies, especially after crystal structure determination of some PKSs which showed 
an academic importance in addition to the essential role for the reasonable reconfiguration of 
these enzymes for the production of novel compounds (Staunton and Weissman, 2001; Lukacin 
et al., 2005). Several factors are related to the molecular variation of the polyketide products 
such as the choice of the starter substrate, the number of polyketide chain elongations, and the 
cyclization and aromatization reaction mechanism. Interestingly, only a few modifications of the 
active site appear to be needed to generate a remarkable functional diversity of the type III PKSs 
(Morita et al., 2001; Raja Abdul Rahman et al., 2012). In this study, site-directed mutagenesis of 
benzophenone synthase (BPS) from selected Hypericum species was carried out. BPS is one of 
the CHS-like enzymes which belong to plant PKSs. Hypericum androsaemum BPS (HaBPS) was 
the first BPS for which a cDNA was cloned from elicitor-treated cell cultures (Liu et al., 2003). 
Recently, BPSs from Garcinia mangostana and Hypericum sampsonii were published (Huang et 
al., 2012; Nualkaew et al., 2012). In addition, our work group isolated cDNAs for the enzymes 
from, the Hypericum perforatum ssp angustifolium and Hypericum calycinum (Zodi, 2011; 
Tocci, 2013). All these BPSs prefer benzoyl-CoA as a starter substrate, forming 2,4,6 
trihydroxybenzophenone. Benzoyl-CoA is considered as a rare starter substrate for type III PKSs 
and it is used by microbial type I and II PKSs to form soraphen A and enterocin respectively 
(Moore, 2005). Using biochemical and molecular genetic studies in addition to homology 
modeling, efforts were carried out to investigate the effect of mutations on the substrate and 
product specificities of the BPSs from H. sampsonii, H. androsaemum, H. perforatum ssp 
angustifolium and H. calycinum. 
1.1 Site-directed mutagenesis (SDM) 
Site-directed mutagenesis is the targeted change of a gene to give a protein with a 
particular modification in its amino acid sequence. Actually, SDM is considered as a very 
powerful tool for the determination of the importance of specific amino acid residues in an 
enzyme. Comparative studies of the mutant enzymes with one another and with the wild-type 
provide valuable information about the role of particular amino acid residues in substrate 
binding, catalysis and enzyme stability. SDM is widely employed in studying protein structure-
function relationships but one has to define which position in the wild-type should be mutated 
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and which mutations of this amino acid should be done. The residues to be mutated are chosen to 
clarify specific points about the mechanism of the enzymatic reaction or to make particular 
modifications in the properties of the enzyme. It is very vital to have a detailed 3D-structure of 
the enzyme or at least of an intimately linked enzyme on which the enzyme of interest should be 
modeled. Depending on the 3D-structure, some amino acids are essential for substrate binding or 
may have a role in catalysis and these amino acids would be the targets of mutation. Eventually 
amino acid sequence alignments provide precious information about the highly conserved amino 
acids which were supposed to play significant roles in structure or function of the enzyme. Upon 
amino acid replacements it should be taken into account that the substitution of an original amino 
acid with a smaller one will not source much interference in the overall protein structure while 
larger amino acids may cause steric interference (Price and Stevens, 1982). 
1.1.1 Types of mutations 
Many divergent ways could be used for modifying DNA leading to different mutation 
types. Some examples are point, neutral, silent, and nonsense mutations. Point mutation is a 
single amino acid exchange in which one base in a codon is displaced with another. Usually, 
base-exchange in the first and second codon positions results in the exchange of the amino acid 
and so eventually the function or structure of the protein. Neutral mutation is a mutation in which 
the base-exchange leads to the incorporation of an amino acid which is chemically related to the 
original one. Silent mutation leads to generation of a codon encoding the same amino acid and 
this kind of mutation is mainly used in molecular cloning experiments in order to create or 
remove a recognition site for restriction enzymes. Nonsense mutation is a change in which the 
single base substitution converts a sense codon into a nonsense (termination) codon. For 
example, TGG (tryptophane) to TGA (stop).This kind of mutation is considered harmful to the 
cell and may impair the cell function as it leads to earlier termination of the protein synthesis and 
accordingly formation of shortened proteins, which may not function at all. Briefly, all of the 
previously mentioned mutations are substitution mutations However; there is also insertion 
mutation, which means the addition of one or more base pairs into the gene of interest. The last 
type is deletion mutation, which means loss or removal of a DNA section (The University of 
California 2010; Rodnina et al., 2011). 
1.1.1.1 Point mutation 
In the current study, we only worked with point mutation, which leads to incorporation of 
a different amino acid residue in a particular position. Performing this procedure requires the 
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designing of two specific, modified, and relatively long primers to be able to specifically bind to 
the required position in which mutation should be done in the SDM-PCR reaction. Practically, 
several protocols are followed to get the desired mutations and all of them are based mostly on 
the QuikChange site-directed mutagenesis protocol (Stratagene, 2005). These protocols differ in 
their ways of designing the mutant primers and are mentioned in details in section (3.1.1).  
1.2 Polyketides 
1.2.1 History of polyketide research 
Orcinol was the first famous polyketide isolated by Collie (1893) and a rough mechanism 
for the synthesis of orcinol and similar compounds was suggested based on their structure. As 
they are divergent from the previously described chemical classes, they are placed in a novel 
class called polyketides. Its compounds are characterized by the repetitive existence of (-CH2-
CO-) which was entitled as ketide. The ketide groups found in polyketides originate from acetate 
units derived from the primary metabolism of the producing organism and this was confirmed by 
radio labeling techniques (Frandsen, 2010). 
1.2.2 Polyketide natural products 
Polyketides are an amazing group of natural products displaying a fabulous variety of 
functional and structural diversity in addition to significant medicinal activities including 
antibiotic, antifungal, anti-parasitic, anticancer, and immunosuppressive properties. Over the last 
50 years, the polyketide secondary metabolites and their semi-synthetic derivatives have 
executed a tremendous role notably in the medicinal field. Polyketides, and their synthesizing 
enzymes which are polyketide synthases (PKSs), represent an important study area attracting a 
lot of scientists principally in the biopharmaceutical research field due to the diversity in their 
biological activities. Noteworthy, the total market for polyketide natural products surpasses $10 
billion annually and the defiance to find new drug candidates becomes a must notably after the 
resistance of organisms to many kinds of known molecules (Staunton and Weissman, 2001). 
1.2.3 Polyketide synthases 
Despite the great variation in the polyketide constructions all of them share a general 
approach in biosynthesis. They are synthesized by PKSs which are a group of enzymes 
structurally and functionally similar to fatty acid synthases (FASs). Both PKSs and FASs have a 
β-keto synthase (KS) activity that stimulates the successive head-to-tail addition of two-carbon 
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acetate units into a developing polyketide chain. In contrast to FASs, which carry out reduction 
and dehydration reactions on each formed β-keto carbon to yield an inert hydrocarbon, PKSs 
skip or change some of these latter reactions, and so resulting in a diversity of the polyketide 
chain. PKS enzymes selectively manipulate the reactivity of polyketide intermediates to support 
intramolecular cyclization, producing a remarkably varied yield of end products from basic 
acetyl precursors (Austin and Noel, 2003; Ainasoja, 2008). 
1.2.4 Types of polyketide synthases  
PKSs divide into type I, II, and III based on their number of subunits and mode of 
synthesis. Type I PKSs resemble the yeast and animal FASs, consisting of multi-domain 
polyproteins that form large multi-functional biosynthetic complexes and act in either a modular 
or iterative mode. Erythromycin biosynthesis in the bacterium Saccharopolyspora erythraea is 
an example of a modular type I PKS, while the biosynthesis of 6-methylsalicylic acid (6-MSA) 
in the fungus Penicillium patulum is carried out by an iterative, homotetrameric type I PKS 
(Austin and Noel, 2003). Principally, type II PKSs are multienzyme complexes composed of 
separated proteins, like the FAS type II systems found in plants and bacteria. In spite of the fact 
that type II polyketide enzymes are disconnected, and not certainly encoded in a linear mode 
within the genome, they are assumed to form complexes in vivo, similar to those of the type I 
PKS systems. Actinorhodin biosynthesis in Streptomyces coelicolor is catalyzed by a typical 
type II PKS (Austin and Noel, 2003; Frandsen, 2010). On the contrary, type III or CHS-like PKS 
enzymes, which are discussed in details in the following section, sustain a simple architecture, a 
homodimer of corresponding KS monomeric domains, making them much more liable to in vitro 
inspection and manipulation in addition to structural analyses. From recent structural studies it 
was suggested that type III PKS enzymes evolved by earning function from the structurally 
identical homodimeric KAS III which stimulates type II FAS biosynthesis by adding a single 
acetate unit to a small starter molecule by decarboxylative condensation with malonyl-ACP 
(Austin and Noel, 2003). Despite the similarity of the biosynthesis mechanism of type III PKSs 
with that of the modular type I and the dissociated type II PKSs, there are several significant 
differences. Most importantly, the simple homodimeric type III PKSs carry out a complete series 
of decarboxylation, condensation, cylization and aromatization reactions within a single active 
site cavity by using CoA-linked substrates without participation of the acyl carrier protein (ACP) 
which is mainly used by type I and II PKSs to shuttle substrates and intermediates among active 
sites (Staunton and Weissman, 2001).  
Introduction 
5 
 
1.2.5 Plant type III polyketide synthases   
 This group of enzymes generates the main skeleton of a large number of plant secondary 
metabolites with fascinating biological activities such as flavonoids, phloroglucinols, resorcinols, 
benzophenones, biphenyls, chromones, isocoumarins, 4-hydroxycoumarins, acridones, pyrones, 
curcuminoids, stilbenes, etc. They share 30–95% amino acid sequence identities with each other, 
but only 21–31% identity with type III PKSs of bacterial origin (Abe, 2008; Liu et al., 2010; 
Jeya et al., 2012). Type III plant PKSs are usually known as the chalcone synthase (CHS) 
superfamily as they were detected after the CHS enzyme. They catalyze the condensation of a 
CoA-ester starter with extender molecules mostly malonyl-CoAs to give a linear polyketide 
intermediate which is properly folded for cyclization to the end product. The starter substrate 
selection, the number of condensations, and the particular folding type lead to the great 
functional diversity of type III PKSs (Lukacin et al., 2005). Investigation of the biosynthesis 
variability of this group of enzymes suggests new procedures for expanding the resistance of 
plants to different infections in addition to the possible production of pharmaceutical drugs in 
genetically modified plants (Jez et al., 2001). A large number of functionally different plant type 
III PKSs have been cloned and characterized including stilbene synthase (STS) (Morita et al., 
2001; Austin et al., 2004), acridone synthase (ACS) (Lukacin et al., 1999; Lukacin et al., 2001; 
Morita et al., 2007; Wanibuchi et al., 2007), benzalacetone synthase (BAS) (Abe et al., 2001; 
Abe et al., 2003; Abe et al., 2007; Shimokawa et al., 2010), 2-pyrone synthase (2PS) 
(Eckermann et al., 1998; Jez et al., 2000), aloesone synthase (ALS) (Abe et al., 2004; Abe et al., 
2006), benzphenone synthase (BPS) (Liu et al., 2003; Huang et al., 2012; Nualkaew et al., 2012), 
biphenyl synthase (BIS) (Liu et al., 2004; Liu et al., 2007; Liu et al., 2010), and quinolone 
synthase (QNS) (Resmi et al., 2013). In addition, various bacterial type III PKSs were also 
cloned and characterized such as 1,3,6,8-tetrahydroxynaphthalene synthase (THNS or RppA) 
from Streptomyces coelicolor and Streptomyces griseus (Izumikawa et al., 2003) and PhlD from 
Pseudomonas fluorescens which catalyzes the formation of phloroglucinol from three molecules 
of malonyl-CoA (Zha et al., 2006). Most of the previously cited type III PKSs, especially those 
which are referred to in the current study will be discussed in more details in the next sections. 
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1.2.5.1  Type III PKSs preferring aromatic starters 
 Chalcone synthase (CHS) 
Chalcone synthase is the most famous member of type III PKSs in plants, of course due 
to its main role in initiating flavonoids biosynthesis as it provides chalcone to a group of 
downstream enzymes, which modify it to produce a large number of flavonoids end products. 
These metabolites are important biologically active compounds used as antimicrobial 
phytoalexins, anthocyanin pigments, UV photo-protectant, and inducers of symbiotic root 
nodulation by Rhizobium bacteria leading to nitrogen fixation (Jez et al., 2000; Austin and Noel, 
2003). Flavonoids are the majority ample polyphenols present in the human diet and are the main 
components of many herbal products. A lot of studies have suggested that a high intake of 
flavonoids may help in decreasing the risk of cancer, coronary diseases, and osteoporosis in 
addition to its antiallergenic, antiviral, anti-inflammatory, vasodilating, and antioxidant activities 
(Pietta, 2000; Zhang et al., 2004; Raja Abdul Rahman et al., 2012). CHS catalyzes the iterative 
condensation of one starter molecule of p-coumaroyl-CoA with three extender molecules of 
malonyl-CoA in the same active site, followed by intramolecular cyclization and aromatization 
which result in chalcone formation (Fig. 1). The crystal structure of CHS2 alone and complexed 
with substrates and products was determined by Ferrer et al. (1999), and these structures provide 
the basis for understanding the biosynthesis of various polyketides. 
 
 
 
Fig. 1  Chalcone synthase (CHS) reaction mechanism 
 
 Benzophenone synthase (BPS) 
This enzyme is the focus of the present study, so it will be explained in more details. The 
pivotal reaction in xanthones and benzophenones biosynthesis is the formation of the C13 
skeleton which is catalyzed by benzophenone synthase (BPS). Liu et al. (2003) cloned and 
characterized the first BPS from Hypericum androsaemum (Clusiaceae) cell cultures (EC 
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2.3.1.151). It is a homodimer with a molecular mass of 42.8 kDa catalyzing iterative 
condensations of one molecule of benzoyl-CoA with three molecules of malonyl-CoA to form a 
linear tetraketide intermediate which is cyclized into 2,4,6-trihydroxybenzophenone by C6→C1 
intramolecular Claisen condensation (Fig. 2) (Liu et al., 2003). In contrast, BPS from 
Centaurium erythraea (Gentianaceae) accepts and prefers 3-hydroxybenzoyl-CoA as a starter 
substrate catalyzing the formation of 2,3',4,6-tetrahydroxybenzophenone after three malonyl-
CoA extensions (Beerhues, 1996). Recently G. mangostana and H. sampsonii BPSs were found 
to also accept 2-hydroxybenzoyl-CoA as a minor substrate forming 4-hydroxycoumarin (Huang 
et al., 2012; Nualkaew et al., 2012). This observation is similar to Sorbus. aucuparia biphenyl 
synthases with salicoyl-CoA as starter substrate (Liu et al., 2010). Trihydroxy and 
tetrahydroxybenzophenones (Fig. 3) are the building blocks of xanthones and prenylated 
benzophenone derivatives which are considered as an important group of phenolic natural 
products with fascinating pharmacological activities such as anti-HIV, antimicrobial, anti-
inflammatory, and antioxidant properties of guttiferone F in addition to the anticancer activity of 
garcinol (Fig. 3). These polyprenylated benzophenones are restricted in their occurrence to the 
family Guttiferae = Clusiaceae (Liu et al., 2003; Klundt et al., 2009). Other structurally 
complicated benzophenone derivatives are sampsoniones (Fig. 3) which were isolated from the 
Chinese medicinal plant Hypericum sampsonii. They showed cytotoxic activity and are 
characterized by unique caged tetracyclic skeletons (Hu and Sim, 2000). In addition to 
polyprenylation, intramolecular cyclization of benzophenones to form xanthones is a second 
choice, as tetrahydroxybenzophenone could be converted to 1,3,5- and 1,3,7-
trihydroxyxanthones by regiospecific oxidative phenol coupling catalyzed by cytochrome P450 
enzymes (Peters et al., 1997). 1,3,5-Trihydroxyxanthone is the precursor of psorospermine which 
is found in the African medicinal plant Psoropermum febrifugum and shows significant activity 
against drug resistant human leukaemia cell lines and AIDS-related lymphoma (Habib et al., 
1987; Kwok and Hurley, 1998). This DNA-alkylating topoisomerase II agent is considered as a 
lead in the design of new anti-cancer drugs. 1,3,7-Trihydroxyxanthone is the precursor of 
rubraxanthone (Fig. 3) which was isolated from Garcinia mangostana and showed antibacterial 
activity against methicillin-resistant Staphylococcus aureus even higher than the antibiotic 
vancomycin (Liu et al., 2003). Ultimately, gambogic acid (GA) is a famous example of a bridged 
polycyclic xanthone. Recently, it was reported that GA has anticancer effect and inhibits the 
growth of multiple types of human cancer cells in vitro and in vivo. It is isolated from approved 
Chinese herbs that are used for clinical trials in cancer patients by the Chinese Food and Drug 
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Administration. GA efficiently inhibits tumor growth with minimal side effects and with little 
toxicity on the immune system (Klundt et al., 2009; Li et al., 2013). Transformation of BPS into 
a functional phenylpyrone synthase (PPS) was done by point mutation in the active site cavity 
(Thr135Leu) (Klundt et al., 2009). The H. androsaemum T135L mutant (PPS) catalyzed 
formation of 4-hydroxy-6-phenyl-pyrane-2-on after two malonyl-CoA extensions of benzoyl-
CoA followed by C5-oxy→C1 lactonization (Fig. 2). PPS may be a promising biotechnological 
implement for manipulating benzoate-primed biosynthetic pathways for the production of new 
compounds (Klundt et al., 2009). 
 
Fig. 2  Reaction mechanism of H.androsaemum benzophenone synthase (HaBPS) wild-type and the 
HaT135L mutant (PPS) 
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Fig. 3  Examples of biologically active benzophenone derivatives modified from; Liu et al., (2003); 
Klundt et al., (2009). 
 
 Biphenyl synthase (BIS) 
BIS is the second type III PKS, which accepts and prefers the rare starter substrate, 
benzoyl-CoA, after the previously mentioned BPS. It is the key enzyme responsible for the 
synthesis of the C12 skeleton of bipehnyls and dibenzofurans. It shares 53–66% amino acid 
sequence identity with other plant type III PKSs. The BIS activity was first detected in yeast-
extract-treated S. aucuparia cell cultures (Liu et al., 2004). The cDNA for biphenyl synthase was 
also cloned and characterized by Liu et al., (2007). The enzyme catalyzes the iterative 
condensation of benzoyl-CoA with three malonyl-CoAs to form a tetraketide intermediate which 
undergoes intramolecular C2→C7 aldol condensation with the removal of a carboxyl group to 
yield 3,5-dihydroxybiphenyl (Fig. 4, A). This product is considered as the precursor of all 
biphenyls and dibenzofurans, which are the phytoalexins of the Pyrinae (formerly Maloideae), a 
subtribe of the economically important Rosaceae. This family includes valuable fruit trees such 
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as apple and pear. 3-Hydroxybenzoyl-CoA was also accepted but the product formed was 3-
hydroxybenzoyl diacetic acid lactone after two malonyl-CoA extensions. In contrast, upon 
replacement of benzoyl-CoA with salicoyl-CoA as a starter substrate the enzyme catalyzes a 
single decarboxylative condensation with malonyl-CoA to form an intermediate diketide, which 
undergoes intramolecular cyclization via nucleophilic attack of the phenol group on the CoA- or 
cysteine-tethered C-1 thioester, yielding 4-hydroxycoumarin after enolization (Fig. 4, B). 
Subsequently, two cDNAs encoding additional isoenzymes (BIS2, BIS3) were cloned and 
characterized (Liu et al., 2010). They prefer salicoyl-CoA over benzoyl-CoA as a starter 
substrate. Notably, no 4-hydroxycoumarin was identified in the cell cultures of S. aucuparia 
possibly due to the unavailability of salicoyl-CoA as endogenous substrate. 4-Hydroxycoumarin 
could be detected only after feeding of the cell cultures with salicoyl-NAC, with N-
acetylcysteamine (NAC) mimicking the activation by coenzyme A (Fig.4, C). This showed that 
formation of 4-hydroxycoumarin in vivo could be one of the BIS functions in the plant and is not 
only a side reaction of BIS with a non-physiological starter substrate (Schröder, 2009; Liu et al., 
2010), as these derailment reactions are well-known for type III PKSs. The role of BIS in 4-
hydroxycoumarin formation is significant because some plant species of the Apiaceae (Ferula 
communis) and Asteraceae (Gerbera jamesonii) contain 4-hydroxycoumarin or its derivatives 
independent of the action of microorganisms. It is a good idea that plant type III PKSs might be 
involved (Schröder, 2009; Liu et al., 2010). Finally, the BIS reaction corresponds to the 
benzalacetone synthase (BAS) reaction that is recommended as a prospect for a type III PKS 
activity in the quinolone alkaloids biosynthesis, which was proved recently by cloning and 
characterization of Aegle marmelos quinolone synthase (QNS) which will be discussed in details 
in a later section (Abe et al., 2006; Resmi et al., 2013).  
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Fig. 4  Reaction mechanism of biphenyl synthase, A: with benzoyl-CoA, B: with salicoyl-CoA (Liu et al., 
2010), C: Structure comparison of coenzyme A and N-acetylcysteamine ‘NAC’ (Austin and Noel, 2003). 
 
 Stilbene synthase (STS) 
Stilbene synthases (STSs) are CHS-like enzymes which synthesize an identical linear 
tetraketide intermediate (from p-coumaroyl-CoA and three malonyl-CoAs) as CHS. However, 
where CHS cyclizes this intermediate using an intramolecular Claisen condensation between 
carbons C6 C1 (numbering from the cysteine thioester), STS forms resveratrol via linking 
C2 C7 by intramolecular aldol condensation with additional decarboxylative loss of the C1 
carbon as CO2 (Fig. 5). Both STS and CHS displayed over 50% amino acid sequence identity 
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besides the presence of the same amino acid residues in the active site and around the substrate 
entrance cavity although catalyzing the formation of different products from the same tetraketide 
intermediates (Austin and Noel, 2003; Abe and Morita, 2010; Gleason and Chollet, 2012). The 
first STS protein purification was carried out from induced cell suspension cultures of peanut 
(Arachis hypogaea). Subsequently, STS genes and cDNAs were cloned from grape (Vitis 
vinifera) and scots pine (Pinus sylvestris). Resveratrol (3,4',5-trihydroxystilbene) belongs to a 
category of polyphenolic compounds called stilbenes which are produced in some plants in 
response to injury, stress, fungal infection, or UV radiation. They are widespread but not 
universally distributed in higher plants and have antioxidant activity, prevent blood platelet 
aggregation and lipid peroxidation, and exhibit anti-inflammatory activity, vasodilation, and anti-
cancer properties (Higdon, 2008). This class of polyphenolic compounds became a hot research 
area especially after the first report about the presence of resveratrol in red wine, which led to the 
famous postulation that resveratrol might be the explanation of the so-called ‘French Paradox’ 
which is the low mortality rate by coronary heart diseases in France despite high saturated fats 
dietary levels (Gleason and Chollet, 2012). In addition, stilbenes are known for their agricultural 
properties like increased resistance to fungal infection of transgenic plants encoding STS gene 
(Austin and Noel, 2003).  
 
Fig. 5  Reaction mechanism of stilbene synthase (STS). 
 
 Benzalacetone synthase (BAS) 
Benzalacetone synthase (BAS) is another interesting example of plant type III PKSs. It is 
the key enzyme in the biosynthesis of the C6–C4 skeleton of the biologically active 
phenylbutanoids, such as raspberry ketone (p-hydroxyphenylbutan-2-one, pHPB) (Fig. 6, A), 
which grants the specific aroma of raspberries, Rubus idaeus (Borejsza-Wysocki and Hrazdina, 
1996) and the anti-inflammatory glucoside lindleyin (Fig. 6, A) in rhubarb, Rheum palmatum 
(Abe et al., 2001). Up to date, cloning of five BAS-encoding cDNAs have been reported: Rheum 
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palmatum RpBAS (Abe et al., 2001), Wachendorfia thyrsiflora WtPKS1 (Brand et al., 2006), 
Rubus idaeus RiPkS4  (Zheng and Hrazdina, 2008), and Polygonum cuspidatum PcPKS1 and 
PcPKS2 (Ma et al., 2009; Ma et al., 2009). BAS catalyzes a single decarboxylative condensation 
of malonyl-CoA with p-coumaroyl-CoA to give a linear diketide intermediate which after 
decarboxylation produces p-hydroxyphenylbut-3-en-2-one (p-hydroxybenzalacetone), which 
undergoes hydrogenation of the aliphatic double bond by a NADPH-dependent benzalacetone 
reductase to form pHPB (Fig. 6, A). RpBAS showed broad substrate specificity as it accepts 
various non-physiological substrates to produce a set of chemically and structurally diverse 
unnatural polyketides such as 1-(4-hydroxyphenyl) pent-1-en-3-one which is an unnatural novel 
diketide produced from condensation of methyl-malonyl-CoA as extender substrate with 4-
coumaroyl-CoA as starter (Fig. 6, B) (Abe et al., 2002). Notably, RpBAS also accepts 
methylmalonyl-CoA as a sole substrate to form a methylated C9 triketide pyrone, 6-ethyl-4-
hydroxy-3,5-dimethyl-2-pyrone as a single product from three molecules of methylmalonyl-CoA 
(Fig. 6, C) (Abe et al., 2006). Most notable is the formation of 4-hydroxy-2(1H)-quinolones (Fig. 
6, D) by RpBAS from the condensation of N-methylanthraniloyl-CoA with one molecule of 
either malonyl-CoA or methylmalonyl-CoA. The RpBAS enzymatic reaction with the 
anthraniloyl starter proceeds without the decarboxylation step as amide formation takes place 
immediately after the condensation reactions with malonyl-CoA. Remarkably, the best yield was 
obtained with the combination of N-methylanthraniloyl-CoA and methylmalonyl-CoA. The 
steady-state kinetics for the formation of 4-hydroxy-1,3-dimethyl-2(1H)-quinolone revealed a Km 
= 23.7 μM and a Kcat =1.48 min−1 for N-methylanthraniloyl-CoA, which were comparable to 
those for the formation of benzalacetone. This suggests the presence of an unidentified novel 
type III PKS that produces quinolones from the CoA thioester of anthranilic acid (Abe et al., 
2006). 
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Fig. 6  The proposed mechanisms for A: benzalacetone formation by R. palmatum BAS, B: C6–C5 
diketide formation, C: formation of methylated C9 triketide pyrone, D: diketide quinolones formation.  
adapted from Abe, (2012). 
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 Acridone synthase (ACS) 
Acridone alkaloids derived from anthranilic acid are considered as an interesting class of 
secondary metabolites due to their important biological activities and their biosynthesis 
mechanism. This group of secondary metabolites including around 100 naturally known acridone 
alkaloids, such as melicopicine, acronycine and rutacridone (Fig. 7, C) is mainly present in the 
family Rutaceae (Austin and Noel, 2003; Schröder, 2009). Recently, this group of alkaloids is 
being intensively studied as potent anticancer drugs due to their planar structure which facilitates 
DNA and RNA strands intercalation, in addition to their hydrophilic-lipophilic balance which 
helps in crossing the biological membranes to reach the nucleus in which they perform their 
effect. In vitro results of this group of compounds are promising; however, their clinical 
application may be restricted due to their significant side effects. They also showed various 
biological activities such as anti-bacterial, anti-protozoal, and anti-HIV activities (Cholewinski et 
al., 2011; Srikanth G. et al., 2013). The key enzyme which is responsible for the synthesis of the 
acridone skeleton is acridone synthase (ACS), which is another CHS-like enzyme. ACS 
catalyzes three malonyl-CoA condensations with one molecule of N-methylanthraniloyl-CoA 
starter, followed by Claisen condensation reaction of the formed tetraketide intermediate and C–
N linkage by a nucleophilic addition reaction, dehydration and enolization leading to formation 
of the stable aromatic 1,3-dihydroxy-N-methylacridone (Fig. 7, A) (Dewick, 2002; Austin and 
Noel, 2003; Schröder, 2009). Several ACS isoenzymes have been cloned from either elicited or 
irradiated cell cultures or immature flowers of R. graveolens, after the purification of the first 
ACS from the cell suspension culture of the same plant. Determination of the amino acid 
residues which are responsible for substrate specificity difference between ACS and CHS 
requires many efforts. Noteworthy, the ACS wild-type showed around 15% CHS-like activity in 
vitro forming naringenin chalcone from p-coumaroyl-CoA while N-methylanthraniloyl-CoA was 
not accepted as a substrate for RgCHS nor any other known CHS or STS. While there were 
around 100 different amino acid residues between ACS and CHS only three of them were lining 
the active site cavity. Due to the ACS side activity with p-coumaroyl-CoA it was quite easy to 
increase its CHS-like side activity by mutation of these three amino acids in the ACS active site 
to their CHS corresponding amino acids (S132T, A133S and V265F). This effort completely 
transformed ACS to a functional CHS with relatively low side ACS activity while the 
corresponding reverse CHS triple mutant was not successful. It is important to mention that, the 
RsACSV265F single mutant impaired the ACS-like activity and did not improve the CHS-like 
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activity. The MsCHSF215S mutant was surprising in accepting N-methylanthraniloyl-CoA as a 
substrate and carrying out three condensation reactions with malonyl-CoA but it formed N-
methylanthraniloyltriacetic acid lactone (Fig. 7, A) instead of acridone as the unsuccessful CHS-
type ring-folding usually results in a pyrone-type product. Due to the enlargement of the active 
site entrance the MsCHSF215S mutant accepted the bulky N-methylanthraniloyl-CoA substrate 
(Jez et al., 2002; Austin and Noel, 2003; Schröder, 2009). Ultimately, Wanibuchi et al. (2007) 
cloned HusPKS1 from the Chinese club moss Huperzia serrata (Huperziaceae) which is a new 
multifunctional type III PKS that accepts bulky starter substrates like 4 methoxycinnamoyl-CoA 
and N-methylanthraniloyl-CoA forming 4-methoxy-2',4',6'-trihydroxychalcone and 1,3-
dihydroxy-N-methylacridone respectively after three malonyl-CoAs condensation. Remarkably, 
this is the first enzymatic formation of acridone alkaloid by a type III PKS from a non-Rutaceae 
plant. As mentioned before, ACS from R. graveolens is the only characterized type III PKS that 
accepts N-methylanthraniloyl-CoA and forms acridone alkaloids which restrict to plants of the 
family Rutaceae. H. serrata PKS1 shared only 44-66% identity with other plant type III PKSs 
and showed in vitro broad substrate specificity as it accepts aromatic and aliphatic substrates but 
not all of the products showed the completed CHS-type ring folding. Nearly all kinds of pyrone 
products after one, two or three condensation reactions were detected. Notably, H. serrata PKS1 
produces N-methylacridone after three malonyl-CoA condensations with N-methylanthraniloyl-
CoA and in addition the diketide quinolone (4-hydroxy-1-methyl-2(1H)-quinolone) beside 
triketide and tetraketide lactone derailment products (Fig. 7, B). It is probable that H. serrata 
PKS1 has a larger starter substrate binding pocket as active site and guides the Claisen-type 
aromatic ring formation reaction of the tetraketide intermediate. 
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Fig. 7  Reaction mechanisms of A: acridone synthase (ACS) and the M. sativa CHS F215S mutant, B: 
H.serrata PKS1. C: Examples of some acridone alkaloid derivatives. 
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 Quinolone synthase (QNS) 
Very recently, Resmi et al. (2013) cloned and characterized a new type III PKS from 
Aegle marmelos (Rutaceae) which is named quinolone synthase (QNS) depending on its activity. 
It catalyzes decarboxylative condensation of malonyl-CoA with N-methylanthraniloyl-CoA to 
form an intermediate which cyclized spontaneously by amide formation to form 4-hydroxy-
2(1H)-quinolone (main product 89%) and acridone (minor product 11%). QNS also accepts p-
coumaroyl-CoA and forms benzalacetone. The whole reactions catalyzed by QNS enzyme are 
summarized in (Fig. 8). Interestingly, besides the diketide condensation the QNS wild-type 
displays a minor tetraketide condensation leading to acridone formation like ACS. But under 
most of the experimental conditions, QNS favours stopping of the chain extension at the diketide 
stage and quinolone alkaloid formation which supports a different reaction mechanism of this 
novel PKS (Resmi et al., 2013). The most interesting point is that RpBAS also accepts N-
methylanthraniloyl-CoA and forms quinolone alkaloids but up to date no quinolone alkaloids 
have been isolated from R. palmatum (Polygonaceae) they are mainly restricted to Rutaceae. So 
the physiological role of BAS in quinolone alkaloid biosynthesis still open. Meanwhile the QNS 
from A. marmelos which is a Rutaceous plant rich in quinolone and acridone alkaloid derivatives 
is a more physiologically new type III PKSs catalyzing quinolone biosynthesis. In A. marmelos 
QNS T132, S133 and F265 amino acid residues lining the active site of MsCHS are replaced by 
S132, A133, and V265 in QNS. These amino acids line the active site cavity of QNS and are not 
conserved in other PKSs except ACS. Replacement of S132 to T and A133 to S in a QNS double 
mutant (S132T/A133S) completely transformed QNS into a functional CHS which completely 
lost the ability to accept N-methylanthraniloyl-CoA. This could be postulated as an active site 
cavity constriction by the introduction of a methyl group in T132 residue. The smaller size of the 
substrate-binding pocket of the double mutant when compared to the wild QNS did not allow for 
bulky starter substrate binding and consequently prevented quinolone or acridone formation. 
Eventually, this new type III PKS which is involved in quinolone formation is similar to SaBISs 
which perform the same mechanism with salicoyl-CoA and form 4-hydroxycoumarin after only 
one malonyl-CoA condensation reaction and that expands the extent of functional diversity of 
type III PKSs family members (Liu et al., 2010). 
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Fig. 8  Reactions catalyzed by quinolone synthase (QNS). 
 
1.2.5.2 Type III PKSs preferring aliphatic starters 
 Valerophenone synthase (VPS) 
Humulus lupulus (hop) used since long time in beer preparation as a stabilizing agent due 
to its bitter acids constituents such as humulone (Fig. 9) and lupulone. VPS is the key enzyme 
responsible for the bitter acids skeleton formation in hop. It is another example of a type III PKS 
that accepts aliphatic starter substrates such as isovaleryl or isobutyryl-CoAs catalyzing their 
condensation with three molecules of malonyl-CoA to form a tetraketide intermediate which 
undergoes C6 C1 Claisen condensation and formation of phlorisovalerophenone or 
phlorisobutyrophenone respectively (Fig. 9). The enzyme products undergo stepwise prenylation 
reactions and formation of the bitter acids natural products. Unlike CHS enzymes which accept 
isovaleryl-CoA in vitro forming a mixture of phlorisovalerophenone and a triketide lactone as a 
side product, hop VPS did not accept p-coumaroyl-CoA as a starter substrate (Zuurbier et al., 
1998; Austin and Noel, 2003). Amino acid sequence comparison of the cloned VPS from hop 
and CHS showed important differences near the starter substrate-binding pocket such as 
replacement of threonines at positions 132 and 197 which are conserved in CHSs with glycine 
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and isoleucine respectively in VPS. However, VPS cloned from Psilotum nudum (a primitive 
vascular plant) has serines at positions 132 and 197 and a valine at position 338 which is serine 
in CHSs hops VPS, and all other plant type III enzymes which catalyze the CHS-like 
intramolecular Claisen cyclization (except BPS). So it seems that the VPS reaction proceeds 
based on various active site configurations (Austin and Noel, 2003).  
 
 
Fig. 9  Reaction mechanism of valerophenone synthase (VPS). 
 
 Isobutyrophenone synthase (BUS) 
Hyperforin which is a polyprenylated acylphloroglucinol derivative and its homologue 
adhyperforin (Fig. 10) are present mainly in the aerial parts especially flowers and fruits of H. 
perforatum and exhibit similar pharmacological properties. Their biosynthesis is still open at 
least at the molecular level. Feeding experiments revealed that a type III PKS with either 
isobutyryl-CoA (hyperforin) or 2-methylbutyryl-CoA (adhyperforin) synthesizes the 
phloroglucinol part (Karppinen et al., 2007; Schröder, 2008). BUS is considered as the key 
enzyme in the formation of the hyperforin and adhyperforin skeletons and it was detected in cell-
free extracts of H. calycinum cell cultures (Klingauf et al., 2005). The enzyme catalyzes the 
condensation of one molecule of the starter isobutyryl-CoA or 2-methylbutyryl-CoA with three 
molecules of the extender malonyl-CoA to give phlorisobutyrophenone or 2-
methylbutyrophenone respectively (Fig. 10). These intermediates then undergo stepwise 
prenylation to give hyperforin and adhyperforin. It seems that 2-methylbutyryl-CoA is the 
preferred starter substrate in cell cultures of H. calycinum as they mainly contain adhyperforin 
(Klingauf et al., 2005). VPS (1.2.5.2) is the enzyme which is functionally similar to BUS. As 
mentioned, VPS is responsible for the biosynthesis of the backbone of bitter acids in H. lupulus. 
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In both species, H. lupulus and H. calycinum the PKS products undergo stepwise prenylation to 
give bitter acids and hyperforins respectively so it will be interesting after BUS sequence 
determination to compare it with the VPS sequence from hop (H. lupulus) which also accepts 
isobutyryl-CoA as a starter substrate. 
 
 
Fig. 10  Reaction mechanism of isobutyrophenone synthase (BUS). 
 
 2-Pyrone synthase (2-PS) 
Pyrone synthases are considered as a subfamily of type III PKSs with limited distribution 
between plants (Gleason and Chollet, 2012). Although they share around 74% sequence identity 
with CHS they differ in the starter substrate, number of malonyl-CoA condensations and the type 
of cyclization (Austin and Noel, 2003). The basic pyrone synthase that was cloned from the 
ornamental plant Gerbera hybrida (Asteraceae) is the key enzyme in pyrone derivatives 
biosynthesis. The recombinant enzyme is a polyketide synthase that catalyzes iterative 
condensation of one molecule of acetyl-CoA and two malonyl-CoAs to form a linear triketide 
intermediate that undergoes C5-oxy→C1 lactonization and formation of 6-methyl-4-hydroxy-2-
pyrone (triacetic acid lactone, TAL) (Fig. 11) which is the precursor of pyrone derivatives like 
gerberin and parasorboside glucosides. These metabolites are natural products with reduced 
pyrone skeleton and related to pathogen and insect resistance by inhibiting bacterial and fungal 
growth. The enzyme also accepts benzoyl-CoA which then undergoes lactonization after two 
malonyl-CoA condensations to synthesize 6-phenyl-4-hydroxy-2-pyrone which composes the 
skeleton of some HIV-1 protease inhibitors (Helariutta et al., 1995; Eckermann et al., 1998; 
Austin and Noel, 2003). The sequence comparison suggests that CHS and pyrone synthase are 
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different in four amino acids: Thr197, Ile254, Gly256 and Ser338 which were replaced with Leu, 
Met, Leu and Ile respectively in Gh2-PS (numbering from MsCHS). Only three of them which 
contribute to the size and shape of the active site namely Thr197, Gly256 and Ser338 were 
sufficient to alter CHS into a functional 2PS (Schröder, 2008).  
 
Fig. 11  Reaction mechanism of 2-pyrone synthase (2-PS). 
 
 Pentaketide chromone synthase (PCS) 
From the young roots of aloe (Aloe arborescens) which is a medicinal plant rich in 
aromatic polyketides such as chromones and anthraquinones, a cDNA encoding  a novel type III 
PKS named pentaketide chromone synthase (PCS) was cloned (Abe et al., 2005). The cloned 
enzyme shares 50-60% identity to CHS enzymes and 50% identity with R. palmatum ALS. The 
products of the recombinant enzyme with malonyl-CoA is 5,7-dihydroxy-2-methylchromone 
(Fig. 12, A) which is the precursor in the biosynthesis of the anti-asthmatic furochromones 
khellin and visnagin (Fig. 12, A). A. arborescens PCS showed broad substrate specificity as it 
also accepts aromatic and aliphatic CoA-esters as starters and performs two and three 
condensations with malonyl-CoA to form triketide and tetraketide pyrones. Sequence 
comparison displayed that the catalytic triad and most of the CHS active site residues are 
conserved in A. arborescens PCS but one of the most important character of A. arborescens PCS 
is that the CHS active site residues Thr197, Gly256, and Ser338 (numbering in M. sativa CHS) 
are replaced with Met, Leu, and Val respectively. Interestingly, the three residues are also 
changed in the heptaketide-forming R. palmatum ALS (T197A/G256L/ S338T) and in G. 
hybrida 2-PS (T197L/G256L/S338I) that also selects acetyl-CoA as a starter to produce a 
triketide pyrone. A CHS triple mutant (T197L/G256L/S338I) transformed CHS into 2-PS, 
indicating the responsibility of these three residues for the starter substrate specificity. 
Ultimately, a single amino acid substitution in the active site of A. arborescens PCS, M207G, 
completely transformed it into an octaketide synthase which forms the aromatic octaketides 
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SEK4 and SEK4b after seven malonyl-CoA condensations (Fig. 12, B; Abe et al., 2005; Morita 
et al., 2006; Morita et al., 2007; Schröder, 2009). 
 
 
Fig. 12  Reactions catalyzed by pentaketide chromone synthase (PCS) wild-type (A) and the PCS M207G 
mutant (B). 
 
 Aloesone synthase (ALS) 
ALS was the first plant type III PKS enzyme which catalyzes more than three condensation 
reactions. It was cloned from young roots of rhubarb (R. palmatum) a medicinal plant rich in 
aromatic polyketides such as chromones, naphthalenes, phenylbutanones, and anthraquinones 
and later from A. arborescens. ALS catalyzes the formation of an aromatic heptaketide called 
aloesone (2-acetonyl-7-hydroxy-5-methylchromone) (Fig. 13) by iterative condensation of one 
acetyl-CoA and six molecules of malonyl-CoA followed by cyclization of the heptaketide 
intermediate with the removal of a carboxyl group. The enzyme shared 60% amino acid 
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sequence identity with CHSs and nearly maintained the conserved amino acids lining the active 
site of plant type III PKSs including the CoA binding sites and the catalytic triad. It also shares 
the overall fold like CHS. The most interesting point is the replacement of the CHS active site 
residues lining the initiation/elongation cavity Thr197, Ile254, Gly256 and Ser338 with Ala, 
Met, Leu and Thr in RpALS. Remarkably, a large number of mutants were constructed to 
elucidate the roles of specific residues responsible for the substrate and product specificities of 
this enzyme compared to other type III PKSs. Only replacement of Ala197 to Thr transformed 
heptaketide synthase (RpALS) into a pentaketide synthase which forms 2,7-dihydroxy-5-
methylchromone instead of aloesone (Abe et al., 2004; Abe et al., 2006; Schröder, 2009). 
 
 
Fig. 13  Reaction mechanism of aloesone synthase (ALS). 
 
 Oktaketide synthas (OKS) 
From young roots of A. arborescens a cDNA encoding the octaketide synthase (OKS) 
was cloned. The enzyme showed 50-60% identity to type III plant PKSs and more than 90% 
identity with A. arborescens PCS (Abe et al., 2005). The enzyme accepts malonyl-CoA as a 
starter substrate catalyzing seven condensations with malonyl-CoA to yield the aromatic 
octaketides SEK4 and SEK4b the longest polyketides synthesized by plant type III PKSs (Fig. 
14). However, the Aloe plant does not produce these substances but forms anthrones and 
anthraquinones that are probably derived from octaketides. Despite of accepting the suggested 
starter substrate and carrying out the correct condensation number with malonyl-CoA the right 
cyclization of the linear polyketide intermediate to the predicted final products failed in vitro and 
only the formation of the shunt products SEK4 and SEK4b takes place. This may be due to 
misfolding of the protein in the E. coli expression system or because of the absence of 
interactions with a yet unidentified tailoring enzyme such as ketoreductase. The involvement of 
tailoring enzymes is supported by the fact that SEK4 and SEK4b are also formed as shunt 
products by a type II PKS of Streptomyces coelicolor involved in actinorhodin antibiotic 
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biosynthesis when the enzyme is incubated in the absence of ketoreductase (Fu et al., 1994). A. 
arborescens OKS showed broad substrate specificity as it also accepts, in addition to malonyl 
and acetyl-CoAs, aromatic and long-chain fatty acyl-CoA esters as starters and performed 
sequential condensations with malonyl-CoA to produce triketide and tetraketide pyrones 
(Mizuuchi et al., 2009). Sequence comparison of A. arborescens OKS with other PKSs showed 
absolute conservation of the catalytic triad and most of the CHS active-site residues except 
CHS’s Thr197, Gly256 and Ser338 which are substituted with Gly, Leu, and Val in AaOKS 
respectively (Fig. 84 appendix). As mentioned earlier, these three residues are changed in a 
number of type III PKSs such as heptaketide synthase from R. palmatum, ALS 
(T197A/G256L/S338T) (Abe et al., 2004), pentaketide synthase from A. arborescens, PCS 
(T197M/G256L/S338V) (Abe et al., 2005), and triketide synthasee from G. hybrida, 2PS 
(T197L/G256L/S338I) (Eckermann et al., 1998; Jez et al., 2000). It has been proposed that these 
inert active site residues control the starter substrate selectivity and polyketide chain length by 
steric modulation of the initiation/elongation cavity (Abe et al., 2005). Replacement of Gly207 in 
AaOKS by the Met207 of AaPCS led to an enzyme similar to PCS i.e. it produces a pentaketide. 
However, it was not the expected 5,7-dihydroxy-2-methylchromone but the isomeric 2,7-
dihydroxy-5-methylchromone (Fig. 14, B). Thus, a single change in direction to PCS was 
sufficient to convert the octaketide synthase into a pentaketide synthase but the difference in the 
products indicates that the enzymes are in this case not properly inter-convertible. 
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Fig. 14  Reaction mechanisms of A: octaketide synthase (OKS) wild-type, B: OKS G207M mutant. 
1.2.6 Active site of plant type III polyketide synthases 
For a better understanding of the function of each amino acid used in this study, amino 
acid sequences alignment for selected type III PKSs (Fig. 84) is provided. Recent 
crystallographic and site-directed mutagenesis studies on plant and bacterial enzymes provide 
valuable structural and functional details of this class of enzymes which are structurally simple 
small homodimeric proteins of approximately 40–45 kDa that share almost the same three-
dimensional overall fold and common active-site architecture with an absolutely conserved Cys, 
His and Asn catalytic triad. The first resolved PKS structure was that of M.sativa (alfalfa) CHS 
alone and complexed with substrate and product analogues which showed that the active site of 
CHS2 consists of three inter-connected cavities which are the CoA-binding tunnel, a coumaroyl-
binding pocket and a cyclization pocket. Each type III PKS monomer utilizes the triad within an 
internal active site cavity which is connected to the outer aqueous environment by a narrow 
CoA-binding tunnel. This partition of the active site separated pockets represents the structural 
basis for the capability of the CHSs-like enzymes to catalyze different reactions within a single 
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buried active site cavity. Multiple sequences alignments displayed high sequence similarity 
between divergent type III PKS proteins. Nearly 30–95% similarity was noticed between CHSs 
and plant type III PKSs. This high similarity suggested a strict conservation between CHSs from 
plant species. Around 21–31% similarity was observed in fungal and bacterial type III PKSs 
meanwhile the non-CHS proteins showed more than 70% similarity (Abe et al., 2001; Jeya et al., 
2012, Radhakrishnan EK, 2009; Mallika et al., 2011).  
1.2.6.1 Catalytic residues 
Structural insights into the catalytic machinery of M. sativa CHS revealed the 
conservation of four amino acid residues (Cys164, Phe215, His303 and Asn336 numbering from 
MsCHS) except in R. palmatum BAS (which is a non-CHS protein) where Phe215 is replaced 
with Leu. In addition there is a substitution of the conserved Asn336 with Ala in Persea 
americana (Avocado) CHS (Q9ZU06) (Mallika et al., 2011). The conserved catalytic triad 
(Cys164, His303 and Asn336) is positioned at the top of the active site cavity (Fig. 15, A) where 
it acts on substrates incorporated into the active site by the pantetheine arm of the CoA-linked 
molecules. Interestingly, the catalytic cysteine (Cys164) which is strictly conserved in all 
thiolase-fold enzymes is situated at the amino terminal end of one of a pair of buried α-helices 
that make the buried central α-layer of the thiolase-fold architecture (Fig. 15, B ). Phe215 is 
located at the bottom of the binding pocket (Fig. 15, A). It is one of two ‘gatekeeper’ 
phenylalanines which block the lower portion of the opening between the CoA-binding tunnel 
and the active site cavity. It is stated that ‘Phe215’ is implicated in the decarboxylation of 
malonyl-CoA and may help in the orientation of substrates and reaction intermediates at the 
active site. The conformational flexibility of these gate keeper residues (deduced from 
comparison of several crystal structures) may grant the ability of CHS to restrict the access of 
water to the active site while harboring substrates and intermediates of variable size (Jez and 
Noel, 2000; Austin and Noel, 2003; Mallika et al., 2011). 
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Fig. 15  A: Buried active site cavity of CHS with naringenin bound. View is from the outside looking 
through the CoA-binding tunnel. The interface of the active site cavity and the CoA-binding tunnel is 
mediated by the ‘gatekeeper’ phenylalanines at positions 215 and 265. Other active site residues 
discussed in the text are also shown, B: position of the catalytic cysteine at the N-terminal end of one of a 
pair of buried α-helices that make the buried central α-layer of the thiolase-fold architecture, modified 
from; Austin and Noel, (2003). 
1.2.6.2 Substrate binding pocket residues 
Despite of the fact that PKSs have broad substrate specificity, the amino acid residues 
forming the substrate binding pocket were found to have steric and mechanistic effects on the 
substrate selectivity (Brand et al., 2006). Ser133, Glu192, Thr194, Thr197 and Ser338 
(numbering from MsCHS) are the amino acid residues located at the substrate binding pocket 
and presented high degree of conservation with a number of exceptions. Ser133 was replaced 
with Thr in all fungal and bacterial type III PKSs in addition to P. sylvestris STS and R. 
palmatum ALS. In G. hybrida 2-PS, R. palmatum BAS, R. graveolens ACS and A. marmelos 
QNS Ser133 was substituted with Ala. Also in A. arborescens PCS and OKS Ser133 was 
replaced with Cys. Glu192 showed absolute conservation while Thr194, Thr197 and Ser338 
displayed variations. Like the replacement of Thr194 with Cys in most of the fungal and 
bacterial type III PKSs and with Gly, Ile, Thr, and Val in selected Hypericum BPSs and S. 
aucuparia BIS, Gerbera hybrida 2-PS, R. palmatum ALS, A. arborescens PCS and OKS 
respectively (Mallika et al., 2011). Thr197 showed variation especially in non-CHSs enzymes 
like SaBIS, Gh2PS, HlVPS, RpBAS, RpALS, AaPCS and OKS where it was replaced with Phe, 
Leu, Ile, Cys, Ala, Met and Gly respectively. It was reported that Ser at position 338 played a 
role in the starter substrate selectivity and is mainly substituted in non-CHSs for a special 
function (Abe et al., 2006). For example, Ser338 was replaced with Ile and Thr in Gh2PS and. 
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RpALS, respectively. In SaBIS and selected Hypericum BPSs it was replaced with Gly. Finally, 
Val replaces Ser338 in AaPCS and OKS 
1.2.6.3 Cyclization pocket residues 
Thr132, Met137, Phe215, Ile254, Gly256, Phe265, and Pro375 are the amino acid 
residues that form the cyclization pocket. They show high degree of conservation in CHSs but 
with a number of exceptions in other type III PKSs and they are essential for providing the 
required steric guidance to the linear polyketide (Austin and Noel, 2003). Thr132 which is our 
amino acid of interest during this study was conserved in CHSs from all plants with an exception 
of C. erythraea PPS which is a natural phenylpyrone synthase (Gaid, unpublished results). In 
Zingiber officinale CHS, Thr132 was replaced with Ile (Radhakrishnan EK, 2009; Mallika et al., 
2011). In most of non-CHS enzymes like RpBAS, SaBIS and HlVPS, Thr132 was replaced with 
Leu, Ala, and Gly respectively. In RgACS, AmQNS, AaPCS and OKS it was substituted with 
Ser. Finally Thr132 was replaced with Cys in most of the fungal and bacterial type III PKSs 
(Mallika et al., 2011). Met137 is strictly conserved except in PsSTS where it was substituted 
with Leu. Pro375 amino acid residue displayed stringent conservation across different type III 
plant PKSs. Position 254 mainly contains Ile but in SaBIS it was replaced with Val while in 
Gh2PS and RpALS it was substituted with Met. Gly256 is conserved in most of CHSs while in 
non-CHSs like SaBIS and selected Hypericum BPSs it was replaced with Ala while in Gh2PS, 
RpAlS, AaPCS and OKS it was substituted with Leu. Position 265 occupied with the second 
gatekeeper Phe in most of CHSs. But it was replaced with Tyr in SaBIS and selected Hypericum 
BPSs while in CePPS, RgACS and in AmQNS it was substituted with Val. Ultimately, Pro138, 
Gly163, Gly167, Leu214, Asp217, Gly262, Pro304, Gly305, Gly306, Gly335, Gly374, Pro375 
and Gly376 are conserved amino acid residues maintaining the overall architecture of the 
MsCHS enzyme. Interestingly, minor changes in the amino acid residues lining these pockets 
may have profound effects on the reaction mechanism leading to metabolic divergence (Abe et 
al., 2001; Radhakrishnan EK, 2009). 
1.2.7 Proposed type III PKS reaction mechanism  
All polyketide synthases have a conserved catalytic triad consisting of His, Cys, and Asn 
residues in their active sites. The (His) imidazole-N acts as a base and removes a proton from the 
(Cys) sulfhydryl group generating a reactive thiolate anion. This anion attacks the carbonyl 
carbon of starter-CoA and displaces the CoA moiety. The second substrate, malonyl-CoA binds 
near the (Asn) residue. The (Asn) amide-NH2 forms a H-bond with the carbonyl oxygen of 
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malonyl-CoA facilitating its decarboxylation. The produced acetyl carbanion attacks the 
carbonyl carbon of the starter-Cys complex and produces a diketide intermediate which rebounds 
to the Cys by thiolate nucleophilic attack on carbonyl thioester of the diketide The second 
equivalent of malonyl-CoA is attached to the Asn residue, decarboxylated and added to the 
diketide. The resulting triketide intermediate undergoes another elongation round by binding to 
the active site (Cys) and acetate addition to yield a tetraketide intermediate. Cyclization and 
aromatization of the teraketide intermediate occur while it is still bound to the enzyme to 
produce the final product (Fig. 16). Briefly, the reaction of polyketide formation is started by 
loading the starter substrate at the active site Cys, followed by malonyl-CoA decarboxylation, 
elongation of the  polyketide chain, and ultimate cyclization of the polyketide intermediate to the 
final product (Staunton and Weissman, 2001; Austin and Noel, 2003; Gleason and Chollet, 
2012). However, further analysis of the flexibility and catalytic potential of the functionally 
divergent plant type III PKSs pledge to reveal fine structural details of the enzyme-catalyzed 
processes and so enriching the field of structure-based engineering of this class of enzymes will 
of course lead to the production of structurally and chemically variable novel polyketide 
compounds with possibly important pharmacological activities (Abe, 2008).  
 
Fig. 16  Proposed reaction mechanism of type III polyketide synthases. a: starter substrate loading, b: first 
malonyl decarboxylation and condensation with the growing ketide chain (polyketide extension), c: 
reloading of the diketide intermediate, d: second malonyl decarboxylation and condensation with the 
growing ketide chain (polyketide extension), e: reloading of the triketide intermediate, f: third malonyl 
decarboxylation and condensation with the growing ketide chain (polyketide extension), g: reloading of 
the tetraketide intermediate, h: cyclization, aromatization and then release of the final product from the 
active site modified from; Abe, (2008). 
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1.3 Hypericum 
The genus Hypericum is the largest genus of the family Hypericaceae previously 
classified as Guttiferae or Clusiaceae (Stevens, 2007). This family contains nine genera 
(Hypericum, Cratoxylum, Eliea, Harungana, Lianthus, Santomasia, Thornea, Triadenum and 
Vismia) (Wikipedia, 2013 ). Hypericum as a genus consists of about 500 species of shrubs, herbs 
and a few trees classified into 36 taxonomical sections and containing approximately 80 % of the 
diversity of Hypericaceae (Ocak et al., 2013). Plants of this genus are widely distributed all over 
the world mainly in the temperate regions and present in almost all kinds of temperate habitats 
(Nürk 2011). A general overview of the taxonomy of the genus and the distribution of relevant 
secondary metabolites is presented in Crockett and Robson (2011). The plants of this genus 
contain a wide range of structurally different and biologically active secondary metabolites 
belonging to at least ten different classes (Menichini et al., 2013) with preponderance of 
naphthodianthrons ‘hypericin and pseudohypericin’, phloroglucinols ‘hyperforin’, flavonoids 
‘rutin, hyperoside, isoquercitrin, quercitrin, quercetin, amentoflavone’ and phenylpropanoids 
‘chlorogenic acid’ (Bruni et al., 2005) in addition to xanthones. However, great variations in 
contents have been reported for wild populations worldwide from Australia (Southwell and 
Campbell, 1991) to Turkey (Çirak et al., 2006) and this may explain its various supposed 
therapeutic indications like wound healing, anti-inflammatory, and antiseptic activities, treatment 
of anxiety and sleep disorders in addition to its sedative or tonic effects (Usai et al., 2003). The 
name Hypericum possibly comes from the Greek words hyper (above) and eikon (picture) and 
this indicates that using this plant over Gods pictures may keep the owner from evil (Czygan, 
2003). Hypericum species have received significant interest due to the increasing market 
requirements (Usai et al., 2003). So the  economic value of plants of this genus to the herbal 
industry is one of various factors that motivated research into phytochemical diversity of H. 
perforatum specifically and of other members of the genus in general (Crockett and Robson, 
2011). Extracts of the inflorescences and upper stem leaves of H. perforatum are prescribed for 
many years in Europe and are available as dietary supplements in the United States to treat mild 
to moderate depression (Crockett and Robson, 2011). High efficacy and tolerability of the herb’s 
extract is unimpeachable, while its clinical activity is comparable to other antidepressants 
(Woelk, 2000). H. perforatum also shows promising antiviral and anti-inflammatory activities 
and is being studied for its prospect benefit to AIDS patients. It has long been used as a cure for 
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 uterine spasm, bedwetting, and anxiety. St. John's wort is also used internally and externally for 
pain relief (Hobbs, 2013). 
1.3.1 H .perforatum ssp angustifolium (Hpa) 
 According to the Flora of Italy by Pignatti (1982), there are three different subspecies: 
perforatum, veronense and angustifolium distinguished by the size of their sepals (Dukovčić et 
al., 2012). H. perforatum ssp angustifolium (Fig. 18, 4) has linear lanceolate leaves and found to 
be the highest in hypericin content which is accumulated in the black globules that are present in 
all the aerial parts of the plant (Males et al., 2006). The extract of H. perforatum ssp 
angustifolium showed an efficacy which was similar to that obtained with the treatment with the 
classical antidepressant imipramine or H. perforatum ssp perforatum. Furthermore, H. 
perforatum ssp angustifolium extract was active at doses eight times lower than those necessary 
to produce a comparable activity with H. perforatum ssp perforatum extracts (Usai et al., 2003). 
1.3.2 Hypericum calycinum (Hc) 
H. calycinum L. (rose of Sharon; Fig., 18, 3) is a common ornamental plant in the United 
States. It is a deciduous shrub. Its flowers and leaves are much larger than those of H. 
perforatum. Since it accepts a wide range of soil types including sand and showed adaptation to 
different habitats, H. calycinum used by gardeners for ground cover and rock gardens and to 
stabilize hillsides.  H. calycinum bears yellow flowers that resemble wild roses. This hardy shrub 
is free of most serious plant diseases and has no insect problem that affects its existence 
(Spengler, 2013). Interestingly, antibiotic substances isolated from H. calycinum are comparable 
in their activity to those in H. perforatum (Shakirova, 1970; Hobbs, 1998), in addition to its 
fungicidal activity against Cladosporium cucumerinum, in vitro antimalarial and anticancer 
activity (Decosterd et al., 1989; Decosterd et al., 1991). Ozturk (1997) stated that the alcoholic 
extract of H. calycinum has antidepressant properties while other tested species like H. 
hyssopifolium ssp. elongatum var. elongatum were free of antidepressant effects.  
1.3.3 Hypericum androsaemum (Ha) 
Hypericum androsaemum L. (Guttiferae, Fig. 18, 2) is a medicinal plant growing in West 
Europe in shady or clammy places. Investigation of this species includes only the separation and 
identification of its constituents like flavonoids, phenolic acids in addition to xanthones which 
occur mainly in roots but minor amounts can also be present in leaves (Nielsen and Arends, 
1979; Schmidt et al., 2000; Valentão et al., 2003). These phenolic compounds may be 
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responsible for the properties and pharmacological activities of this plant. In traditional medicine 
H. androsaemum leaves were used in preparation of teas with diuretic and antihepatotoxic 
activities ( Valentão et al., 2002; Klundt, 2008). The lyophilized infusion of H. androsaemum 
showed antioxidant activity against superoxide radical, hydroxyl radical and hypochlorous acid 
which is probably due to the predominance of several quercetin glycosides in this species 
(Valentão et al., 2002). In addition to the hepatoprotective activity of H. androsaemum infusion 
which may be due to the phenolic compounds, 5-O-caffeoylquinic acid, and quercetine 
derivatives that inhibited lipid peroxidation (Valentão et al., 2004). 
1.3.4 Hypericum sampsonii (Hs) 
H. sampsonii Hance (Fig. 18, 1) is a small evergreen shrub distributed and cultivated in 
the north and south of China. Its fruits are used in the treatment of lung disease and whooping 
cough while roots used in case of  rheumatism, cough and back pain (Healthcare, 2011). It is the 
most closely related species of St. John’s wort in China which has been used in traditional 
medicine for many diseases like snakebites, menstrual irregularity hematemesis, epistaxis, 
external traumatic injury, and swellings. Recent studies have shown that H. sampsonii possesses 
anti-cancer activity however, how H. sampsonii exerts its various biological effects remains 
substantially unknown (Zeng et al., 2006). There is also antibacterial activity against multidrug-
resistant (MDR) strains of Staphylococcus aureus (Xiao et al., 2010). Due to its important 
bioactivities prolonged phytochemical studies showed that H. sampsonii contains a lot of 
polyprenylated phloroglucinol derivatives with complex caged tetracyclic skeletons (Fig. 17) 
which exhibited moderate antibacterial and cytotoxic activities (Xiao et al., 2007; Xiao et al., 
2010; Xin et al., 2011). Recently, sampsonols A and B (Fig. 17) are new polyprenylated 
phloroglucinol derivatives isolated from the arial parts of the petroleum ether extract of H. 
sampsonii and showed significant cytotoxicity against human breast, hepatoma, colon and lung 
tumor cell lines. These compounds may serve as lead compounds with interesting therapeutic 
potential as antitumor and anti-inflammatory agents (Xin et al., 2012). Despite their important 
pharmacological activities especially as anti-cancers biosynthesis of these benzophenone 
derivatives is still poorly understood. The main nucleus of these compounds is a benzophenone 
which is biosynthesized by benzophenone synthase (Beerhues and Liu, 2009). The first 
published BPS (HaBPS) cDNA was cloned from elicitor-treated H. androsaemum cell cultures, 
which served as a model system for studying benzophenone metabolism (Liu et al., 2003). The 
second BPS cDNA was cloned and characterized from Garcinia mangostana (Nualkaew et al., 
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2012). Recently, cloning and functional characterization of a cDNA encoding BPS from 
H.sampsonii was carried out in addition to the analysis of the organ-specific expression pattern 
by quantitative PCR (Huang et al., 2012). 
 
Fig. 17  Structures of some isolated polyprenylated phloroglucinol derivatives and xanthones from 
Hypericum sampsonii. 
 
Fig. 18  Selected Hypericum species 1: H. sampsonii (Herbarium, 2013), 2: H. androsaemum (Germer, 
2008), 3: H. calycinum (Flicksi, 2011),  4: H. perforatum ssp. angustifolium (Lleida, 2010). 
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1.4 Homology modeling 
Despite of the increasing number of known 3D structures of proteins but they still cover a 
tiny part of the identified proteins. Therefore comparative homology models for proteins with 
unknown 3D structures are one of the most essential approaches for studying protein 
structure/function relationships and guiding mutation experiments. Homology modeling is a 
technique which generates the 3D-structure of an unknown protein (target) from its amino acid 
sequence based on the known structure of a closely related protein (template). This method 
depends on the fact that homologous proteins evolved from a common ancestor have conserved 
3D structures. The accuracy of the model based mainly on the sequence identity between the 
target protein and the selected template. More than 50% sequence identity usually results in 
reliable models (Chothia and Lesk, 1986). Simply, few steps should be followed to generate a 
homology model including (i) selection of the template which shows highest similarity to the 
target protein from PDB (protein data bank), (ii) amino acid sequences alignment of the template 
and the target protein, and (iii) generation of the model and checking its validity. The computer 
work done in the current study was a kind cooperation with Dr. Marco Bocola (Head of 
computational biology, Institute of Biotechnology, RWTH Aachen). 
1.5 Research strategies and objectives  
The functional behavior of H.androsaemum BPS was dramatically changed by a single 
amino acid substitution in the active site cavity of the enzyme (T135L) (Klundt et al., 2009). The 
most interesting point on which this work is based is the replacement of Leu with other amino 
acids such as Gly, Ala, Val, Ile, Asn, and Tyr which gave catalytically inactive proteins while 
Ser and Phe gave mutants which were similar to the wild type but with lower activities (Klundt 
et al., 2009). As mentioned before, Thr135 is one of the amino acids which form the cyclization 
pocket of type III PKSs and play an important role in providing the required steric guidance to 
the linear polyketide in the active site (Austin and Noel, 2003). Thr135 is conserved in most 
plant PKSs with some exceptions such as CePPS, SaBIS, and RpBAS in which Thr was replaced 
with Ile, Ala, and Leu respectively. The amino acids lining the active site cavities of the BPSs 
from H. sampsonii, H. androsaemum, H. calycinum and H. perforatum ssp. angustifolium are 
identical, especially Thr135. 
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The main objectives of this study were: 
 Screening the effects of the other 19 amino acids in position 135 in H. sampsonii 
BPS. 
 Investigation of the effect of Leu in position 135 in BPSs of selected Hypericum 
species other than H. androsaemum. 
 Functional and kinetic characterization of the BPS mutants that showed novel 
activities. 
 Homology modeling of the enzyme mutants that exhibited dramatic changes in 
the product and substrate specificities (in cooperation with Dr. Bocola, Aachen). 
 Analysis of structure-function-relationships. 
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2 Materials 
2.1 Chemicals, nutrient media, solutions and buffers 
2.1.1 Chemicals 
Chemicals unless otherwise mentioned were purchased from the following companies: 
Roth, Sigma-Aldrich, Applichem, Fischer Scientific and Fluka. Deionized water was supplied 
from Milli-Q water purification system (Sartorius, Germany), and used in preparing all aqueous 
solutions used in the study. All solutions were autoclaved by 120C for 20 min. Solutions of 
thermolabile compounds were sterile filtered and added to autoclaved solutions under sterile 
conditions. All salts required for the plant or bacterial culture media were supplied from Roth or 
Applichem.  
 
Chemical Supplier 
For bacterial culture medium 
Yeast Applichem 
Peptone (casein) Roth 
NaCl Roth 
Agar Applichem 
KH2PO4 Roth 
K2HPO4 Roth 
MgSO4.7H2O Roth 
Glycerol Roth 
 
Stationary phases used in protein desalting and affinity purification 
PD10-cartridge Sepharose G-25 columns GE Healthcare 
Nickel-nitrilotriacetic acid Qiagen 
Substrates used for enzyme assays 
Benzoyl-CoA, malonyl-CoA Sigma-Aldrich 
Anthraniloyl-CoA Synthesized according to (Stöckigt and Zenk, 
1975; Beuerle and Pichersky, 2002) 
2-Hydroxybenzoyl-CoA Synthesized according to (Stöckigt and Zenk, 
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1975; Beuerle and Pichersky, 2002) 
3-Hydroxybenzoyl CoA Synthesized by Dr. M. Gaid (our work group) 
4-Hydroxybenzoyl CoA Synthesized by Dr. B. Liu (our work group)  
2-Methoxybenzoyl-N-acetylcysteamin Synthesized according to (Suo et al., 2000) 
2-Mercaptobenzoyl-N- acetylcysteamin Synthesized according to (Suo et al., 2000) 
Phlorbenzophenone  ICN Biomedicals Inc. 
Reagents for biochemistry and molecular biology 
IPTG Applichem 
dNTPs Thermo Scientific 
Imidazole Roth 
Tris-HCl  Roth 
Antibiotics 
Ampicillin Roth 
Chloramphenicol Applichem 
Reagents for gel electrophoresis 
peqGold universal agarose Peqlab 
Ethidium bromide Roth 
Acrylamide/Bisacrylamide 30% Bio-Rad 
TEMED Bio-Rad 
Ammonium persulfate Roth 
SDS Roth 
-mercaptoethanol Roth 
Bromophenol blue Sigma-Aldrich 
Commassie-blue R250 and G250 Merck 
Solvents for HPLC 
Methanol, Acetonitrile Fischer Scientific 
Orthophosphoric acid Roth 
Ladder 
Gene Ruler DNA ladder Mix Thermo Scientific 
Page Ruler Unstained Protein Ladder Thermo Scientific 
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2.1.2 Nutrient media for Bacterial culture 
Medium Composition 
LB medium  
 
 
 
For solid medium 
 Peptone (casein)                                                           10 g/l 
 Yeast extract                                                                 5  g/l 
 NaCl                                                                             10 g/l 
 
 Agar                                                                                1% 
SOC Medium  Peptone (casein)                                                            20 g/l 
 Yeast extract                                                                 5 g/l 
 1 M NaCl                       10 ml/l 
 1M KCl                                                                         10 ml/l 
 Autoclave and then add the sterile filtered solution of 
 2 M Mg
2+
                                                                     10 ml/l 
 2 M glucose                                                                  10 ml/l 
For induction of protein 
expression 
 IPTG (Isopropyl--D-thiogalactopydranoside) 0.12 g/ml (0.5 M) 
 Final concentration in bacterial culture                0.5mM 
Antibiotic for selection of 
transformed bacteria 
 Ampicillin (0.269 M)   (100 mg /ml aqueous soln.) 
 Chloramphenicol ( 0.093 M) (30 mg/ml  soln. in ethanol) 
For preservation of 
bacterial culture 
 Glycerol:LB (Medium 60:40)                   250 µl 
 Bacterial culture                                                                  750 µl 
2.1.3 Buffers and solutions  
2.1.3.1 Buffers for DNA- gel electrophoresis 
50X TAE buffer Tris-HCl                               2 M 
EDTA                              0.05 M 
Adjust pH to 8 with glacial acetic acid 
 
To examine DNA products less than 300 bp, 2% agarose gel was prepared; for larger sizes, 1% 
agarose gel was prepared. 
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2.1.3.2 Buffers for protein electrophoresis (SDS-PAGE) 
Staking gel (for 2 small gels) Water                                             2.72 ml 
1 M Tris-HCl (pH 6.8)                    504 µl 
30% Acrylamide/Bis                       664 µl 
10% (w/v) SDS                                 40 µl 
10% (w/v) APS                                 40 µl 
TEMED                                               4 µl 
Resolving gel (for 2 small gels) Water                                               2.3 ml 
1.5 M Tris-HCl (pH 8.8)               1.75 ml 
30% acrylamide/Bis                        2.8 ml 
10% (w/v) SDS                                70 µl 
10% (w/v) APS                                70 µl 
TEMED                                            2.8 µl 
Protein loading buffer (2X) Water                                                2.7 ml 
0.5 M Tris-HCl (pH 6.8)                  1.0 ml 
Glycerol                                            2.0 ml 
10% (w/v) SDS                                3.3 ml 
-mercaptoethanol                           0.5 ml 
0.5% (w/v) bromophenolblue          0.5 ml 
SDS-electrode buffer (10X) Tris base                                            15 g 
Glycine                                             72 g 
SDS                                                    5 g 
Water                                         ad 500 ml 
Staining solution Coomassie blue R-250                        1 g 
Mathanol                                       500 ml 
Acetic acid                                      75 ml 
Water                                      ad 1000 ml 
Destaining solution Methanol                                       200 ml 
Acetic acid                                      76 ml 
Water                                       ad 1000 ml 
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2.1.3.3 Buffers for extraction and purification of His6-tagged fusion protein 
Lysis buffer 50 mM Na2HPO4                            3.44 g 
30 mM NaCl                                   0.87 g 
20 mM Imidazole                           0.68 g 
Water                                        ad 500 ml 
Washing buffer 50 mM Na2HPO4                            3.44 g 
1.5 mM NaCl                                  0.04 g 
50 mM Imidazole                             1.7 g 
Water                                         ad 500 ml 
Elution buffer 50 mM Na2HPO4                             3.4 g 
300 mM NaCl                                  8.76 g 
250 mM Imidazole                        8.51 g 
Water                                         ad 500 ml 
2.1.3.4 Buffers for plasmid isolation (miniprep)  
Buffer I (pH 8) Tris-HCl                    50 mM   1.5 g/250 ml 
EDTA                        10 mM   0.93 g/250 ml 
RNase A                   10µl/ml 
RNase A was added freshly before use 
Buffer II  NaOH                    0.2 M         2 g/250 ml 
SDS                     1% (w/v)     2.5 g/250 ml 
Buffer III (pH 5.5) K acetate                2.55 M      62.57 g/250 ml 
Glacial acetic acid to adjust pH  
2.1.3.5 Solution to determine the protein amount 
Bradford-dye 
solution 
Coomassie-Brilliant blue G-250     
100 mg 
Ethanol 96%    50 ml                              
o-phosphoric acid 85% w/v           
100 ml 
water ad 1000 ml 
The Coomassie-Brilliant blue G250 
powder was dissolve in ethanol by 
stirring. Orthophosphoric acid was 
added, and then the volume was 
completed with water. The solution 
was filter till no blue color could be 
seen It was kept protected from light in 
an amber glass bottle by 4C. 
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2.1.3.6 Solutions for PD10 washing and Ni-NTA agarose regeneration 
PD10 washing solution 
NaOH (0.15 M) 
Wash with 25 ml (5x column volume) then 
wash with water till getting a neutral eluent. 
Ni-NTA agarose washing and regeneration 
solution. Wash with the following solutions 
in the same order. 
0.2 M acetic acid 
30% glycerol 
Deionized water  
2.1.3.7 Buffer for enzyme assay 
Buffer KH2PO4 
100 mM 1.36 g 
dH2O ad 100 ml 
pH adjusted by KOH  
2.1.4 Materials used for molecular biology 
2.1.4.1 Host cells 
E. coli  Purpose Genotype 
DH5 
 
Deliver high yield plasmid preparation 
for downstream applications, 
chemically competent 
F'φ80δlacZ9M15endA1hsdR17(rk-
mk+)supE44thi1 λgyrA96relA19 
(lacZYA-argFV169) deoR 
BL21(DE3) pLysS 
 
For protein overexpression 
(Invitrogen), chemically competent 
F-, ompT hsdSB (rB- mB-) gal dcm 
(DE3) pLysS (CamR) 
2.1.4.2 Cloning vector 
pRSET-B vector  (protein expression)  Invitrogen 
2.1.4.3 Enzymes 
Name Purpose Supplier 
Pfu DNA polymerase  High fidelity amplification of DNA Thermo Scientific 
Phusion Hot Start II High 
fidelity DNA polymerase 
High fidelity amplification of DNA Thermo Scientific 
Dpn I Digest the parental DNA template and to 
select for mutation containing 
synthesized DNA 
Thermo Scientific 
Kpn I Endonucleolytic cleavage of DNA to 
give specific double-stranded fragments 
Thermo Scientific 
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with terminal 5'-phosphates 
RNase A Digestion of RNA by plasmid isolation Thermo Scientific 
2.1.4.4 Primers 
All the primers were synthesized in HPSF (High Purity Salt Free) quality at MWG-
Biotech AG (Ebersberg, Germany). 
 
 HaBPS mutation primers 
Designed according to (Zheng et al., 2004) 
 
HaBPSE54D Sen Tm 64.2°C 5'- CAC ATG ACC GAt CTC AAG GAG AAA TTT AAA C-3'   
Ha BPSE54D Ant Tm 70.8°C 5'- CTC CTT GAG aTC GGT CAT GTG CTC GCT GTT G-3'   
HaBPSV146A Sen Tm 75°C 5'- GCA GAC TAC Gct ATC ACC CGC CTC CTC GGC C-3'   
HaBPSV146A Ant Tm >75°C 5'- GCG GGT GAT agC GTA GTC TGC CCC GGG CAT C-3'   
HaBPSV359L Sen Tm 74.8°C 5'- G AGC TCC AAG cTC AAC GGG AAG CCC ACC ACC-3'   
HaBPSV359L Ant Tm 70.8°C 5'- C TT CCC GTT GAg CTT GGA GCT CTT CCT AAG C-3'   
HaBPSN360S Sen Tm >75°C 5'-CC AAG  GTC Agt  GGG AAG  CCC ACC ACC GGC-3'   
HaBPSN360S Ant Tm 72.3°C 5'-GGG CTT CCC acT GACCTT GGA GCT CTT CC-3'   
HaBPSC230G Sen Tm >75°C 5'- C ATC GGG GCA gGC CCT GAC GTT GCT TCT GGG -3'   
HaBPSC230G Ant Tm >75°C 5'- C GTC AGG GCc TGCCCC GAT GAT CAG AGCAGC -3'   
HaBPSS235A Sen Tm 75°C 5'- GAC GTT GCT gCT GGGGAG CGC GCA GTG TTC-3'   
HaBPSS235A Ant Tm >75°C 5'- GCG CTC CCC AGc AGCAAC GTC AGG GCA TGC-3'   
 
 HsBPST135L mutation primers  
Designed according to (Stratagene, 2005) 
HsBPST135L Sen Tm >75°C 5'-GAT CAC CCA CGT GGT GTT TGC GAC Cct cTC CGG 
GTT CAT GAT GCC CGG C-3' 
HsBPST135L Ant Tm >75°C 5'-GCC GGG CAT CAT GAA CCC GGA gag GGT CGC 
AAA CAC CAC GTG GGT GAT C -3' 
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 HsBPS mutation primers  
Designed according to (Zheng et al., 2004) 
 
HsBPST135A Sen Tm>74.5°C 5'- GTG TTT GCG ACC gcc TCC  GGG TTC ATG ATG CC-3' 
HsBPST135A Ant Tm >75°C 5'- GAA CCC GGA ggc GGT CGC AAA CAC CAC GTG G -3' 
HsBPST135G Sen Tm 74.6°C 5'-GTG TTT GCG ACC ggc TCC GGG TTC ATG ATG CC -3' 
Hs BPST135GAnt Tm >75°C 5'-GAA CCC GGA gcc GGT CGC AAA CAC CAC GTG GG  -3' 
HsBPST135D Sen Tm 73.3°C 5' –GTG TTT GCG ACC  gac TCC GGG TTC ATG ATG CC-3' 
HsBPST135D Ant Tm >75°C 5'-GAA CC GGA gtc GGT CGC AAA CAC CAC GTG GG -3' 
HsBPST135K Sen Tm 72.1°C 5'- GTG TTT GCG ACC aag TCC GGG TTC ATG ATG CC -3' 
HsBPST135K Ant Tm 74.6°C 5'- GAA CCC GGA ctt GGT CGC AAA CAC CAC GTG GG -3' 
HsBPST135W Sen Tm 73.3°C 5'-GTG TTT GCG ACC tgg TCC GGG TTC ATG ATG CC -3' 
HsBPST135W Ant Tm >75°C 5'-GAA CCC GGA cca GGT CGC AAA CAC CAC GTG GG -3' 
HsBPST135Y Sen Tm 72.1°C 5'-GTG TTT GCG ACC tac TCC GGG TTC ATG ATG CC-3' 
HsBPST135Y Ant Tm 74,6°C 5'-GAA CCC GGA  gta GGT CGC AAA CAC CAC GTG GG -3' 
HsBPST135I Sen Tm 72.1° C 5'-GTG TTT GCG ACC atc TCC GGG TTC  ATG ATG CC-3'   
HsBPST135I  Ant Tm 74.6° C 5'-GAA CCC GGA gat GGT CGC AAA CAC CAC GTG GG-3'   
HsBPST135V Sen Tm 73.3°C 5'-GTG TTT GCG ACC gtc TCC GGG TTC ATG ATG CC-3'   
HsBPST135V Ant Tm >75°C 5'-GAA CCC GGA gac GGT CGC AAA CAC CAC GTG GG-3'   
HsBPST135M Sen Tm 72.1°C 5'-GTG TTT GCG ACC atg TCC GGG TTC ATG ATG CC-3'   
HsBPST135M Ant Tm 74.6°C 5'-GAA CCC GGA cat GGT CGC AAA CAC CAC GTG GG-3'   
HsBPST135F Sen Tm 72.1°C 5'-GTG TTT GCG ACC ttc TCC GGG TTC ATG ATG CC-3'   
HsBPST135F Ant Tm 74.6°C 5'-GAA CCC GGA gaa GGT CGC AAA CAC CAC GTG GG-3'   
HsBPST135H Sen Tm 73.3°C 5'-GTG TTT GCG ACC cac TCC GGG TTC ATG ATG CC-3'   
HsBPST135H Ant Tm >75°C 5'-GAA CCC GGA gtg GGT CGC AAA CAC CAC GTG GG-3'   
 HpaBPS mutation primers 
Designed according to (Zheng et al., 2004) 
HpaBPST135L Sen Tm 73.3 5'- GTG TTT GCG ACC ctC TCC GGG TTC ATG ATG CC-3' 
HpaBPST135L Ant Tm >75°C 5'- GAA CCC GGA Gag GGT CGC AAA CAC GAC GTG GG-3' 
HpaBPST135I Sen Tm 72.1° C 5'-GTG TTT GCG ACC atc TCC GGG TTC  ATG ATG CC-3'   
HpaBPST135I  Ant Tm 74.6° C 5'-GAA CCC GGA gat GGT CGC AAA CAC CAC GTG GG-3'   
HpaBPST135K Sen Tm 72.1°C 5'- GTG TTT GCG ACC aag TCC GGG TTC ATG ATG CC -3' 
HpaBPST135K Ant Tm 74.6°C 5'- GAA CCC GGA ctt GGT CGC AAA CAC CAC GTG GG -3' 
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 HcBPS mutants primers 
Designed according to (Liu and Naismith, 2008) 
HcBPST135L Sen Tm >75°C 5'- GCT ACG ctC TCC GGG TTC ATG ATG CCA GGC GCG 
GAC TAC G -3' 
HcBPST135L Ant Tm >75°C 5'- CCC GGA Gag CGT AGC GAA CAC AAC GTG GGT GAT 
CTT GGA G -3' 
HcBPST135I Sen Tm >75°C 5'-GCT ACG atC TCC GGG TTC ATG ATG CCA GGC GCG 
GAC TAC G -3' 
HcBPST135I Ant Tm >75°C 5'-CCC GGA Gat CGT AGC GAA CAC AAC GTG GGT GAT 
CTT GGA G -3' 
HcBPST135K Sen Tm >75°C 5'-GCT ACG Aag TCC GGG TTC ATG ATG CCA GGC GCG 
GAC TAC G -3' 
HcBPST135K Ant Tm >75°C 5'-CCC GGA ctT CGT AGC GAA CAC AAC GTG GGT GAT 
CTT GGA G -3' 
 
2.2 Instruments 
Instrument Model Company 
Balance LA 230S Sartorius Germany Balance LA 230S Sartorius 
Autoclave Vx-120 Systec GmbH Labor-systemtechni Systec 
pH Meter Digital pH meter 325 WTW 
Centrifuge Universal 32R        Hettich 
Biofuge 13  
Avanti

- J-E Centrifuge 
Heraeus Sepatech 
Beckman Coulter 
Sigma 1-15K Sigma Centrifuges 
-80°C Freezer Hera Freeze  Heraeus 
Spectrophotometer  Ultrospect 1000  Pharmacia Biotech 
Incubator shaker  HT  Infors HT 
Thermo block Dri Block DB-3 Techne 
Water purification system  Arium 611 VF Sartorius, Germany 
Clean bench  LaminarAir HLB 2472  Heraeus 
Laminar Air HBB 2460 Heraeus 
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Instrument Model Company 
Heating circulator water bath  MW-4  Julabo 
Magnetic rotator VF2 IKA-Labortechnik 
(Janke & Kunkel) 
Ultrasonic Cell- Disruptor Sonifier 250 Branson (G. Heinemann) 
PCR cycler  T-Proffessional Gradient Biometra 
Gel documentation MultiImage TM Light Cabient Alpha In. Corp 
Electrophoresis Mini-Sub Cell BioRad 
Sub Cell GT BioRad 
Protein Chamber  Biometra 
LC-MS (ESI-MS)  3200 Q TRAP, Analyst 
version 1.4.2 software, N2 
collision gas. 
Applied Biosystems Sciex 
 
 
EI-MS double focussing sectorfield,  
Resolution: 2000 (10% 
valley definition), Source 
Temp.: 180 °C, Electron 
energy: 70 eV 
Thermofinnigan MAT 
(Bremen, Germany) 
 
HPLC Elite LaChrom series VWR-Hitachi 
 
 
 
 L-2200 auto sampler 
 quaternary L-2130 Pump 
equipped with low-
pressure gradient 
 L-2455 diode array 
detector 
 EZ Chrome Elite software  
Hyper Clone ODS column 
(C18, 250 x 4.6 mm, 3μm) 
Phenomenex 
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3 Methods 
3.1 General molecular biology methods 
3.1.1 Design of mutant primers 
3.1.1.1 Primers design according to the QuickChange SDM protocol 
The QuickChange

 site-directed mutagenesis System (QCM) developed by Stratagene 
‘La Jolla, CA’ (Zheng et al., 2004; Stratagene, 2005) is the simplest and most broadly usable 
protocol with this approach; the mutation is introduced in a single PCR with one pair of 
complementary primers containing the mutation of interest. The mutagenic primers for use in 
this protocol must be designed individually according to the desired mutation. The following 
considerations should be made for designing mutagenic site and selection primers: 1- Both of the 
mutagenic primers must contain the desired mutation and anneal to the same sequence on 
opposite strands of the plasmid. 2- Primers should be between 25 and 45 bases in length and the 
melting temperature (Tm) of the primers should be greater than or equal to 78°C. 3- The desired 
mutation should be in the middle of the primer with ~10–15 bases of correct sequence on both 
sides. 4- The primers optimally should have a minimum GC content of 40% and should 
terminate in one or more C or G bases. In this protocol (Fig. 19) the wild type and the two 
mutant primers are used. During the temperature cycling Pfu DNA polymerase extends the 
primers (containing the desired mutation). Annealing of the mutant primers produces a mutated 
plasmid containing staggered nicks. After the PCR reaction the product is treated with Dpn I. 
restriction enzyme which is specific for methylated and hemimethylated DNA. Dpn I is used for 
parental DNA template digestion and selection for mutation containing synthesized DNA. DNA 
isolated from almost all E. coli strains is methylated and digested by Dpn I. The last step is the 
transformation of the nicked plasmid containing the required mutations in DH5α competent 
cells. To decrease the possibility of random mutations through the PCR reaction, it is essential to 
use small amount of the template, high fidelity of the Pfu DNA polymerase, and decrease the 
number of thermal cycles. 
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Fig. 19  Schematic representation of the QuikChange® site-directed mutagenesis method  modified from; 
Loening, (2005). 
3.1.1.2 Primer design according to (Zheng et al., 2004) 
In this protocol, they developed a new primer design method based on the QuickChange

 
SDM protocol which significantly improves the PCR amplification efficiency. This design 
method minimizes primer dimerization and ensures the priority of primer-template annealing 
over primer self-pairing during the PCR. The simple and efficient modification for QCM stated 
in this protocol overcomes and eliminates the problems associated with primer pair self-
annealing. With this modification the primer can be designed as for routine PCR experiments 
since the Tm value of the primer does not appear to be a strict determining factor anymore. 
Partial overlapping automatically enlarges the Tm difference between primer to template 
annealing and primer-pair self-annealing. A few rules should be considered during designing the 
mutant primers based on this protocol. 1- At least eight non-overlapping bases should be 
introduced at the 3' terminus of the primer. 2- The targeted mutation (s) should be included into 
both primers, and a silent mutation should be present in at least one of them. 3- At least one G or 
C should be placed at the end of each terminus.  
3.1.1.3 Primer design according to (Liu and Naismith, 2008) 
They have developed a site-directed mutagenesis protocol that conserved the one step 
simple procedure of the QuikChange site-directed mutagenesis and at the same time enhances 
its efficiency. This modified protocol used a new primer design that enhanced primer-template 
annealing by removing primer dimerization and allowed the newly synthesized DNA to be used 
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as the template in subsequent amplification cycles. These two factors are the fundamental 
reasons for the enhanced amplification efficiency. This modified protocol mainly increased the 
efficiency of single and multiple mutations in a single experiment an option discordant with the 
standard QuikChange. Moreover, the new protocol required significantly less parental DNA 
which supported the DpnI digestion after the PCR amplification and enhanced the overall 
efficiency and reliability.  
3.1.2  Site-directed mutagenesis PCR (SDM-PCR) 
In this work, different approaches were used to get the mutant enzymes and all of them 
depend mainly on the simple one-step procedure of the QuickChange site-directed mutagenesis 
protocol from Stratagene. In this protocol the PCR technique was performed in order to make a 
point mutation in a DNA fragment that was inserted in a super coiled double-stranded DNA 
vector. Two synthetic oligonucleotide primers either completely or partially overlapping 
containing the desired mutation were designed (see 3.1.1). During extension of the mutagenic 
primers in PCR cycles catalyzed by Pfu or Phusion DNA polymerase a mutated plasmid 
containing nicked circular strands was generated and so the product of the reaction is never used 
as a template. This mean that, this is a linear amplification technique (except in case of the 
primers designed according to Liu and Naismith, (2008) in which the PCR product could be used 
as a template because the non-overlapping part is long enough to bridge the formed nick. A 
schematic presentation of the SDM-PCR amplification process is illustrated in (Fig.20). 
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Fig. 20  Schematic representation of mutagenesis PCR amplification processes, A: using the primers 
designed as recommended in the QuickChange protocol. PCR extension fails when primers annealed to 
the newly synthesized ‘nicked’ DNA. B: using primers designed according to Zheng et al., (2004). C: 
using the primer designed according to Liu and Naismith, (2008) to generate single-site mutation. The 
gray cycles represent the parental plasmid DNA, the cycles of dash lines represent the DNA amplified 
using the parental DNA as templates while the cycles of gapped dash line are the DNA amplified using 
the newly-synthesized DNA as templates. Arrows indicate the numbered primers; Triangles indicate the 
location of the mutations; Short bars indicate the ‘nicks’ in the newly synthesized DNA molecules. 
3.1.3 PCR program and reaction composition used for HsBPS mutants 
production 
The program used and the composition of each PCR reaction is slightly variable with 
each group of amino acids as follows: 
3.1.3.1 HsThr135Leu mutant  
The amounts used in the PCR reaction and the program are summarized in The following 
(Tab. 1). 
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Tab. 1  PCR reaction conditions and program used for HsT132L mutant production 
PCR reaction constituents PCR program 
10  pmol  
Sense mutagenic primer 
1.5 µl   Temp., °C Time Step 
10 pmol  
Anti-sense mutagenic primer 
1.5 µl  Lid Temp. 99                           preheating on 
Template DNA Plasmid 1 µl  95     Pause  
10 x Pfu buffer 5 µl  95  4  min                             Initial 
denaturation 
10 mM dNTP mix 1.5 µl  70  pause  
3 U/μl Pfu DNA polymerase 0.5 µl  95     30 sec                           Denaturation 
 Up to 50 μl PCR water x µl  60  45 sec                           Annealing 
  72  10 min 4 25             Extension 
  72  15 min                          Final
extension 
  15     pause  
3.1.3.2 HsThr135Ala, Asp, Gly, Lys, Trp and Tyr mutants 
The same previous conditions were used but the mutagenic primers were designed 
according to (Zheng et al., 2004).  
3.1.3.3 HsThr135Glu, Phe, His, Ile, Met and Arg mutants 
Also the (Zheng et al., 2004) method was used for designing the primers but we added 
10µl enhancer mixture prepared according to (Ralser et al., 2006) which is an effective, low-cost 
and concentration-dependent  PCR enhancer. It is a combination of betaine, dithiothreitol, and 
dimethyl sulfoxide that broadly enhanced the quantitative and/or qualitative output of PCRs 
especially in case of poor amplification of GC-rich DNA sequences.  
3.1.3.4 HsThr135Cys, Asn, Pro, Gln, Ser, and Val mutants 
For the production of this group of mutants, a different enzyme was used in addition to 
different PCR reaction composition and program, which are summarized in (Tab. 2). 
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Tab. 2  PCR reaction and program used for HsT135C, HsT135N, HsT135P, HsT135Q, HsT135S, and 
HsT135V mutants production 
PCR reaction constituents PCR program 
10 pmol Sense  
mutagenic primer 
1.5 µl   Temp., °C Time Step 
10 pmol Antisense  
mutagenic primer 
1.5 µl  Lid temp. 
99  
 preheating on 
Template DNA Plasmid 1 µl  98  Pause  
5 x Phusion GC buffer 10 µl  98  1 min                             Initial  
denaturation 
10 mM dNTP mix 1.5 µl  98  30 sec                           Denaturation 
2 U/μl Phusion Hot Start II 
 High fidelity DNA polymerase 
0.5 µl  68  30 sec                           Annealing 
 Up to 50 μl PCR water x µl  72  2 min  3  34             Extension 
  72  10 min                          Final extension 
  15     pause  
3.1.3.5 HaBPS, HpaBPS and HcBPS mutants  
The same previous reaction constituents were used with some PCR program 
modifications as shown in (Tab. 3). 
Tab. 3  PCR program used for HaBPS, HpaBPS, and HcBPS mutants 
Temperature (°C) Time Step 
Lid temp.99 °C                           preheating on 
98  Pause  
98  2.30 min                             Initial denaturation 
98    20 sec                           Denaturation 
68 45 sec                           Annealing 
72  3 min   3  34             Extension 
72  10 min                          Final extension 
15     pause  
 
All the SDM-PCR products were treated with DpnI to digest the parental DNA template 
and to select mutation-containing synthesized DNA. The DpnI enzyme is specific for methylated 
and hemimethylated DNA. After 2 h of incubation at 37°C, five µl of DpnI treated DNA was 
used for transformation in DH5α competent cells (3.1.6.1). 
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3.1.4 Agarose gel electrophoresis 
This method is used for analysis and separation of DNA and RNA based on their size and 
charge. Small DNA molecules migrate faster than larger molecules through the agarose matrix 
under effect of electric current. Based on the size range of DNA molecules in the sample agarose 
gel is prepared in ranges of 0.5-2% agarose in TAE buffer. The higher the proportion of agarose 
the smaller the pore sizes of the matrix and the slower the migration rate. In this study 1% 
agarose gel was used. Ethidium bromide is used for visualization of bands. It intercalates nucleic 
acid molecules and its fluorescence increases 20-fold after this binding. According to the number 
of samples, the corresponding volume of TAE buffer and agarose weight were mixed and boiled 
in a microwave. After cooling down ethidium bromide was added and then poured in the gel tray 
and left to solidify at room temperature. Samples were loaded on the gel after mixing with 
loading dye along with DNA or RNA ladder. Then samples were run in a gel chamber filled with 
TAE buffer and under electric current (220 V). The gel was developed till the visible dyes in the 
loaded sample migrate 2/3 the distance. The bands in the gel are visualized under UV-equipped 
transilluminator. 
3.1.5 Preparation of competent cells 
The foreign DNA-plasmid can be taken in E.coli cells treated with calcium ions 
(competent cells) to produce large quantities of the plasmid in a process known as 
transformation. Calcium ions increase the permeability of the cell membrane to the foreign 
DNA. Preparation of the competent cells was done according to modified methods (Mandel and 
Higa, 1970; Cohen et al., 1972; Dagert and Ehrlich, 1979). A single colony from an overnight 
agar plate or a sterile loopful from frozen culture was inoculated into 5 ml of LB medium and 
incubated at 37°C with shaking at 225 rpm overnight. One ml of this fresh culture was 
transferred to 50 ml LB medium. Incubated at 37°C with shaking at 225 rpm until the OD600 
reached 0.6-0.8. The culture was then chilled for 10 min on ice and the cells were harvested by 
centrifugation at 3000 rpm and 4°C for 10 min. The bacterial pellet was washed with 50 ml of 
ice-cold 0.1M CaCl2. Cells were harvested by centrifugation as above and re-suspended in 20 ml 
of 0.1M CaCl2. The cell suspension was then kept in ice for 20 minutes. After centrifugation and 
removing of the supernatant the pellets were re-suspended in 940 μl of 0.1M CaCl2 solution. 
After 15 min incubation on ice 140 μl glycerol was added. Afterwards, the competent cells were 
stored at -80°C as 50 μl aliquots until further use. 
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3.1.6 Transformation of plasmid DNA in E.coli 
3.1.6.1 Transformation into DH5α 
This strain of E. coli was used for plasmid maintenance; because it has high 
transformation efficiency and high plasmid yields. The following procedure was used: 50 μl E. 
coli DH5α competent cells from a -80 °C storage (3.1.5) were incubated 5 minutes in ice then 
addition of 1 μl of foreign plasmid DNA, mixing and incubation of the mixture on ice for 25 
minutes. Heat shock at 42 °C for 45 seconds was applied to force the foreign plasmid into the 
cells followed directly by 5 minutes incubation at 4 °C. In order to maximize transformation 
efficiency cells were allowed to grow in 250 μl SOC medium with continuous shaking at 37°C 
for 90 min. The whole bacterial suspension is plated on LB-agar medium containing ampicillin 
(100 μg/ ml).  
3.1.6.2 Transformation into BL21 (DE3) pLysS 
E. coli BL21 is mainly used for high-level of gene expression and production of 
recombinant protein in a bacterial system. The transformation procedure was the same as with 
DH 5α (3.1.6.1) except that the heat shock time was for 20 seconds and 700 μl SOC medium was 
used for growing bacterial culture. After one hour of incubation at 37°C about 100 μl of bacterial 
suspension was finally plated on LB-agar medium containing ampicillin (100 μg/ml) and 
chloramphenicol (60 μg/ml). Ampicillin resistance is acquired from the expression vector and 
chloramphenicol resistance is acquired from the host cells. Bacterial cultures containing 
plasmids with target insert were stored at -80°C in autoclaved solution of 20% glycerol/LB-
medium. This continuous culture from E. coli BL21 (DE3) containing the desired gene can be 
used as a permanent supply to start protein expression. 
3.1.7 Plasmid DNA isolation by minipreparation 
Plasmid isolation by alkaline hydrolysis was carried out as described by Birnboim and 
Doly (1979). A single colony of the transformed DH5 plate was inoculated into 5 ml LB 
medium containing 20µg/ml ampicillin and grown over night at 37C. In the second day, 2ml 
culture were centrifuged at 5000 rpm for 5 min. Bacterial pellets were resuspended in ice-cooled 
buffer I (300 µl) containing RNase A. Then buffer II (300µl) was added and the bacterial 
suspension was mixed by inverting cautiously 6 times and incubate at room temperature for 
maximum 5 min. Lysis of the cell wall took place in addition to denaturation of large 
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chromosomal DNA. RNA is destroyed by RNase I. Precipitation of proteins and denaturation of 
large chromosomal DNA were done by adding  ice-cooled buffer III (300 µl), gentle mixing by 
inversion upside-down 6 times and incubation on ice for 20 min. Centrifugation at 13.000 rpm 
for 10 min was done to exclude the denatured proteins and DNA. The clear supernatant 
containing the DNA solution (800 µl) was transferred to a new Eppendorf tube. Residual 
contaminants and hydrolysed protein were extracted by vortex with 800 µl chloroform followed 
by centrifugation at 13.000 rpm for 10 min. The aqueous layer was transferred to a new 
Eppendorf tube. Isopropanol (0.7 volume) was added, mixed and followed by centrifugation at 
13000 rpm for 30 min to precipitate plasmid DNA. The pellets were washed with 70% ethanol 
(500 µl) followed by centrifugation at 13.000 rpm for 10 min. The supernatant is discarded and 
the plasmid pellets are dried by 37C and then dissolved in 50 µl distilled water. This purified 
plasmid can be directly used after measuring the concentration as described in (3.1.8) for 
transformation (3.1.6) restriction analysis (3.1.9) or stored at -20 °C for further usage.  
3.1.8 Determination of the concentration of nucleic acids 
 Nucleic acids concentration was determined spectrophotometrically by measuring the 
absorbance value of the DNA or RNA samples at wavelength 260 nm. 10 µl samples were 
diluted (50) in water and measured in a 0.5 ml quartz cuvette. The concentration is determined 
by using the following equation (Sambrook et al., 2001). Concentration (C) = A260 x absorbance 
x dilution factor. Where A260 is the absorbance coefficient which equals 40 ng/μl for single-
stranded RNA or 50 ng/μl for double-stranded DNA. Purity of RNA was determined by 
measuring the ratio of absorbance at the wavelength 280 nm and 260 nm. Pure samples should 
have a ratio >1.5. Contaminations with proteins or phenolics would reduce this value due to their 
absorbance at 280 nm. 
3.1.9 Restriction analysis 
Restriction enzymes (endonucleases) are a group of enzymes which recognize a particular 
sequence of DNA bases and catalyze the cleavage of the double-stranded DNA. Plasmid DNA 
obtained from a normal spin mini preparation (3.1.7) was digested by KpnI restriction enzyme 
using the following restriction protocol.(Tab. 4). 
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Tab. 4  Restriction protocol used for KpnI digestion 
Plasmid DNA 2 μl 
10x restriction KpnI buffer 2 μl 
Restriction enzyme 0.5 μl 
 
The reaction was incubated at 37°C for 2 hours, the sample was loaded on an Agarose gel 
(3.1.4), the size of the band was visualized and confirmed under UV-light and the plasmid with 
target DNA was prepared for sequencing. 
3.1.10 Heterologous expression of recombinant protein in E. coli 
pRSET-B vector containing wild-type or mutated BPS was transformed in E. coli BL21-
Codon Plus (DE3) which was grown on agar plates containing ampicillin and chloramphenicol 
for selection. 10 ml LB medium containing 150 µg/ml ampicillin and 45 µg/ml chloramphenicol 
was inoculated with one colony and incubated on a shaker (225 rpm) at 37°C over-night (18 h). 
About 4 ml of the overnight culture was inoculated into 100 ml of the LB medium containing 
ampicillin (100 µg/ml). The cultures were grown at 37C until OD600 of 0.6-0.8 was reached. one 
ml sample was immediately taken before induction (non-induced control), centrifuged at 5000 
rpm for 5 min and the pellets were stored at -20°C until SDS-PAGE analysis. IPTG was added at 
final concentration of 0.5 mM in order to induce the production of the recombinant protein. The 
culture was then incubated in dark by shaking at 23C for 20 h and then a second one ml sample 
(induced control) was collected, centrifuged and stored at -20°C until SDS-PAGE analysis. 
Bacterial cells after IPTG induction were harvested by centrifugation at 5000 rpm and 4C each 
100 ml into two halves (50 ml). and stored at -20C for further use. Protein expression was done 
at low temperature to slow the metabolic processing of the bacteria and giving the chance for the 
protein to be folded in the right way. The aliquots of induced and control cultures were then 
analyzed for expression of the recombinant protein by SDS-PAGE analysis. 
3.1.11 Extraction of expressed proteins from E. coli cells 
Sonication (mechanical disruption of the cell wall) is a common method for breaking the 
cell wall and isolating the soluble protein. The frozen cell pellet from 50 ml culture (3.1.10) was 
re-suspended in 5 ml of lysis buffer with 20 mM imidazole, pH 8 at 4°C. Sonication of the cells 
was carried out on ice for 5 min at duty cycle 40% and output control of 1.5 using a Branson 
Sonifier B15. Cell debris was separated by centrifugation at 12000 rpm and 4ºC for 10 min. An 
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aliquot of the supernatant, after centrifugation had been taken as expressed protein control and 
stored at -20°C until SDS-PAGE analysis.  
3.1.12 Purification of His6 -tagged proteins by affinity chromatography 
Affinity chromatography principle is based on the specific interaction between the tagged 
protein needed to be purified and the affinity matrix. So that the over-expressed protein binds 
specifically to the matrix while the other proteins are washed away and the target protein will be 
eluted thereafter with a special buffer. In this study, the cDNA of BPS is cloned into a pRSET B 
vector which is constructed so that the N-terminus of the expressed enzyme is a sequence of six 
histidine residues which has high affinity for divalent cations such as Ni
2
. So the supernatant 
which contained either His6-BPS wild-type or its mutants as described in (3.1.11) was purified 
by using the nickel-nitrilotriacetic acid (Ni-NTA) protein purification system. 200 μl Ni-NTA 
were added to 3 ml cleared supernatant and the mixture was incubated with shaking at 4 °C for 
one hour to allow binding of the protein to the Ni ions. The slurry is transferred to an empty 
column and left to drop out the buffer. Unbound protein is eluted using washing buffer 4 ml (4 
times 1 ml each). The His6-tagged-fusion protein was eluted by using 2.5 ml (0.5 ml each) 
elution buffer which contained high concentration of imidazole. 
3.1.13 Buffer change and desalting of protein samples 
 Desalting (removal of imidazole used in elution buffer from the protein) was done by gel 
filtration through PD10 column equilibrated with 25 ml (5 x elution volume of column) of 0.1 M 
potassium dihydrogen phosphate buffer pH 7. Then 2.5 ml of the protein sample was loaded onto 
a PD10 column. Soluble proteins were eluted with 3.5 ml 0.1 M potassium dihydrogen phosphate 
buffer pH 7. 
3.1.14 SDS-PAGE gel electrophoresis 
SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) is the most 
common analytical technique used to separate and characterize proteins according to their 
molecular masses (Laemmli, 1970). It is also used to confirm the successful expression of cloned 
cDNAs in heterologous expression systems. Polyacrylamide gel consists of a polymerized 
mixture of acrylamide and bisacrylamide. Acrylamide alone forms linear polymers. The 
bisacrylamide introduces crosslinks between polyacrylamide chains. The 'pore size' is 
determined by the ratio of acrylamide to bisacrylamide and by the concentration of acrylamide. 
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Induction of polymerization is done by addition of ammonium per-sulfate (APS) which 
spontaneously decomposes to form free radicals and N,N,N′,N′-tetramethylethylenediamine 
(TEMED) which is a free radical stabilizer and usually included to induce and accelerate 
polymerization. Sodium dodecyl sulfate (SDS) is a detergent which has an anionic head group 
and a lipophilic tail. It binds non-covalently to proteins and causes proteins to denature and 
disassociate from each other. It also gives protein negative charge. In the presence of SDS the 
actual charge of a protein is masked. During SDS-PAGE all proteins migrate toward the anode. 
SDS-treated proteins have very similar charge-to-mass ratios and similar shapes. During PAGE 
the rate of migration of SDS-treated proteins depends only on the molecular mass. Glycerol in 
the sample buffer helps the samples to sink and settle down in the wells. Bromophenol blue is a 
small size dye whose particles migrate faster than any protein and will help in tracing the 
development of the gel. The protein samples are denaturated in the presence of the sample 
loading buffer (ratio 1:1) at 95C for 5 min. SDS-PAGE gel consists of 2 gels, stacking and 
resolving gels. In the stacking gel, proteins migrate through large pores and so no separation 
occurs only all the proteins in a sample will collect as a thin compact band at front of the 
resolving gel. The resolving gel has a narrower pore size and proteins will be separated 
according to their masses. Low molecular weight proteins will run faster than large molecular 
weight proteins. The ingredients of the resolving gel are mixed together in a flask. Then poured 
between the glass plates of the instrument and then water added to the surface to avoid air bubble 
and unsmooth surface formation. After 30 min, the gel polymerized and water is removed with a 
filter paper. The same procedure is carried out for the stacking gel except the addition of a comb 
to create the sample wells and no water is used. Protein samples are prepared as mentioned 
before. Bacterial pellets (from 1 ml bacterial suspension) are suspended in sample buffer (100 
µl). Denatured in the same way as protein samples. Samples are loaded on the gel and run at 35 
mA/200 V max supplied by a Standard Power Pack P25 (Biometra). The gel was run until the 
dye front reached the bottom. After electrophoresis, the protein bands of interest must be located 
in the gel by staining. The gel is stained by immersing in coomassie blue solution with gentle 
shaking for 30 min then de-stained by immersing in de-staining solution overnight.  
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3.2  Biochemical methods 
3.2.1 Determination of protein concentration by dye-binding assay 
This is a photometric protein assay which was carried out using the Bradford assay 
(Bradford, 1976). The principal of this assay depends on the interaction of Coomassie® Brilliant 
Blue G-250 with aromatic and basic amino acids of the protein. The negative charged sulfonate 
anions of the dye give charges to cationic amino acids which results in exposure of the 
hydrophobic part of the protein which by van der Waals forces interact with the phenyl residues 
of the dye. After this interaction with protein, the absorption maximum of the dye shifts from 
465 nm (red, free form) to 595 nm (blue, bound form). 10 μl of a protein sample was mixed 
gently with 90 μl buffer and 900 μl Bradford-dye solution, incubated for 5 minutes at room 
temperature and measured for the absorbance at 595 nm. The assay was performed in a cuvette 
of one cm width at 595 nm in an UV/VIS spectrophotometer. Protein concentrations were 
calculated from a calibration curve which was prepared using serial dilutions (from 1 µg/ml to 
10 µg/ml) of bovine serum albumin (BSA) stock solution (1 mg/ml).  
3.2.2 Enzyme assays 
3.2.2.1 Benzophenone synthases (BPSs) wild-types and mutants assays  
The standard assay was carried out in a final volume of 250 µl and contained the amounts 
summarized in (Tab. 5) for the starter and the extender CoAs (which equals 2.5 x their reported 
Km values) protein amounts, and buffer. After incubation at 35 °C for 10 min for all BPSs except 
HsBPS (30 °C) the reaction was stopped with 27.0 µl 50% acetic acid and the products were 
extracted twice with 250 µl ethyl acetate by vigorous mixing for 1 min and centrifugation at 
13.000 rpm for 10 min. The organic phases were dried under vacuum and the residue was 
dissolved in 50 µl of methanol for HPLC. Analysis of the enzymatic products was performed by 
HPLC. The detection wavelength was 306 nm (benzophenones), 317, 325 nm (phenylpyrones) 
and 279 nm (4-hydroxycoumarin). Standard solutions of reference compounds served for 
quantification. For LC-MS analysis of the new enzymatic products (quinolone alkaloid and 4-
hydroxycoumarin) the reaction volume, incubation time and the protein amount were increased 
to 500 µl, 60 min and 10 µg purified recombinant protein respectively. The reaction was stopped 
with 58 µl 50% acetic acid and the products were extracted three times with 500µl ethyl acetate 
by vigorous mixing for 1 min and centrifugation at 13.000 rpm for 10 min. The organic phases 
were collected in glass vials and dried under air. The products are dissolved 300 µl methanol and 
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purified using HPLC analytical column (Hyper Clone ODS column (C18, 250 x 3μm). The 
purified enzymatic products were analyzed using ESI MS/MS (3.3.2.1). 
Tab. 5  Benzophenone synthases assay 
 Starter- 
CoA 
Extender- 
CoA 
Protein 
amount 
Buffer Temp. °C Incubation  
Time  min. 
HsBPS 
(Huang et al., 2012) 
40 µM 232 µM 2 µg 
 
0.1M 
KH2PO4 
(pH 7.0) 
30 10  
HaBPS 
 (Liu et al., 2003) 
22 µM 79 µM 35 10  
HcBPS 
(Zodi, 2011) 
27 µM 39 µM 35 10  
HpaBPS  
(Tocci, 2013) 
10 µM 36 µM 35 10  
3.2.3 HPLC analysis of enzyme assays 
Analysis of enzymatic products including benzophenones, phenylpyrones, 4-
hydroxycoumarin and quinolone alkaloids were carried out on HPLC. The mobile phase 
consisted of water containing 0.1% phosphoric acid (A) and methanol (B). The HPLC method 
gradient and the detection wave lengths are represented in (Tab.6).  
Tab. 6  HPLC method gradient and detection wavelengths 
Gradient Compounds analyzed Detection  (max, nm) 
Time (min) Methanol (%)  
Benzophenones 
 
Phenylpyrones 
 
4-Hydroxycoumarins 
 
Quinolones 
 
306  
 
317, 325 
  
279 
 
270  
0 30 
2 30 
15 80 
18 90 
20 95 
23 95 
25 30 
33 30 
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3.2.4 Characterization of the over-expressed proteins 
3.2.4.1 Determination of pH and temperature optima 
The incubations were carried out as in (3.2.2.1) at pH values from 5.5 - 9 in 0.1M 
KH2PO4 buffer with 2 µg purified protein at 37°C for 10 min. Then the enzymatic products were 
analyzed by HPLC and the optimum pH was determined. At the optimum pH value another 
series of incubations were performed at different temperatures between 20 to 50 °C.  
3.2.4.2 Determination of substrate specificity  
At the pH and temperature optima, BPS mutants assays were performed using malonyl-
CoA as extender substrate and a series of starter substrates: benzoyl-CoA, 2-hydroxybenzoyl-
CoA, 3-hydroxybenzoyl-CoA, p-hydroxybenzoyl-CoA, anthraniloyl-CoA, N-
methylantheraniloyl-CoA, 2-mercaptobenzoyl-N-acetylcysteamine, 2-methoxybenzoyl-N-
acetylcysteamin. After incubation (at 30 °C for 5 min in KH2PO4 buffer pH 7.0) the products 
were extracted and analyzed by HPLC.  
3.2.4.3 Linearity with protein amount and incubation time 
The amount of the formed enzymatic products was determined as a function of the 
protein amount in the standard assay (0.145 -14.5μg) and incubation time (2, 4, 6, 10, 15, 20, 25, 
and 30 min). 
3.2.4.4 Determination of kinetic data 
The kinetic properties of BPS mutants were determined using different concentrations of 
benzoyl-CoA or 2-hydroxybenzoyl-CoA at a saturating concentration of malonyl-CoA or using 
different concentrations of malonyl-CoA at a saturating concentration of benzoyl-CoA or 2-
hydroxybenzoyl-CoA. The used concentrations of these substrates were summarized in (Tab. 7). 
The protein amount used was 1.5 μg per assay and the incubation time for HsBPS mutants was 5 
min. 2 μg protein and 10 min incubation time were chosen for HaBPS mutants so that the 
reaction velocity was linear during the assay period. The apparent Km values for the HsBPS 
mutants substrates were calculated using Hyper 32, a hyperbolic regression program for the 
analysis of enzyme kinetic data (http://homepage.ntlworld.com/john.easterby/software.html). 
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Tab. 7  Concentrations of starter and extender -CoAs used for the determination of the kinetic data of BPS 
mutants 
Mutant 2-Hydroxybenzoyl-CoA (mM) Benzoyl-CoA (mM) Malonyl-CoA (mM) 
HsT135K 0.003- 0.144   0.149- 4.46  
HsT135L  0.002- 0.061  0.149- 2.25  
HsT135I  0.003- 0.129  0.112- 3.5  
HaV146A/T135K 0.003- 0.252   0.037- 2.35  
HaE54D  0.005- 0.044  0.037- 0.3  
HaV146A  0.005- 0.202  0.037-0.374  
HaC230G  0.003- 0.044 0.02- 0.3  
HaV359L  0.005- 0.044  0.037- 0.3  
HaN360S  0.005- 0.055  0.037- 0.3 
3.3 Chemical methods 
3.3.1 Chemical synthesis of acyl-CoAs, 2-hydroxy- and 2-aminobenzoyl-CoAs 
Synthesis of 2-hydroxybenzoyl-CoA (salicoyl-CoA) and 2-aminobenzoyl-CoA 
(anthraniloyl-CoA) was performed according to (Lapidot et al., 1967; Stöckigt and Zenk, 1975). 
The synthesis consists of two steps. In the first step synthesis of N-hydroxysuccinimide ester 
(NHS) intermediate was done and in the second step transesterification of  NHS ester with the 
free CoASH was performed. 
3.3.1.1 Synthesis of NHS ester of 2-hydroxy and 2-aminobenzoic acid 
2-Hydroxybenzoic acid (2.07 g, 15 mM) or 2-amino benzoic acid (2.06 g, 15 mM) was 
dissolved under heating (50 C) in 75 ml dichloromethane then 1.73 g (15 mM) of N-
hydroxysuccinimide (NHS) was added. The previous solution was cooled to 30 C and then 3.5 g 
(17 mM) of N,N dicyclohexylcarbodiimide (DCC) were added. The reaction mixture was left for 
16 hours at room temperature (with continuous gentle stirring for the first 6 hours then left 
stagnant). Dicyclohexyl urea was removed by filtration twice. The filtrate (CH2CL2) was washed 
with 1 M (21 g/250 ml H2O) sodium bicarbonate (NaHCO3) three times (75 ml each) and then 
three times with water (75 ml each). The wash was rejected. The filtrate (CH2CL2) was dried 
over anhydrous sodium sulfate and evaporated under vacuum. The resulting residue contained N-
hydroxysuccinimide ester of 2-hydroxy or 2- amino benzoic acid. These intermediates was 
purified on a silica gel column (60 g, 20 x 2.5 cm). Elution was done using petroleum ether: 
ethyl acetate 7:3 (to remove all impurities) followed by CH2CL2 to elute the target compound. 
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Fractions of 100 to 250 ml were collected and monitored by using silica gel plates solvent 
system petroleum ether: ethyl acetate: methanol (6:2.5:1.5) as developer and UV light for 
detection of the spots. Fractions containing the intermediate ester were collected and evaporated 
to dryness before the ester was identified by mass spectrometry (Fig. 45, 46). 
3.3.1.2 Transesterification of 2-hydroxy and 2-aminobenzoic-NHS esters  
In 5 ml water 55 mg NaHCO3 (to adjust pH 7.5-8) and 50 mg free CoA was dissolved. 80 
mg of intermediate ester was dissolved in 4 ml acetone and add to the previous solution. In order 
to get a high yield of the product the previous mixture should be in a single phase by addition of 
excess amounts of acetone which also maintain the homogeneity of the solution (Al-Arif and 
Blecher, 1969). N2 gas was applied for two minutes then the solution was kept for 18 h at 4° with 
continuous gentle stirring. 245  l (1:10) formic acid was added at the end of the reaction to 
precipitate the product and all of the excess reactants. Acetone was evaporated under vacuum at 
room temperature. The aqueous phase was extracted with ethyl acetate three times (5 ml each). 
Discard ethyl acetate which contains the unreacted esters. The remaining aqueous phase was 
measured. 
3.3.1.3 Purification of the CoA esters 
Purification of 2-hydroxy and 2-aminobenzoyl-CoA esters was carried out according to 
(Beuerle and Pichersky, 2002) by using LC-18 solid-phase extraction cartridges (SPE) (Supelco, 
1 g). The column was washed with 10 ml methanol, dH2O and then with 4% ammonium acetate 
solution to remove any traces of water (5 column volumes each). The previously measured water 
phase was mixed with equal volume of 8% ammonium acetate to a final concentration of 4%. 
The mixture was loaded on the preconditioned column. The column was washed with 4% 
ammonium acetate solution until the effluent showed no free CoASH (determined by 
spectrophotometer at max 261nm). The CoA esters were eluted by distilled water. Fractions 
containing the CoA esters were detected by their UV spectrum and then lyophilized overnight. 
LC-MS analysis was performed for the lyophilized product. 
3.3.1.4 Electrospray ionization-mass spectrometry for 2-aminobenzoyl-CoA 
Purified 2-aminobenzoyl (anthraniloyl)-CoA (0.1 mM) was analyzed using ESIMS/MS 
by direct infusion with a flow rate of 10 μl/min. Mass spectrometric analysis was performed in 
the ESI negative Enhanced MS mode (EMS
-
). MS/MS experiments were carried out using 
Enhanced Product Ion Scan in ESI negative mode (EPI-). Instrument setting and mass 
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standardization during the whole fragmentation pattern was dependent on the molecular ion peak 
[MH]. The method parameters are summarized in (Tab. 8). 
Tab. 8  Method parameters used in ESI-MS and ESI-MS/MS for 2-aminobenzoyl (anthraniloyl)-CoA 
Parameter/Experiment EMS

 EPI

 
Curtain Gas  10 psi 10 psi 
Collision Gas  high high 
Ion Spray Voltage  4500 V 4500 V 
Heater    
Ion Source Gas 1  10 psi 10 psi 
Ion Source Gas 2   
Declustering Potential   100 V 100 V 
Entrance Potential  10 V 10 V 
Collision Energy  10 V 48 V 
Collision Cell Entrance potential  19.06 V 44.41 V 
3.3.2 Synthesis of 2-methoxy and 2-mercaptobenzoyl-NAC esters  
Synthesis of these two compounds as -NAC thioesters was carried out according to (Suo 
et al., 2000). (1 eq) of 2-methoxybenzoic acid or 2-mercaptobenzoic acid was dissolved in 10 ml 
tetrahydrofuran (THF). (1.2 eq) 1-hydroxybenzotriazole dissolved in another 10 ml THF. DCC 
(1.2 eq) is also dissolved in 10 ml THF. The three solutions were mixed together in one flask. 5 
eq N-acetylcysteamin was added. The reaction mixture was stirred for 1 h at room temperature 
then K2CO3 (1eq) was added and the stirring continued for another 2 hours. The solution was 
filtered and the filtrate was evaporated to dryness under vacuum. The resulting residue was 
dissolved in 15 ml ethyl acetate, washed with 15 ml 10% NaHCO3 solution once and then 
washed with 15 ml distilled water twice. The solution was dried over anhydrous Na2SO4 and 
concentrated under vacuum. The residue was purified using a silica gel column (60 g, 20 x 2.5 
cm). Elution was carried out using 1-5% MeOH/CH2CL2 to give NAC thioester. The identity of 
the product was checked by EI mass spectrometry. 
3.3.2.1 Electrospray ionization mass spectrometry for enzymatic products 
HPLC purified enzymatic products (10 µg/ml) of HsBPS wild type, HsT135K and 
HsT135L mutants were analyzed using ESI-MS/MS. Mass spectrometric analysis was performed 
in the ESI positive Enhanced MS mode (EMS
+
) for the whole compounds. For further 
confirmation of 4-hydroxy-1-methyl-2(1H)-quinolone product the ESI negative Enhanced MS 
mode (EMS
-
) was done. MS/MS experiments were carried out using Enhanced Product Ion Scan 
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in +ESI positive mode (EPI
+
) for the whole compounds and -ESI negative mode (EPI
-
) for 4-
hydroxy-1-methyl-2(1H)-quinolone confirmation. Instrument setting and mass standardization 
during the whole fragmentation pattern was dependent on the molecular ion peak. The method 
parameters are summarized in (Tabs. 9, 10). 
Tab. 9  Method parameters of ESI-MS used for enzymatic products identification 
Parameter/Experiment EMS

 EPI

 
Curtain Gas  10 psi 10 psi 
Collision Gas  high high 
Ion Spray Voltage  5500 V 5500 V 
Heater    
Ion Source Gas 1  14 psi 14 psi 
Ion Source Gas 2   
Declustering Potential   51 V 51 V 
Entrance Potential  5.5 V 5.5 V 
Collision Energy  10 V Depend on the compound
 
 Collision Cell Entrance potential  14.34 V 
Compound  Collision Energy
 
Collision Cell Entrance potential
 
1: 2,4,6 Trihydroxybenzophenone 30 16.61 
2: 6-Phenyl-4-hydroxy-2-pyrone 30 15.43 
3: 2,3',4,6-Tetrahydroxy-benzophenone 35 17.06 
4: 6-(3-Hydroxy-phenyl)-4-hydroxy-2-pyrone 30 15.88 
5: 4-Hydroxycoumarin 35 14.71 
6: 4-Hydroxy-2(1H)-quinolone 35 14.68 
7:4-Hydroxy-1-methyl-2(1H)-quinolone 52 15.07 
Tab. 10  Method parameters of ESI-MS used for 4-hydroxy-1-methyl-2(1H)-quinolone confirmation 
Parameter/Experiment EMS

 EPI

 
Curtain Gas  10 psi 10 psi 
Collision Gas  high high 
Ion Spray Voltage  -4500 V -4500 V 
Heater    
Ion Source Gas 1  14 psi 14 psi 
Ion Source Gas 2   
Declustering Potential   -20 V -20 V 
Entrance Potential  -10 V -10 V 
Collision Energy  -10V -10V 
Collision Cell Entrance potential  -17.21 V -18.09 V 
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4 Results 
4.1 Site-directed mutagenesis of Hypericum sampsonii BPS (HsBPS)  
HsBPS is one of the plant type III PKSs. In most of these PKSs, threonine residues 
occupy three active site positions (135, 197, and 200 corresponding to alfalfa CHS2 132, 194, 
and 197) (Austin et al., 2004). The hydroxyl groups of threonines in these three positions are 
supposed to help driving and trapping polyketide intermediates using polar and/or hydrogen 
bonding interactions along the growing polyketide chain (Ferrer et al., 1999; Austin and Noel, 
2003) It was shown that threonines in position 132 and 197 are involved in cyclization 
specificity in STS (Austin et al., 2004) and CHS respectively (Jez et al., 2000). Recently (Klundt 
et al., 2009) reported that replacement of Thr135 by leucine transformed HaBPS into 
phenylpyrone synthase (PPS) but the replacement of the Thr135 residue with glycine, alanine, 
valine, isoleucine, asparagine, and tyrosine instead of a leucine gave catalytically inactive 
proteins. Basically in this work we are interested in the position Thr135 in additional BPSs from 
different Hypericum species like Hypericum sampsonii (HsBPS) (Huang et al., 2012), 
Hypericum calycinum (HcBPS) (Zodi, 2011) and Hypericum perforatum  ssp angustifolium 
(HpaBPS) (Tocci, 2013) which were recently cloned in our work group. All of these Hypericum 
BPSs are identical in the amino acids lining the active site cavity especially in the amino acid of 
interest (Thr135) which is conserved in all of them. The amino acids which are different between 
these Hypericum BPSs are located away from the active site. Initially we started with HsBPS to 
test different amino acids instead of Thr in position 135. 
4.1.1 Detection of enzyme activity of wild-type HsBPS 
First we had to reproduce the results of Huang et al. (2012) which were published about 
the activity of wild-type HsBPS. The highest activity was found with benzoyl-CoA (Fig. 21, a). 
It forms 2,4,6-trihydroxybenzophenone as a major product. In addition, a small amount of 4-
hydroxy-6-phenylpyran-2-one as a side product was detected. HsBPS also accepts 3-
hydroxybenzoyl-CoA as the second best substrate (Fig. 21, b) forming 2,3',4,6-
tetrahydroxybenzophenone as major product and 4-hydroxy-6-(3-hydroxy) phenylpyran-2-one as 
a side product which is formed by only two decarboxylative condensations with malonyl-CoA. It 
also accepts 2-hydroxybenzoyl-CoA, anthraniloyl-CoA and N-methylanthraniloyl-CoA forming 
small amounts of 4-hydroxycoumarin, 4-hydroxy-2(1H)-quinolone and 4-hydroxy-1-methyl-
2(1H)-quinolone (Fig. 21, c, d and e) respectively. All the results were confirmed by the UV 
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spectra, Rt values and LCMS/MS (4.1.7) analysis for the major enzymatic products. 
Quantification of the products was done by using standard solutions of the available respective 
authentic reference compounds. HsBPS is inactive with 4-hydroxybenzoyl-CoA, 2-
mercaptobenzoyl-N-acetylcysteamine and 2-methoxybenzoyl-N-acetylcysteamine. Control 
incubations with boiled enzyme lacked the respective enzymatic products. 
   
  
 
Fig. 21  HPLC analysis of wild-type HsBPS assays with a- benzoyl-CoA, b- 3-hydroxybenzoyl-CoA, c- 
2-hydroxybenzoyl-CoA, d: anthraniloyl-CoA, e: N-methylantraniloyl-CoA.  
 
1: 2,4,6-trihydroxybenzophenone. 2: 6-phenyl-4-hydroxy-2-pyrone, * unidentified peaks. 
3: 2,3',4,6-tetrahydroxybenzophenone, 4: 6-(3-hydroxy-phenyl)-4-hydroxy-2-pyrone,  
5: 4-hydroxycoumarin, 6: 4-Hydroxy-2(1H)-quinolone, 7: 4-hydroxy-1-methyl-2(1H)-quinolone,  
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4.1.2 Single mutations of wild-type HsBPS 
H. sampsonii wild-type BPS accepts and prefers benzoyl-CoA as starter substrate and 
catalyzes its condensation with three molecules of malonyl-CoA forming 2,4,6-
trihydroxybenzophenone as main product and a small amount of 4-hydroxy-6-phenylpyran-2-one 
as side product. The first aim was investigating the effect of replacement of Thr135 with the 
other 19 amino acids (Fig. 86 appendix) on the catalytic activity, substrate and product 
specificities of H.sampsonii BPS. 
4.1.2.1 SDM-PCR to produce HsThr135Leu mutant  
The polar amino acid threonine in position 135 in HsBPS was changed to non polar 
leucine by site-directed mutagenesis (Fig. 22, a). The resulting mutation is identified in that the 
first letter indicates the original amino acid at the corresponding position in the wild-type HsBPS 
protein and the last letter indicates the newly introduced amino acid. Under the PCR conditions 
described in (3.1.3.1) and the HsBPS mutagenic primers based on the QuickChange site-
directed mutagenesis protocol (Stratagene, 2005) were used. Actually, primers designed using 
this protocol were successful only with leucine and failed with other amino acids due to the high 
GC content of HsBPS especially in the mutation part. In addition, primer dimer formation is 
favored due to the complete overlapping between the primer pairs. 
4.1.2.2 SDM-PCR to produce HsThr135Asp, Gly, Lys, Trp, Tyr and Ala mutants 
In order to get this group of mutants (Fig. 22, c), six partially overlapping mutant primers 
were designed following the Zheng et al. (2004) method. This partial overlapping minimizes 
primer-self annealing, emphasizes primer-template annealing and will thus improve the PCR 
amplification efficiency. 
4.1.2.3 SDM-PCR to produce HsThr135Glu, Phe, His, Ile, Met and Arg mutants 
For this group of enzyme mutants (Fig. 22, e) we also designed a group of partially 
overlapping primers following the method mentioned by Zheng et al. (2004) but we were not 
able to get any product except by addition of 10 µl of enhancer mixture (Ralser et al., 2006). 
This is a low-cost concentration-dependent PCR enhancer which consists of a combination of 
betaine, dithiothreitol, and dimethyl sulfoxide and widely enhances the PCR yield especially in 
high GC content genes. 
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4.1.2.4 SDM-PCR to produce HsThr135Cys, Asn, Pro, Gln, Ser, and Val mutants 
A lot of trials were done to get this group of mutants (Fig. 22, g) although the primers 
were designed using the same method (Zheng et al., 2004). No product was detected after the 
SDM-PCR amplification reaction. The only successful trial was achieved by changing the 
enzyme from Pfu DNA polymerase to Phusion Hot Start II DNA polymerase. 
4.1.3 DpnI digestion of the sequences for the 19 HsBPS mutants 
The resulting 19 SDM-PCR amplification products (which contained the remaining wild-
type strand) used as a template and the newly formed mutated plasmids with staggered nicks 
were subjected to DpnI digestion. This is an endonuclease (target sequence 5´-Gm6ATC-3´) 
specific for methylated and hemimethylated DNA and is used to remove the wild-type DNA 
template.  
4.1.4 Transformation, plasmid isolation and restriction analysis of HsBPS mutant 
sequences 
Transformation of the HsBPS mutant sequences in E coli DH5α was performed as 
described in (3.1.6.1) followed by plasmid isolation (3.1.7) and then restriction analysis (3.1.9) 
for size confirmation (Fig. 22, b, d , f, and h). All the mutated plasmids with target DNAs were 
confirmed by sequencing. 
4.1.5 Expression of sequences encoding HsBPS and its mutants 
Confirmation of the over-expression of HsBPS wild-type and its mutants (HsThr135Asp, 
Gln, Pro, Lys, Ile and Leu) was done by means of SDS-PAGE analysis (3.1.14). The following 
fractions were analyzed: crude bacterial protein extracts before and after induction, the soluble 
portion of the protein extract after induction and the affinity-purified proteins (Fig. 23, A, B,  and 
C). Protein bands were stained with Coomassie brilliant blue. Both the HsBPS wild-type and the 
mutants had subunit molecular masses of about ~43 kDa however, the Hs T135D, T135Q and 
T135P mutants did not show any over-expression in the host cells 
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Fig. 22  SDM-PCR amplification products of HsBPS mutants a: Leu. c: Asp, Gly, Lys, Trp, Tyr, and Ala. 
e: Glu, Phe, His, Ile, Met, and Arg. g: Cys, Asn, Pro, Gln, Ser, and Val. KpnI digestion for size 
confirmation of HsBPS sequences with single mutations, b: Leu. d: Asp, Gly, Lys, Trp, Tyr,  and Ala. f: 
Glu, Phe, His, Ile, Met, and Arg. h: Cys, Asn, Pro, Gln, Ser, and Val. 
 Agarose gel electrophoresis  
of SDM PCR amplification products. 
Agarose gel electrophoresis  
of the mutated sequences after KpnI digestion. 
  
    
 
    
  
 
 
  
  
 
 
 
  
 
 
 
g h 
a b 
c d 
e f 
4.2 kb 
  Cys    Asn    Pro     L    Gln   Ser   Val    L    Cys    Asn    Pro   Gln   Ser   Val 
 Glu    Phe    His     L     Ile   Met    Arg    L     Glu    Phe   His    Ile    Met    Arg 
4.2 kb 
4.2 kb 
   L     Asp    Gly    Lys   Trp     Tyr    Ala    L     Asp    Gly    Lys   Trp   Tyr   Ala 
4.2 kb 
    L             Leu     L             Leu 
L: DNA Ladder Mix   
(Thermo Scientific) 
 
Results 
 
71 
 
A 
 
 
B 
 
 
C 
 
      
Fig. 23  SDS-PAGE demonstrating the purification by the Ni-NTA system, A: HsBPS wild-type and 
HsT135K, B: HsT135I and T135L mutants, C: HsT135D, HsT135Q and HsT135P mutants.  
M: protein marker, 1: pre-induction, 2: post-induction, 3: soluble protein, 4: affinity-purified protein (10 
µg). 
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4.1.6 Testing the activities of the HsBPS single mutants  
Each PCR-mutated plasmid was transferred in E.coli BL21 as described in (3.1.6.2) for 
protein over-expression. The Ni-NTA system was used for the purification of the His6-tagged 
HsBPS mutants (3.1.12) which were then subjected to BPS assays (3.2.2.1) using HPLC (3.2.3) 
to characterize their catalytic activity and substrate specificity (3.2.4). The activities of the 
affinity-purified single mutants with various starter substrates were determined in (ng/assay) and 
compared with those of HsBPS wild-type. All the results are summarized in (Tab. 11). From the 
tested 19 amino acids, three of them showed no over-expression in the host cells (HsT135D, 
HsT135Q and HsT135P) and the others either decreased the activity markedly (HsT135E, 
HsT1135R, HsT135G, HsT135W, and HsT135Y) when compared to the wild-type HsBPS or 
they gave mutants which were more or less similar to the wild-type in their activity with 
different starter substrates. HsT135K, HsT135L and HsT135I mutants showed dramatic changes 
in the product and substrate specificities. Notably, the HsT135K mutant preferred 2-
hydroxybenzoyl-CoA as a starter substrate forming 4-hydroxycoumarin as main product (Fig. 
24, c). It catalyzes a single decarboxylative condensation with malonyl-CoA to form an 
intermediate diketide which undergoes intramolecular cyclization and enolization yielding 4-
hydroxycoumarin  (Liu et al., 2010). The HsT135L and HsT135I mutants prefer benzoyl-CoA 
forming 4-hydroxy-6-phenylpyran-2-on as main product (Figs. 25, a and 26, a). They catalyze 
iterative condensation of one benzoyl-CoA with two malonyl-CoAs forming a triketide 
intermediate which undergoes cyclization via C-5 keto-enol oxygen to C-1 and thus lactonization 
into phenylpyrone (Klundt et al., 2009). Interestingly, anthraniloyl and N-methylanthraniloyl-
CoAs were accepted as substrates forming 4-hydroxy-2(1H) quinolone and 4-hydroxy-1-methyl-
2(1H)-quinolone products respectively (Fig. 25, d and e). Nothing was reported about the 
acceptance of BPSs to anthraniloyl and N-methylanthraniloyl-CoA substrates and formation of 
quinolone alkaloids. Remarkably, HsT135K, HsT135L and HsT135I mutants showed higher 
activity with anthraniloyl-CoA than with N-methylanthraniloyl-CoA unlike benzalacetone 
synthase (BAS) from Rheum palmatum (Polygonaceae). This is a diketide-producing PKS and 
can efficiently catalyze condensation of N-methylanthraniloyl-CoA or anthraniloyl-CoA with 
malonyl-CoA or methylmalonyl-CoA to produce 4-hydroxy-2(1H)-quinolones. It was reported 
that the activity with N-methylanthraniloyl-CoA and anthraniloyl-CoA is 80% and 4%, 
respectively (Abe et al., 2006). Incubation with heat-denatured protein failed to show any 
activity indicating the enzymatic origin of the formed products. Identification of the enzymatic 
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products was done in comparison to authentic reference compounds by co-chromatography, UV 
spectroscopy and LC-MS/MS (4.1.7) analysis of the major enzymatic products. All the HPLC 
chromatograms of the HsT135K, HsT135L, and HsT135I assays are represented in (Figs. 24, 25, 
and 26). 
Tab. 11  Effect of replacement of Thr135 in HsBPS with different amino acids on the product formation 
profiles with various starter substrates. Amounts of the products were calculated in ng/assay. The final 
volume of the assay was 125 µl, and 2 µg protein and 10 min incubation time at 30 C were used. 
Interesting changes compared to the wild-type are highlighted in bold. 
  Benzoyl-CoA 3-Hydroxybenzoyl-CoA Salicoyl-CoA 
 Enzyme mutant 2,4,6-
trihydroxy-
benzophenone 
 
6-phenyl-4-
hydroxy-2-
pyrone 
 
2,3',4,6-
tetrahydroxy-
benzophenone 
 
6-(3-hydroxy-
phenyl)-4-
hydroxy-2-pyrone 
4-hydroxy- 
coumarin 
1  T135D (aspartic acid)  No expression 
2  T135Q (glutamine)  No expression 
3  T135P (proline)  No expression 
4 HsBPS wild-type 135 5 95.6 4.3 7 
5  T135E (glutamic acid)  No product 10.9 No product 4.5 No product 
6  T135R (argenine)  No product 2.1  No product 1.5  No product 
7  T135G (glycine)  2.1 2 1.5  3  7.8  
8  T135W (tryptophane)  No product 3  No product  2.5  15.3  
9  T135Y (tyrosine)  2  13.9 No product 2.7 5.7 
10 T135A (alanine) 62.3 45.3 20.2 67.9 12.3 
11 T135V (valine) 29 36.6 18.3 68.5 6.9 
12 T135L (leucine) 4.4 226.6 5.8 160.4 7.4 
13 T135I (isoleucine) 3.6 250.8 No product 102 7 
14 T135K (lysine) No product 4.8 No product 1.7 175.8 
15 T135M (methionine) 32.9 76 No product 85 44.6 
16 T135F (phenylalanine) No product 12.5 No product 3.5 30.8 
17 T135H (histidine) No product 21.5 No product 14.7 12.9 
18 T135N (aspragine) 22.3 2.8 29.7 18.4 3 
19 T135S (serine) 124.7 18.2 69.2 40.7 13 
20 T135C (cysteine) 50.8 17.6 40.1 42.1 5.9 
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Fig. 24  HPLC analysis of HsT135K assays with, a: benzoyl-CoA, b: 3-hydroxybenzoyl-CoA, c: 2-
hydroxybenzoyl-CoA, d: anthraniloyl-CoA, e: N-methylantraniloyl-CoA. 
2: 6-phenyl-4-hydroxy-2-pyrone, 4: 6-(3-hydroxy-phenyl)-4-hydroxy-2-pyrone, 5: 4-hydroxycoumarin, 6: 
4-hydroxy-2(1H)-quinolone, 7: 4-hydroxy-1-methyl-2(1H)-quinolone, *: unidentified peaks. 
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Fig. 25  HPLC analysis of HsT135L assays with a: benzoyl-CoA, b: 3-hydroxybenzoyl-CoA, c: 2-
hydroxybenzoyl-CoA, d: anthraniloyl-CoA, e: N-methylantraniloyl-CoA. 
 2: 6-phenyl-4-hydroxy-2-pyrone. 4: 6-(3-hydroxy-phenyl)-4-hydroxy-2-pyrone, 5: 4-hydroxycoumarin, 
6: 4-hydroxy-2(1H)-quinolone, 7: 4-hydroxy-1-methyl-2(1H)-quinolone, *: unidentified peak. 
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Fig. 26  HPLC analysis of HsT135I assays with a: benzoyl-CoA, b: 3-hydroxybenzoyl-CoA, c: 2-
hydroxybenzoyl-CoA, d: anthraniloyl-CoA, e: N-methylantraniloyl-CoA. 
2: 6-phenyl-4-hydroxy-2-pyrone. 4: 6-(3-hydroxy-phenyl)-4-hydroxy-2-pyrone, 5: 4-hydroxycoumarin, 6: 
4-hydroxy-2(1H)-quinolone, 7: 4-hydroxy-1-methyl-2(1H)-quinolone, *: unidentified peaks. 
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4.1.7 Results of LC-MS/MS analysis of enzymatic products 
The structures of the major HPLC-purified enzymatic products of H. sampsonii wild-type 
and its mutants (HsT135K and HsT135L) were confirmed by LC-MS/MS ‘Positive Full-Scan 
Mode analysis’ using the enzymatic products themselves and authentic reference compounds. 
This type of scan displays one mass unit higher than the initial mass of the tested compounds 
[MH]+. The x-axis shows the expanding mass-to-charge (m/z) ratio whereas the y-axis 
represents the relative abundance of each ion which is associated to the number of times that an 
ion of that m/z ratio hits the detector. The mass spectra of the major enzymatic products and the 
corresponding reference compounds (4-hydroxycoumarin, 4-hydroxy-2(1H)-quinolone, 4-
hydroxy-1-methyl-2(1H)-quinolone, 6-phenyl-4-hydroxy-2-pyrone, 6-(3-hydroxy-phenyl)-4-
hydroxy-2-pyrone, 2,4,6-trihydroxybenzophenone and 2,3',4,6-tetrahydroxybenzophenone)  are 
illustrated in (Figs. 27-39). LC-MS/MS ‘Negative Full-Scan Mode analysis’ was also done for 4-
hydroxy-1-methyl-2(1H)-quinolone to compare the spectrum to the published results (Resmi et 
al., 2013). 
 
 
Fig. 27  Mass spectrum (EPI

) of authentic 4-hydroxycoumarin reference. 
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Fig. 28  Mass spectrum (EPI

) of 4-hydroxycoumarin enzymatic product. 
 
 
 
Fig. 29  Mass spectrum (EPI

) of authentic 4-hydroxy-2(1H)-quinolone reference. 
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Fig. 30  Mass spectrum (EPI

) of 4-hydroxy-2(1H)-quinolone enzymatic product. 
 
 
 
Fig. 31  Mass spectrum (EPI

) of 4-hydroxy-1-methyl-2(1H)-quinolone enzymatic product. 
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Fig. 32  Mass spectrum (EPI

) of 4-hydroxy-1-methyl-2(1H)-quinolone enzymatic product. 
 
 
 
Fig. 33  Mass spectrum (EPI

) of 4-hydroxy-1-methyl-2(1H)-quinolone enzymatic product formed by 
Aegle marmelos QNS (Resmi et al., 2013). 
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Fig. 34  Mass spectrum (EPI

) of 6-phenyl-4-hydroxy-2-pyrone enzymatic product. 
 
 
 
Fig. 35  Mass spectrum (EPI

) of 6-(3-hydroxy-phenyl)-4-hydroxy-2-pyrone enzymatic product. 
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Fig. 36  Mass spectrum (EPI

) of authentic 2,4,6-trihydroxybenzophenone reference. 
 
 
 
Fig. 37  Mass spectrum (EPI

) of 2,4,6-trihydroxybenzophenone enzymatic product. 
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Fig. 38  Mass spectrum (EPI

) of authentic 2,3',4,6-tetrahydroxybenzophenone reference. 
 
 
 
Fig. 39  Mass spectrum (EPI

) of 2,3',4,6-tetrahydroxybenzophenone enzymatic product. 
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4.1.8 Characterization of the HsT135Lys, Leu and Ile mutants 
The upshot of screening 19 enzyme mutants altered in position Thr135 of HsBPS is that 
lysine was the only amino acid which produced an enzyme mutant that preferred 2-
hydroxybenzoyl-CoA as a starter substrate. It forms 4-hydroxycoumarin as the main product 
after a single malonyl-CoA extension. Salicoyl-CoA is a poor substrate for the wild-type HsBPS. 
The mutant was nearly inactive with benzoyl-CoA and 3-hydroxybenzoyl-CoA which are the 
preferred substrates for the wild-type HsBPS. In addition to lysine, leucine and isoleucine were 
able to convert HsBPS into functional phenylpyrone synthases (PPSs), like the H. androsaemum 
T135L mutant (Klundt et al., 2009). Lysine, leucine and isoleucine produced mutants with 
dramatically different substrate and product specificities compared to the wild-type HsBPS. 
Therefore, characterization of these three enzyme mutants was carried out. 
4.1.8.1 pH optima of HsT135Lys, Leu and Ile mutants 
Each enzyme has its specific pH optimum. Extremely low or high pH values lead to 
changes in the ionization state of some amino acid residues which are either lining the active site 
cavity or maintaining the three dimensional structure of the enzyme. An unsuitable pH may also 
cause changes in the substrate ionization state. These effects of low or high pH may change the 
properties of the enzyme, interfere with the binding of the substrate to its active site, or even 
cause loss of the enzyme’s catalytic activity. Determination of the activity of the HsBPS mutants 
was carried out in the pH range 5.5 to 9 and the dependence of the activities on the pH was 
illustrated in (Fig. 40, A, B and C). The data shown are mean values of two independent 
experiments. The optimum pH for all three mutants HsT135K, HsT135L, and HsT135I, was 7.0 
and they were characterized by relatively broad pH optima. All subsequent tests were performed 
at pH 7.0 in potassium phosphate (KH2PO4) buffer.  
4.1.8.2 Temperature optima of the HsT135Lys, Leu and Ile mutants 
The rate of the enzyme-catalyzed reaction increases with temperature to a maximal level 
which is the optimum temperature for the given enzyme. Above this temperature the rate 
decreases because of thermal denaturation of the enzyme due to disruption of non-covalent 
bonds such as hydrogen bonds, hydrophobic and ionic interactions. High temperature thus 
affects the 3-D structure of the enzyme. At low temperature there is not enough energy to 
overcome the energy barrier between the reactants and the product and so the reaction will not 
start. At the optimum pH value of 7.0 standard assays were done as duplicates at 5 °C intervals 
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from 20 °C to 50 °C. Average values of the product amounts were determined (Fig. 41, A, B and 
C). The optimum temperature for all three mutants HsT135K, HsT135L and HsT135I was 30 C. 
In contrast to lysine, both leucine and isoleucine in position 135 increased the stability of the 
enzymes at higher temperatures. 
4.1.8.3 Linearity of product formation with time 
The rate of product formation of the enzyme-catalyzed reaction changes by time. At the 
beginning of the reaction the rate is fast. If the amount of the product is plotted against the time 
the curve will be linear. Later, enzyme instability and substrate depletion may occur. In addition, 
product accumulation may cause any inhibition. All of these factors lead to changes in the rate 
with time and it is critical to measure the rate at the linear part of the curve at a time point which 
gives detectable product amount. The amounts of the products formed by HsT135K, HsT135L, 
and HsT135I were determined as a function of time in the standard assay (Fig. 42, A, B and C). 
Product formation was linear up to 15 min with HsT135K and HsT135I and up to 10 min with 
HsT135L. 
4.1.8.4 Linearity of product formation with enzyme concentration 
Before determination of the kinetic constants it is also critical to examine the suitable 
concentration of the enzyme to be used for the assay. If too low the amount of the product 
formed will be small and difficult to detect. On the other hand, high concentrations may result in 
steric hindrance and hence deviation from linearity. Thus, a concentration that yields high 
product amounts within the linearity is favorable. Product formation by HsT135K, HsT135L and 
HsT135I mutants were plotted against the various enzymes concentrations (Fig. 43, A, B and C). 
It was linear up to 3 µg protein/assay with HsT135L and HsT135I and up to 2 µg with HsT135K. 
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Fig. 40  pH optima of A: HsT135K, B: HsT135L and C: HsT135I mutants. Data are mean values of two 
independent experiments. pH 7 is the optimum pH for the three mutants. 
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Fig. 41  Temperature optima of, A: HsT135K,   B: HsT135L and C: HsT135I mutants. Data are mean 
values of two independent experiments. The optimum temperature for the three mutants is 30 C. 
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Fig. 42  Dependence of the activity of, A: HsT135K, B: HsT135L and C: HsT135I mutants on time  
(min). Data are mean values of two independent experiments. The product formation stays linear up to 15 
min in case of HsT135K and HsT135I and for 10 min in case of HsT135L. 
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Fig. 43  Dependence of the activity of, A: HsT135K, B: HsT135L and C: HsT135I mutants on the protein 
amount. Data are mean values of two independent experiments. 
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4.1.9 Synthesis and use of alternative starter substrates  
In the current study the HsT135K mutant accepts 2-hydroxybenzoyl-CoA as a starter 
substrate. Therefore, synthesis of this substrate was carried out during this work in addition to 
the synthesis of alternative starter substrates like anthraniloyl-CoA, 2-mercaptobenzoyl-NAC 
and 2-methoxybenzoyl-NAC as described in (3.3.1, 3.3.2). The objective was to detect activity 
of the new mutant ‘HsT135K’ with these potential substrates.  
4.1.9.1 2-Hydroxy and 2-aminobenzoyl-CoAs  
Synthesis of 2-hydroxybenzoyl-CoA (salicoyl-CoA) and 2-aminobenzoyl-CoA 
(anthraniloyl-CoA) was performed according to the literature (Lapidot et al., 1967; Stöckigt and 
Zenk, 1975). The synthesis consists of two steps; in the first step synthesis of N-
hydroxysuccinimide (NHS) ester intermediate (Fig. 44, A) was done. These esters are stable to 
be purified and stored at low temperature. NHS esters are prepared by mixing the acid of interest 
with NHS in an anhydrous solvent. NHS acts as an activating agent. N,N 
dicyclohexylcarbodiimide (DCC) is a coupling reagent which forms a highly unstable activated 
acid intermediate (O-acyl urea derivative) which then reacts with NHS and forms a more stable 
activated acid. If the yield of the reaction is low this may be due to the rearrangement of O-acyl 
urea derivatives to form N-acyl urea derivative which is very stable and could not react with 
NHS. Experimental data for 2-hydroxybenzoyl-N-hydroxysuccinimide ester (Fig. 45) were as 
follows. EI-MS (70 eV), m/z (rel. abundance): 235 [M]
+
 (7), 121 (100; 2-hydroxybenzoyl), 120 
(12.5), 93 (11; hydroxyphenyl), 69 (4), 65 (12). Experimental data for 2-aminobenzoyl-N-
hydroxysuccinimide (Fig. 46) were as follows. EI-MS m/z (rel. abundance): 234 [M]
+
 (14.3), 
121(8), 120 (100; 2-hydroxybenzoyl), 119 (5), 99 (6) 92 (19; hydroxyphenyl), 65 (10) 56 (5). 
Exchange of NHS with Coenzyme A (Fig. 44, B) was performed in the second step 
(transesterification) in the presence of a base (NaHCO3) as a catalyst as described in section 
(3.3.1.2). LC-MS analysis was carried out for the purified 2-aminobenzoyl-CoA and data are 
represented in (Fig. 47, B). It is characterized by the presence of the molecular ion peak [MH]– 
at m/z 885.2. This single charged anthraniloyl-CoA ion was selected for further fragmentation 
and the product ions were recorded in negative ion mode. MS/MS

 analysis showed 
characteristic fragments of CoA and phosphoadenosine-containing compounds like [ADP]

 at 
m/z 426, and [ADP-H2O]

 at m/z 408.2 together with fragments containing parts of the 
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anthraniloyl moiety such as [M-AMP]
–
 at m/z 556.5, [M-AMPH2O]
 
at m/z 538.5, [MH2PO3]
 
at m/z 805.7. 
 
Fig. 44  Synthesis scheme of acyl-CoA esters of 2-hydroxy- or 2-aminobenzoic acid, modified from; Gaid 
(unpublished results). 
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Fig. 45  Mass spectrum of 2-hydroxybenzoyl-N-hydroxysuccinimide ester. 
 
 
 
Fig. 46  Mass spectrum of 2-aminobenzoyl-N-hydroxysuccinimide ester. 
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Fig. 47  Structure of anthraniloyl-CoA (A) and the MS/MS

 spectrum (EPI

) of purified anthraniloyl-CoA 
(B). 
4.1.9.2 2-Methoxy and 2-mercaptobenzoyl-NAC esters 
Synthesis of these two substrates as CoA esters was not successful. Only their N-
hydroxysuccinimide intermediates were obtained, as shown by their mass spectra (Figs. 107 and 
108 appendix). However, the transesterification step with CoASH failed and the final product 
was not detected in the LC-MS/MS analysis. It was reported that the N-acetylcysteamine (NAC) 
thioesters were successfully used as starter substrates instead of CoA thioesters for type III PKSs 
(Oguro et al., 2004), thus provoked the idea of synthesizing these two compounds as -NAC 
thioesters. The synthesis was carried out according to Suo et al. (2000).  In this reaction 1-
hydroxybenzotriazole activates the aromatic carboxylic acid in the presence of the coupling 
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reagent DCC and then transesterification with the N-acetylcysteamin follows. The reaction was 
carried out as described in (3.3.2). Experimental data for 2-methoxybenzoyl-NAC (Fig. 49) were 
as follows. EI-MS (70 eV), m/z (rel. abundance): 253 [M]
+
 (2), 210 (2), 136 (11), 135 (100, 2-
methoxybenzoyl), 92 (5), 77 (10). Experimental data for 2-mercaptobenzoyl-NAC (Fig. 50) were 
as follows. EI-MS (70 eV), m/z (rel. abundance): 255 [M]
+
 (2), 136 (100, 2-mercaptobenzoyl), 
224.2 (11), 167.9 (5), 143.1 (9), 109 (17), 99.1 (10), 87 (41), 81.9 (12),  68.9 (19), 60 (41), 56.1 
(20), 42.8 (30).  
 
Fig. 48  Synthesis scheme of 2-methoxy and 2-mercaptobenzoyl-NAC thioesters. 
 
 
 
 
Fig. 49  Mass spectrum of 2-methoxybenzoyl-NAC. 
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Fig. 50  Mass spectrum of 2-mercaptobenzoyl-NAC. 
4.1.10 Substrate and product specificities of HsBPS wild-type and its three mutants 
Using the above-determined optimized conditions enzyme assays were done to test the 
ability of the HsT135K, HsT135L and HsT135I mutants to use different starter substrates. The 
products formed were examined by HPLC. The detection wavelengths were 306 nm (2,4,6-
trihydroxybenzophenon, 2,3',4,6-tetrahydroxybenzophenon), 317 and 321 nm (4-hydroxy-6-
phenylpyran-2-one, 4-hydroxy-6-(3-hydroxy)-phenylpyran-2-one respectively), 279 nm (4-
hydroxycoumarin ), 270 nm (4-hydroxy-2(1H)-quinolone) and 272 nm (4-hydroxy-1-methyl-
2(1H)-quinolone). The HsT135K, HsT135L, HsT135I mutants were incubated in the presence of 
malonyl-CoA with benzoyl-CoA, 2-hydroxybenzoyl-CoA (salicoyl-CoA), 3-hydroxybenzoyl-
CoA, 4-hydroxybenzoyl-CoA, anthraniloyl-CoA, N-methylanthraniloyl-CoA, 2-
mercaptobenzoyl-N-acetylcysteamine and 2-methoxybenzoyl-N-acetylcysteamine. The identity 
of the products formed was established by UV-spectroscopy and co-chromatography with 
authentic reference compounds. All the enzymatic products were quantified using standard 
solutions of the respective authentic reference compounds. The substrate and product specificity 
results are summarized in (Tab. 12). In contrast to HsBPS wild-type (Huang et al., 2012) the 
HsT135K mutant preferred 2-hydroxybenzoyl-CoA as a starter substrate forming 4-
hydroxycoumarin as main product. The HsT135L and HsT135I mutants preferred benzoyl-CoA 
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forming 4-hydroxy-6-phenylpyran-2-one as main product. Interestingly, 3-hydroxybenzoyl-CoA 
was the second best substrate of HsT135L and HsT135I forming 4-hydroxy-6-(3-hydroxy)-
phenylpyran-2-one as main product in good yield unlike the HaT135L mutant from H. 
androsaemum which was nearly inactive with this substrate (Klundt et al., 2009). The HsT135K, 
HsT135L and HsT135I mutants also accepted anthraniloyl and N-methylanthraniloyl-CoAs, 
forming 4-hydroxy-2(1H)-quinolone and 4-hydroxy-1-methyl-2(1H)-quinolone alkaloids 
respectively like benzalacetone synthase from Rheum palmatum (RpBAS) (Abe et al., 2006). All 
of the three mutants were inactive with p-hydroxybenzoyl-CoA, 2-mercaptobenzoyl-N-
acetylcysteamine and 2-methoxybenzoyl-N-acetylcysteamine.  
 
Tab. 12  Substrate and product specificities of HsBPS wild-type and the HsT135K, HsT135L and 
HsT135I mutants 
Substrate Relative activity (%)
*
 
  HsBPS wild-type HsT135L HsT135I HsT135K 
Benzoyl-CoA  100
a 
100
c 
100
c 
3.3 
3-Hydroxybenzoyl-CoA  66.2
b 
64.2
d 
40.7
d 
1.8 
2-Hydroxybenzoyl-CoA  6.3 8.9 16.8 100
e
 
4-Hydroxybenzoyl-CoA  0 0 0 0 
Anthraniloyl-CoA 7.1
f 
42.8
f 
20.3
f 
15.1
f 
N-Methylantraniloyl-CoA 11.6
g
 8.4
g
 5.3
g
 6.1
g
 
2-Methoxybenzoyl-NAC
** 
0 0 0 0 
2-Mercaptobenzoyl-NAC
**
 0 0 0 0 
* 
Data are mean values of two independent experiments
  
  ** 
-N-acetylcysteamine 
  a
 2,4,6-Trihydroxybenzophenone         
b
 2,3´,4,6-Tetrahydroxybenzophenone 
  c
 4-Hydroxy-6-phenylpyran-2-one       
d
 4-Hydroxy-6-(3-hydroxy)-phenylpyran-2-one 
  e
 4-Hydroxycoumarin                     
 
      
f
 4-Hydroxy-2(1H)-quinolone  
  g
 4-Hydroxy-1-methyl-2(1H)-quinolone 
  
Results 
 
97 
 
4.1.10.1 Activity of HsT135K mutant and HsBPS wild-type with salicoyl and benzoyl-
NACs 
As mentioned before some starter substrates such as anthraniloyl-CoA, 2-methoxy- and 
2-mercaptobenzoyl-NACs were synthesized during this study. The aim was to get new products 
such as thiocoumarins or substituted benzophenones. However, only anthraniloyl-CoA was 
accepted and the highest activity was found with HsT135L mutant. 2-Methoxy and 2-
mercaptobenzoyl-NACs were accepted as starter substrates neither by HsBPS wild-type nor by 
its mutants. So testing the activity of these enzymes with salicoyl and benzoyl-NACs as positive 
controls was performed. HsT135K mutant did not accept salicoyl-NAC as a starter substrate as 
shown in (Fig. 51, b). In contrast to the CoA-esters the NAC-esters are extractable into the ethyl 
acetate phase. HsBPS wild-type which showed around 5% activity with salicoyl-CoA efficiently 
accepts salicoyl-NAC as a starter substrate forming 4-hydroxycoumarin (Fig. 52, b). Also 
HsBPS wild-type efficiently accepts benzoyl-NAC as benzoyl-CoA forming 2,4,6 
trihydroxybenzophenone (Fig. 52, d). Thus, it could be concluded that HsT135K mutant does not 
accept the NAC-activated starter substrates. The challenge was that synthetic activation of 2-
methoxy and 2-mercaptobenzoic acids as CoA esters failed. Therefore, another trial should be 
done to synthesize them as -CoAs for testing with the HsT135K mutant.  
  
  
Results 
 
98 
 
 
2-Hydroxybenzoyl-CoA 2-Hydroxybenzoyl-NAC 
  
UV of 4-Hydroxycoumarin UV spectra of 2-Hydroxybenzoyl-NAC 
  
Fig. 51  HPLC chromatograms of assays of HsT135K mutant with a: 2-hydroxybenzoyl-CoA, and b: 2-
hydroxybenzoyl-NAC; c: UV spectrum of 4-hydroxycoumarin, d: UV spectrum of 2-hydroxybenzoyl-N-
acetylcysteamine. 
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2-Hydroxybenzoyl-CoA Benzoyl-CoA UV of 2,4,6 Trihydroxybenzophenone 
   
2-Hydrozybenzoyl-NAC Benzoyl-NAC UV of Benzoyl-NAC 
   
Fig. 52  HPLC chromatograms of assays of HsBPS wild-type with a: 2-hydroxybenzoyl-CoA, b: 2-
hydroxybenzoyl-NAC, c: benzoyl-CoA, and d: benzoyl-NAC; e: UV spectrum of 2,4,6 
trihydroxybenzophenone, f: UV spectrum of benzoyl-N-acetylcysteamine. 
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4.1.11 Determination of the kinetic parameters of HsThr135Lys, Leu, and Ile 
mutants 
At the optimum reaction conditions, i.e. pH 7.0, temperature 30°C, 1.5 µg protein/assay 
and 5 min incubation time, the kinetic constants of HsT135K, HsT135L and HsT135I mutants 
were determined. The increase in reaction rate with increasing concentrations of substrates 
(salicoyl-CoA and malonyl-CoA in case of HsT135K and benzoyl-CoA and malonyl-CoA in 
case of the HsT135L and HsT135I mutants) obeyed Michaelis-Menten kinetics. The Michaels 
constants (Km) of the mutants were calculated from Lineweaver-Burk plot which is a linear 
regression of the Michaelis-Menten equation. The kinetic parameters of the H. sampsonii 
mutants are summarized in (Tab. 13) and illustrated in (Figs. 53, 54, and 55). Km is an important 
characteristic of the interaction between the enzyme and its substrate and defined as the substrate 
concentration which results in half of the maximum velocity of the enzymatic reaction. It is 
considered as an inverse measure of the affinity or strength of binding between the enzyme and 
its substrate. The Kcat value (turn over number) is the maximum number of substrate molecules 
that converted into product per active site per unit time when the enzyme is fully saturated. 
(Kcat/Km) is the rate constant (specificity constant) for the interaction of substrate and enzyme. It 
is used as a measure of the catalytic efficiency as it provides information about how fast the 
reaction is when the substrate is bound to the enzyme (Kcat) and how much of the substrate is 
required to achieve half of the maximum rate (Km) and so can characterize the kinetics of the 
enzyme under similar cellular conditions. 
Tab. 13  Steady-state kinetic parameters of HsBPS wild-type and the HsT135K, HsT135L and HsT135I 
mutants from H. sampsonii 
a
 
                           Benzoyl-CoA Salicoyl-CoA Malonyl-CoA 
Enzyme Kcat 
[sec-1] 
Km 
[µM] 
Kcat/Km 
[M-1sec-1] 
Kcat 
[sec-1] 
Km 
[µM] 
Kcat/Km 
[M-1sec-1] 
Km 
[µM] 
HsBPS 
(Huang et al., 2012) 
0.391 15.8 25028    92.5 
HsT135K    1.181 43.92 26889 747 
HsT135L 0.4431 18.03 24575    387 
HsT135I 0.4373 24.95 17529    938 
 a Data are mean values of two independent experiments 
 
Results 
 
101 
 
  
  
Fig. 53  a: Dependence of HsT135K activity on salicoyl-CoA concentration. 
             b: Determination of the Km value for salicoyl-CoA via Lineweaver-Burk plot. 
             c: Dependence of HsT135K activity on the malonyl-CoA concentration.  
             d: Determination of the Km value for malonyl-CoA via Lineweaver-Burk plot. 
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Fig. 54  a: Dependence of HsT135L activity on benzoyl-CoA concentration 
             b: Determination of Km value for benzoyl-CoA via Lineweaver-Burk plot 
             c: Dependence of HsT135L activity on malonyl-CoA concentration 
             d: Determination of Km value for malonyl-CoA via Lineweaver-Burk plot 
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Fig. 55  a: Dependence of HsT135I activity on benzoyl-CoA concentration  
             b: Determination of Km value for benzoyl-CoA via Lineweaver-Burk plot 
             c: Dependence of HsT135I activity on malonyl-CoA concentration 
             d: Determination of Km value for malonyl-CoA via Lineweaver-Burk plot 
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4.2 Site-directed mutagenesis of H. androsaemum BPS (HaBPS) 
H. androsaemum benzophenone synthase (HaBPS) was transformed into a functional 
phenylpyrone synthase (PPS) by a single amino acid substitution in the active site cavity namely 
T135L (Klundt et al., 2009). In the above studies we screened 19 amino acid residues in the 
same position of H.sampsonii (HsBPS), also occupied with Thr, and found that lysine instead of 
threonine in position 135 (HsT135K) converts HsBPS into a functional 4-hydroxycoumarin 
synthase (HCS). Thus, it was tempting to investigate the effect of lysine in position 135 in 
HaBPS and to study the effect of this point mutation on the substrate and product specificities 
and the catalytic activity of the enzyme.  
4.2.1 Single mutation of the H. androsaemum BPS wild-type 
Threonine in position 135 of HaBPS was converted to lysine by SDM-PCR (3.1.2) using 
two mutated partially overlapping primers designed according to Zheng et al., (2004) (Fig. 87, 
A). The resulting PCR amplification product was incubated with DpnI restriction enzyme for 2 h 
at 37 C to remove the un-mutated plasmid followed by DH5α transformation (3.1.6.1), plasmid 
isolation (3.1.7) and then restriction analysis using KpnI for size confirmation (Fig. 87, B). The 
HaT135K mutant was confirmed by sequencing.  
4.2.1.1 Production and isolation of the HaT135K mutant 
Confirmation of the over-expression of the HaT135K mutant in E.coli was done by 
means of SDS-PAGE analysis (3.1.14) (Fig. 87, C). Protein bands were stained with Coomassie 
brilliant blue. The HaT135K mutant has a subunit molecular mass of about ~43 kDa. 
4.2.1.2 Testing the activities of HaBPS wild-type and HaT135K mutant  
First of all the activity of HaBPS wild-type was determined with benzoyl, 3-
hydroxybenzoyl and 2-hydroxybenzoyl-CoAs according to Liu et al., (2003) and Klundt et al., 
(2009) and the highest activity of HaBPS was found with benzoyl-CoA (Fig. 88, a). It forms 
2,4,6-trihydroxybenzophenone and a small amount of 4-hydroxy-6-phenylpyran-2-one as major 
and side products respectively. The other peaks one of them are non-enzymatic and the second is 
not identified and might be a tetraketide lactone product like that identified in G. mangostana 
BPS (Nualkaew et al., 2012). HaBPS also accepts 3-hydroxybenzoyl-CoA as a second best 
substrate (Fig. 88, c) forming 2,3',4,6-tetrahydroxybenzophenone as major product and 4-
hydroxy-6-(3-hydroxy) phenylpyran-2-one as a side product. What is worth mentioning is the 
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acceptance by the HaBPS wild-type of 2-hydroxybenzoyl-CoA as a starter substrate forming a 
small amount of 4-hydroxycoumarin (Fig. 88, e). It was previously stated that this enzyme did 
not accept this substrate (Liu et al., 2003; Klundt et al., 2009). When the HaT135K mutant was 
tested with the previous substrates, this mutation was able to convert HaBPS wild-type into 4-
hydroxycoumarin synthase (HaHCS) which prefers 2-hydroxybenzoyl-CoA as a starter substrate 
forming 4-hydroxycoumarin as a single product (Fig. 88, f). The product amount was around 3 
times higher than that formed by the wild-type (HaBPS). The mutant was nearly inactive with 
benzoyl and 3-hydroxybenzoyl-CoAs (Figs. 88, b and d) which are the best substrates for HaBPS 
wild-type. This result is quite similar to that obtained with the HsT135K mutant but at lower 
activity. A lot of trials were carried out to improve the activity of the HaT135K mutant such as 
changing the pH, temperature, and protein amount but all these trials were not successful.  
However, the important observation is the low activity of HaBPS wild-type with 2-
hydroxybenzoyl-CoA and the confirmation of the ability of lysine in position 135 to dramatically 
change the specificities of HaBPS wild-type and to transform it into HCS which is similar to 
HsT135K. 
4.2.2 H. sampsonii BPS-based mutations of HaBPS 
The amino acid sequence alignments (Fig. 56) indicate only 6 different amino acids 
between these two enzymes. Despite this high degree of similarity (98.2 %) the Km value for 
malonyl-CoA of HsBPS wild-type which equals 92.5 µM (Huang et al., 2012) is around 3 times 
higher than that of HaBPS wild-type (31.3 µM). It was interesting to find out which of these six 
amino acid residues (which are all away from the active site cavity) may be responsible for this 
high HsBPS malonyl-CoA Km value. Six mutated and partially overlapping primers are designed 
according to (Zheng et al., 2004). SDM-PCR was done and the resulting PCR amplification 
product (Fig. 89, A) was incubated with DpnI restriction enzyme for 2 h at 37 C to remove the 
un-mutated plasmid followed by DH5α transformation (3.1.6.1), plasmid isolation (3.1.7) and 
then restriction analysis using KpnI for size confirmation (Fig. 89, B). The HaE54D, HaV146A, 
HaC230G, HaS235A, HaV359L and HaN360S mutants were confirmed by sequencing.  
4.2.2.1 Production and isolation of six H.androsaemum single mutants  
Confirmation of the over-expression of the HaE54D, HaV146A, HaC230G, HaS235A, 
HaV359L and HaN360S mutants was done by means of SDS-PAGE analysis (3.1.14). (Fig. 89, 
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C and D). Only five mutants were over-expressed in the E.coli host cells while the HaS235A 
mutant failed to be over-expressed. 
 
Fig. 56  Alignment of BPS amino acid sequences of H. sampsonii (HsBPS), H. androsaemum (HaBPS), 
H. calycinum (HcBPS) and H. perforatum ssp. angustifolium (HpaBPS). 
4.2.2.2 Testing the activities of H.androsaemum single mutants 
Transformation of the PCR-mutated plasmids of H.androsaemum BPS in E.coli 
BL21 was done as described in (3.1.6.2). Protein over-expression and purification of 
the His6-tagged HaBPS single mutants using the Ni-NTA system (3.1.12) was 
performed and all of the purified mutants were then subjected to BPS assays (3.2.2.1) 
to characterize their specificities (3.2.4.4). The activities of the affinity-purified single 
mutants with various starter substrates were determined and compared with those of 
HaBPS wild-type (Fig. 57). All of these five active single mutants accepted and 
preferred benzoyl-CoA as a starter substrate forming 2,4,6-trihydroxybenzophenone 
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and a small amount of 4-hydroxy-6-phenylpyran-2-one as main product and side 
product respectively. The second best substrate was 3-hydroxybenzoyl-CoA and the 
products were 2,3',4,6-tetrahydroxybenzophenone and 4-hydroxy-6-(3-hydroxy) 
phenylpyran-2-one as main and side product respectively. All of them also accepted 2-
hydroxybenzoyl-CoA forming small amounts of 4-hydroxycoumarin.  
 
Fig. 57  Substrate and product specificities of HaBPS wild-type and HaE54D, HaV146A, HaC230G, 
HaV359L and HaN360S mutants. 
4.2.2.3 Determination of the kinetic parameters of H.androsaemum single mutants 
Our target was to find out which of these amino acids may be responsible for 
the high malonyl-CoA Km value of HsBPS. Therefore, the kinetic constants of the 
HaE54D, HaV146A, HaC230G, HaV359L and HaN360S mutants were determined. 
The increase in reaction rate with increasing concentrations of the substrates benzoyl-
CoA and malonyl-CoA obeyed Michaelis-Menten kinetics. Michaelis constants (Km) of 
the mutants were calculated from Lineweaver-Burk plots. The kinetic results of 
H.androsaemum five single mutants in comparison with HsBPS and HaBPS wild-types 
are documented in (Tab. 14) and represented in (Figs. 90, 91, 92, 93 and 94). The 
determined Km values of the five single mutants showed 3 - 4.9 fold increase for 
malonyl-CoA and 2 - 4 fold increase in benzoyl-CoA compared to the wild-type 
HaBPS (Klundt et al., 2009). These results indicate that, any change in these five 
amino acid residues (which are away from the active site) decreased the substrates 
affinity with pronounced effect on malonyl-CoA. 
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Tab. 14  Steady-state kinetic parameters of HaE54D, HaV146A, HaC230G, HaV359L and HaN360S in 
comparison to HsBPS and HaBPS wild-types 
a 
Benzoyl-CoA Malonyl-CoA 
Enzyme Kcat [sec
-1
] Km [µM] Kcat/Km [M
-1
sec
-1
] Km [µM] 
HsBPS 
(Huang et al., 2012) 
0.391 15.8 25028 92.5 
HaBPS 
(Klundt et al., 2009) 
0.055 8.6 6414 31.3 
HaE54D 0.141 33.66 4189 154.37 
HaV146A 0.082 16.68 6175 128.53 
HaC230G 0.111 24.67 4499 120.84 
HaV359L 0.143 26.75 5345 140.62 
HaN360S 0.096 17.37 5526 100.71 
    a
 Data are mean values of two independent experiments 
4.2.3 Double mutations with the HaBPST135K mutant 
As mentioned before (4.2.1) replacement of HaBPS Thr135 with lysine resulted in 
transformation of HaBPS into HCS. However, the activity of HaT135K was much lower than 
HsT135K activity. Changing pH, temperature, incubation time, and protein amount failed to 
improve this activity and thus provoked the idea of double mutations to determine which of the 
six different amino acids between H. androsaemum and H. sampsonii BPSs (Fig. 56) will 
improve the activity of HaT135K with 2-hydroxybenzoyl-CoA. SDM-PCR (3.1.2) was 
performed using mutated partially overlapping primers designed according to (Zheng et al., 
2004). The resulting PCR amplification product (Fig. 95, A) restriction analysis (Fig. 95, B) 
over-expression (Fig. 95, C and D) and confirmation of these mutants were performed as 
previously explained. 
4.2.3.1 Testing the activities of H. androsaemum lysine double mutants 
The activities of the affinity-purified mutants with various starter substrates were 
determined using HPLC analysis (Fig. 58). All the HPLC chromatograms are shown in (Fig. 96, 
a, b, c, d and e). All the double mutants derived from HaT135K were nearly inactive with 
benzoyl and 3-hydroxybenzoyl-CoAs while showing a high activity with 2-hydroxybenzoyl-CoA 
as a starter substrate forming relatively high amounts of 4-hydroxycoumarin which were around 
3- times higher than with the HaT135K single mutant. 
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Fig. 58 Catalytic activity with salicoyl-CoA of H.androsaemum lysine double mutants, HaE54D/T135K, 
HaV146A/T135K, HaC230G/T135K, HaS235A/T135K and HaV359L/T135K in comparison to 
HaT135K single mutant. 
4.2.3.2 Determination of the kinetic properties of HaV146A/T135K mutant 
From an economical point of view we aimed at finding a 4-hydroxycoumarin synthase 
(HCS) enzyme mutant with lower malonyl-CoA Km value due to the expensive price of acyl-
CoA esters. We decided to determine the kinetic parameters of the HaV146A/T135K double 
mutant as it showed the highest activity with salicoyl-CoA. The HaV146A/T135K double mutant 
showed a Kcat/Km value 4-fold lower than that of HsT135K due to a 3-fold lower Kcat value and 
1.3 fold higher Km value for benzoyl-CoA while it showed around 1.3 fold increase in malony-
CoA Km value compared to HsT135K mutant as shown in (Tab. 15 and Fig. 59). 
Tab. 15 Steady-state kinetic parameters of the HaV146A/T135K double mutant in comparison with those 
of above mentioned enzymes. 
                           Benzoyl-CoA Salicoyl-CoA Malonyl-CoA 
Enzyme 
Kcat 
[sec
-1
] 
Km 
[µM] 
Kcat/Km 
[M
-1
sec
-1
] 
Kcat 
[sec
-1
] 
Km 
[µM] 
Kcat/Km 
[M
-1
sec
-1
] 
Km 
[µM] 
HaBPS wild-type 
(Klundt et al., 2009) 
0.055 8.6 6414    31.3 
HaV146A 0.082 16.68 6175    128.53 
HaV146A/T135K    0.3895 56.97 6838 956.54 
HsBPS wild-type 
(Huang et al., 2012) 
0.391 15.8 25028    92.5 
HsT135K    1.181 43.92 26889 747 
a Data are mean values of two independent experiments 
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Fig. 59  a: Dependence of HaV146/T135K activity on salicoyl-CoA concentration. 
             b: Determination of Km value for salicoyl-CoA via Lineweaver-Burk plot. 
             c: Dependence of HaV146/T135K activity on malonyl-CoA concentration. 
             d: Determination of Km value for malonyl-CoA via Lineweaver-Burk plot. 
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4.2.4 Double mutations with the HaBPST135I mutant 
Replacement of leucine in HaBPS with different amino acids like isoleucine and alanine 
was not successful (Klundt et al., 2009) but in HsBPS isoleucine in position 135 transformed the 
enzyme into phenylpyrone synthase (PPS). Recently, our work group cloned two cDNAs from 
Centaurium erythraea for which blasting results showed close homology to type III PKS. One of 
them functions as PPS (CePKS2/CePPS) (unpublished work) and the most important point is 
that, position 135 in this natural PPS occupied with isoleucine.  It is interesting to find out which 
of the 6 different amino acids between the HaBPS and HsBPS wild-types are able to recover the 
isoleucine activity in position 135 in HaBPS. Similarly, the HsT135A mutant was also active and 
formed around 50% 2,4,6-trihydroxybenzophenone and 50% 6-phenyl-4-hydroxy-2-pyrone with 
benzoyl-CoA starter substrate. So the same idea is applied to this alanine to explore the effect of 
the different amino acids between the two genes (HaBPS and HsBPS) on the activity. SDM-PCR 
was carried out using mutated partially overlapping primers designed according to (Zheng et al., 
2004) (Fig. 97, A).The restriction analysis for size confirmation (Fig. 97, B) and expression of  
the mutants was done (Fig. 97, C) as mentioned before.  
4.2.4.1 Testing the activities of H.androsaemum isoleucine double mutants 
The activities of the affinity-purified double mutants with various starter substrates were 
determined and compared with those of HaBPS wild-type. The results of the activity tests are 
represented in (Fig. 60) and the HPLC assays are summarized in (Figs. 98 and 99). The 
HaE54D/T135I, HaV146A/T135I, HaC230G/T135I, HaS235A/T135I, HaV359L/T135I and 
HaN360S/T135I double mutants preferred benzoyl-CoA as a starter substrate forming 4-
hydroxy-6-phenylpyran-2-on as main product (Fig. 98, a, b, c, d, e and f) they catalyzed iterative 
condensation of one benzoyl-CoA with two malonyl-CoAs forming triketide intermediate which 
undergoes cyclization via C-5 keto-enol oxygen→C-1 lactonization into phenylpyrone (Klundt 
et al., 2009). 3-Hydroxybenzoyl-CoA is the second best substrate for all of the mutants (Fig. 99, 
a, b, c, d, e and f) forming 4-hydroxy-6-(3-hydroxy) phenylpyran-2-one (Klundt et al., 2009). 
They also accepted 2-hydroxybenzoyl-CoA forming small amounts of 4-hydroxycoumarin. The 
HaN360S/T135A double mutant activity results (Fig. 100, a, b and c) were similar to those of the 
HsT135A single mutant confirming the effect of these six amino acids (which are away from the 
active site) on the activity. All the results are confirmed by UV spectroscopy and the products 
were quantified using standard solutions of the respective authentic reference compounds. 
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Fig. 60  Catalytic activity with benzoyl, 3-hydroxybenzoyl and salicoyl-CoAs of H.androsaemum 
isoleucine double mutants. 
4.3 Site-directed Mutagenesis of H. calycinum BPS (HcBPS) 
H. calycinum BPS is one of the BPSs which was cloned in our work group (Zodi, 2011). 
The amino acid sequence alignment (Fig. 56) showed that there are only seven different amino 
acids between HcBPS and HsBPS wild-types. Screening of different amino acids in position 
Thr135 of HsBPS revealed that lysine in this position was able to transform HsBPS into a 
functional 4-hydoxycoumarin synthase (HCS) while Leucine and Isoleucine amino acids were 
able to convert HsBPS into phenylpyrone synthase (PPS). Our main target was to study the 
effect of these three amino acids on the activity and specificities when replacing Thr135. 
4.3.1 Single mutations of HcBPS 
The main problem with the HcBPS cDNA is the low GC content which led to 
unsuccessful mutation. To overcome this difficulty partially overlapping mutated primers were 
designed following the protocol of Liu and Naismith, (2008) which is ideal for low GC content 
genes. Replacement of Thr135 in HcBPS wild-type with lysine, leucine and isoleucine was 
carried out using SDM-PCR (3.1.2) with the afore-mentioned mutated primers (Fig. 101, A). The 
resulting PCR amplification product was incubated with DpnI restriction enzyme for 2 h at 37 C 
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followed by DH5α transformation (3.1.6.1) and plasmid isolation (3.1.7) and then restriction 
analysis using KpnI for size confirmation (Fig. 101, B). The successful mutations were 
confirmed by sequencing. 
4.3.1.1 Protein expression of HcThr135Leu, Ile and Lys mutants 
Monitoring the over-expression of the HcT135L, HcT135I and HcT135K 
mutants was done by means of SDS-PAGE analysis (3.1.14) (Fig. 101, C and D). 
Protein bands were stained with Coomassie brilliant blue. The HcT135L and HcT135I 
mutants had subunit molecular masses of about ~43 kDa. Unfortunately, due to 
misfolding of the over-expressed protein (HcT135K) it aggregated to form inclusion 
bodies which greatly reduced the protein yield to the extent that we were not able to 
find any soluble protein (Fig. 101, D).  
4.3.1.2 Testing the activities of HcBPS wild and HcThr135Leu and Ile mutants 
Each PCR-mutated plasmid was transferred to E.coli BL21 as described in (3.1.6.2) for 
protein over-expression. The Ni-NTA system was used for the purification of the His6-tagged 
HcBPS wild-type and its mutants (3.1.12). BPSs assay (3.2.2.1) for HcBPS wild-type and its 
mutants were done to characterize their catalytic activities and specificities. The activity of the 
affinity-purified wild-type and mutants with various starter substrates were determined (Fig. 61) 
using HPLC. The HPLC chromatograms are shown in (Fig. 102 and 103). HcBPS wild type 
accepts and prefers benzoyl-CoA as a starter substrate forming 2,4,6-trihydroxybenzophenone as 
main product  and  4-hydroxy-6-phenylpyran-2-one side product was also detected. Noteworthy 
is the inactivity of HcBPS wild-type with 2-hydroxybenzoyl-CoA as substrate. Both the 
HcT135L and HcT135I mutants accepted and preferred benzoyl-CoA as a starter substrate 
forming 4-hydroxy-6-phenylpyran-2-one as main product and the second best substrate for those 
mutants is 3-hydroxybenzoyl-CoA which after condensation with 2 malonyl-CoAs forms 4-
hydroxy-6-(3-hydroxy) phenylpyran-2-one as main product and also these two mutants did not 
accept 2-hydroxybenzoyl-CoA. 
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Fig. 61  Catalytic activities and substrate and product specificities of HcBPS wild-type, HcT135L and 
HcT135I mutants. 
4.4 Site-directed mutagenesis of H. perforatum ssp angustifolium (HpaBPS) 
HpaBPS is another BPS cloned in our work group (Tocci, 2013). From amino acid 
sequence alignment there are 22 different amino acids between HsBPS and HpaBPS and all of 
them away from the active site so it is very motivating to study the effect of lysine, leucine and 
isoleucine amino acids instead of Thr135 in HpaBPS on the catalytic activity and substrate 
specificity. 
4.4.1 Single mutation of HpaBPS  
SDM-PCR (3.1.2) using partially overlapping mutated primers designed according to 
(Zheng et al., 2004) was carried out (Fig. 104, A). The resulting PCR amplification product was 
incubated with DpnI restriction enzyme for 2 h at 37 C to remove the un-mutated plasmid 
followed by DH5α transformation (3.1.6.1) and plasmid isolation (3.1.7) and then restriction 
analysis using KpnI for size confirmation (Fig. 104, B). HpaT135L, HpaT135I and HpaT135K 
mutation effectiveness was confirmed by sequencing.  
4.4.1.1 Protein expression of HpaThr135Leu, Ile and Lys mutants 
Monitoring of the over-expression of the HpaT135L, HpaT135I and HpaT135K mutants 
was done by means of SDS-PAGE analysis (3.1.14) (Fig. 104, C). Protein bands were stained 
with Coomassie brilliant blue. HpaT135L and HpaT135I mutants have subunit molecular mass 
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of about ~43 kDa while HpaT135K mutant did not show any over-expression in E.col (Fig. 104, 
D). 
4.4.1.2 Testing the activities of HpaBPS wild-type, HpaThr135Leu and Ile mutants 
Each PCR-mutated plasmid was transformed in E. coli BL21 as described in (3.1.6.2) for 
protein over-expression. Ni-NTA system was used for the purification of the His6-tagged 
HpaBPS wild-type and its mutants (3.1.12). BPSs assay (3.2.2.1) for HpaBPS wild-type and its 
mutants were done to characterize their catalytic activity and substrate specificity. The activity of 
the affinity-purified wild and mutants with various starter substrates (Fig. 62) were determined 
using HPLC. The HPLC chromatograms are shown in (Figs. 105 and 106). HpaBPS wild type 
accepts and prefers benzoyl-CoA as a starter substrate forming 2,4,6-trihydroxybenzophenone as 
main product and 4-hydroxy-6-phenylpyran-2-one side product was also detected. Noteworthy is 
the inactivity of HpaBPS wild with 2-hydroxybenzoyl-CoA substrate. Both of HpaT135L and 
HcT135I mutants accept and prefer benzoyl-CoA as a starter substrate forming 4-hydroxy-6-
phenylpyran-2-one as main product and the second best substrate for those mutants is 3-
hydroxybenzoyl-CoA which in the presence of 2 malonyl-CoAs forms 4-hydroxy-6-(3-hydroxy) 
phenylpyran-2-one as main product and again these 2 mutants did not accepts 2-
hydroxybenzoyl-CoA. 
 
Fig. 62  Catalytic activities and substrate and product specificities of HpaBPS wild-type, HpaT135L and 
HpaT135I mutants. 
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4.5 Results of homology modeling 
In the current study different amino acids especially those with longer and charged side 
chains like lysine were tested in H.sampsonii in addition to studying BPSs from different 
Hypericum species. The initial model of H. androsaemum BPS (Klundt et al., 2009) was created 
by using the Swiss-Model server (Guex and Peitsch, 1997; Arnold et al., 2006) and contained a 
single monomer of HaBPS. An updated model of HsBPS was constructed based on the crystal 
structure of M. sativa CHS2 (Ferrer et al., 1999) complexed with resveratrol (Protein Data Bank 
code 1CGZ) using Yasara Structure (Krieger et al., 2003). The conserved CoA-binding sites and 
catalytic residues were correctly aligned using SSALN (Qiu and Elber, 2006) which indicates 
that the generated model is reliable. This new model contains a dimer as an active species. This 
dimeric quaternary structure is also present in all X-ray crystal structures of related type III 
PKSs. The homology model of the HsBPS dimer was overlaid with the structure 1EE0 (2-pyrone 
synthase complexed with acetoacetyl-CoA (Jez et al., 2000). The dimer model contains no 
acetyl-CoA but can be structurally aligned with the reference structure-1EE0 complexed with 
acetyl-CoA (Fig. 63). The dimer interface in addition to the different amino acids between H. 
sampsonii and H. androsaemum from the amino acid sequence alignment is highlighted. 
 
Fig. 63  Homology model of dimeric HsBPS, red: monomer A, green: monomer B, orange: mutations, 
yellow: active site Cys/His, blue: resveratrol, cyan: acetoacetyl-CoA. The positions 146 and 135 and the 
dimer interface are also highlighted. 
The active site is located very close to the dimer interface and upon mutation of the small 
Thr135 to the large Lys the side chain is too long to fit easily into the active site and so it is most 
likely to reorient towards the dimer interface. Thus, its conformation is completely different from 
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the previous smaller mutations of HaBPS which point directly into the active site as proposed 
before in the published simple monomer model. In the new model, the lysine residue is pointing 
away from the active site with its charged end-group and it is most likely in contact with Met 
140 of monomer B and Met 267 from the dimer interface (Fig.64). 
 
          Fig. 64  Thr135 in wild-type HsBPS (A) and Lys135 in the HsBPS T135K mutant (B). 
 
Rationalization of the effect of the six different amino acids between H.sampsonii and 
H.androsaemum BPSs was performed in the new model. These six different amino acids are not 
catalytic residues or involved in the active site but dramatically affect on the enzyme activity and 
catalysis. In this updated dimer structure the loop from 138 to 144 is part of the dimer interface 
directly adjacent to the active site mutation in position 135 in the other monomer (Fig. 63). 
Therefore, it is likely that the combination of residues in position 135 and 146 is independent but 
will be cooperatively affecting each other. This effect of the adjoining dimer interface will be 
even more pronounced in H. calycinum and H.perforatum ssp angustifolium BPSs. Where the 
active site is identical but the dimer interface contains several exchanges and is most likely 
different. This will result in different orientation of the loop from 138 to 144 which is part of the 
dimer interface directly adjacent to the active site. To clarify this in more detail an X-ray crystal 
structure is required as the current model cannot resolve such global conformational changes.  
The other two residues (Gly230 and Ala235) are surface residues located adjacent to the 
N-terminal dimerization helix and thus may be influencing the dimer interface as well (Fig. 65). 
Interestingly, looking at the alignment (Fig. 56) of H. calycinum and H. perforatum BPSs in this 
region, it can be seen that particularly this loop region 230-235 differs in all sequences 
significantly. When we take the dimer contact residues (N-terminal helix 1 – 20) in this region 
Met 140 
Lys 135 Thr 135 
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into consideration it is second evidence that, despite the high overall sequence identity, exactly 
this dimer contact region has up to 10 exchanges in H. perforatum ssp angustifolium and so the 
dimer interface looks different. 
 
               Fig. 65  Homology model of dimeric HsBPS highlighting positions 230 and 235. 
 
Positions 359 and 360 are located at the end of a helix running into the active site. Any 
conformational changes in this helix from 346 to 360 may impair catalysis globally. Position 
Ala54 (Fig. 66) is in direct contact with -CoA and therefore may be relevant for its binding. This 
can easily explain Km effects if measured on CoA substrates and thus rescue catalysis for the 
mutants. All other residues seem to be related to CoA binding since they are surface residues and 
are located not at the dimer interface but close to the CoA binding site.  
 
                 Fig. 66  Homology model of dimeric HsBPS with position 54 highlighted. 
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5 Discussion 
5.1 Significance of type III PKSs 
The last couple of years resulted in cloning and characterization of a large number of 
CHS genes and several new members of the plant type III PKS gene family with novel and 
unexpected activities and of course future efforts will yield more. These findings confirm the 
significant role of type III PKSs in generating a wealth of substantially variable molecules by 
contributing to the biosynthesis of many classes of plant secondary metabolites in spite of using 
only a small group of biochemical reactions (Abe, 2010; Duckworth, 2012). The first 
investigated and isolated type III PKS was the CHS from parsley (Petroselium hortense) 
(Reimold et al., 1983) due to its significant role in starting the biosynthesis of flavonoids, known 
for their wide distribution in higher plants (Austin and Noel, 2003). The crystallographic studies 
in addition to structure-based mutagenesis investigations of functionally varied type III PKSs 
started to disclose the structural facts of the reactions catalyzed by this fascinating group of 
enzymes. As mentioned before, this group of iterative homodimeric enzymes catalyze the 
sequential condensation of acetyl units derived from the decarboxylation of malonyl-CoA into a 
developing polyketide chain in a reaction similar to that of fatty acid synthases of the primary 
metabolism from which the PKSs probably evolved by gene duplication and subsequent 
refunctionalization of the gene duplicates (Austin and Noel, 2003). PKSs accept a wide range of 
starter substrates leading to functional and chemical diversity in natural products metabolism of 
plants. Divergences in the number of malonyl-CoA condensations in addition to the type of the 
cyclization reactions (Fig. 67) further increase this variation (Austin and Noel, 2003; Flores-
Sanchez and Verpoorte, 2009; Abe, 2010).  
5.2 Mutation and characterization of type III PKSs 
The mutagenic inter-conversion and in vitro characterization of type III PKS enzymes are 
considered as precious tools for confirming functionally relevant divergences inside this 
superfamily. Additionally, the solved crystal structures supply answers to points where 
homology modeling fails to predict the structural and mechanistic effects of vital amino acid 
substitutions (Austin and Noel, 2003). More insights have been  obtained about the steric 
geometry of the active site of type III PKSs and the molecular basis of their reactions after 
resolving the first X-ray crystal structure of MsCHS2 (Ferrer et al., 1999) and structures 
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determination of the following mutagenized forms of MsCHS2 and for 2-pyrone synthase (2PS) 
from G. hybrida (Jez et al., 2000; Jez and Noel, 2002). For example, it was known that, although 
each of the two active sites in CHS and the closely related stilbene synthase (STS) function 
independently, dimerization is required for activity (Tropf et al., 1995). It is now clear that this is 
due to a methionine (Met137) which in each monomer helps to shape the active site cavity of the 
adjoining monomer (Ferrer et al., 1999). It has also been shown that each active site is buried 
within the enzyme and the substrates enter through a long CoA-binding tunnel (Ferrer et al., 
1999). The three key catalytic residues are located within an initiation/elongation cavity, one 
lobe of which forms a coumaroyl binding pocket while the other accommodates and determines 
the length of the developing polyketide chain.  
 
Fig. 67  Cyclization mechanisms catalyzed by plant type III PKSs. The solid arrow illustrates the C6 C1 
Claisen condensation; the long dash-dot arrow represents the C2 C7 aldol condensation, and the round-
dot arrow demonstrates the C5-oxygen C1 lactonization modified from; Flores-Sanchez and Verpoorte, 
(2009). 
Although CHS and 2PS use different substrates (p-coumaroyl-CoA vs. acetyl-CoA) and 
form different products (naringenin and triacetic acid lactone respectively) and exhibit only 74% 
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amino acid sequence identity the three-dimensional overall fold of the two enzymes is almost 
identical with similar catalytic residues and highly conserved CoA-binding residues. However, 
the total cavity volume of the active site of 2PS is one-third of that of MsCHS2 (Fig. 68). 
Remarkably, the steric contraction occurred by alteration of three of the chemically inert residues 
lining the active-site cavity: Thr197, Gly256, and Ser338 in MsCHS2 are substituted with 
Leu202, Leu261, and Ile343 in Gh2PS respectively (Eckermann et al., 1998; Jez et al., 2000). 
Based on the crystal structures of Gh2PS and MsCHS2 these three residues are supposed to play 
a vital role in controlling starter substrate selectivity and the number of malonyl-CoA 
condensations by steric modulation of the active-site cavity and providing an illustration for the 
starter molecule preference of both enzymes.  
The reduced 2-PS active site acts as a size-based filter that sterically precludes the bulky 
p-coumaroyl-CoA but allows entrance of the smaller acetyl-CoA into the initiation/elongation 
cavity. On the other hand, the larger initiation/elongation cavity of CHS allows both binding of 
different-sized aliphatic and aromatic starter molecules. For example, the CHS active site accepts 
long aliphatic CoAs like octanoyl-CoA as a starter while smaller CoAs, such as acetyl-CoA fit 
into the active site but are ineffective starter molecules. The vastness of the CHS active site 
compared to that of 2-PS grants the acetyl moiety greater conformational flexibility that limits 
efficient transfer to the catalytic cysteine (Jez et al., 2000). Interestingly, the 
T197L/G256L/S338I triple mutation in MsCHS2 transformed it into a functional 2PS. These 
results provided the first structural basis of the effect of the volume and shape of the active site 
on the functional diversity of type III PKSs (Dana et al., 2006; Abe, 2010). 
Remarkably, these three residues are also changed in a number of functionally divergent 
type III PKSs including pentaketide synthase from A. arborescens, PCS 
(T197M/G256L/S338V), octaketide synthase from A. arborescens, OKS 
(T197G/G256L/S338V) (Abe et al., 2005), and heptaketide synthase from R. palmatum, ALS 
(T197A/G256L/S338T) (Abe et al., 2004). It has been proposed that these inert active site 
residues control the starter substrate selectivity and polyketide chain length by steric modulation 
of the initiation/elongation cavity (Abe et al., 2005). Comparison between amino acid residues at 
position 197 in different PKSs (Fig. 69) reveals that, the more malonyl-CoA units the enzyme 
adds the smaller the amino acid residue at position 197 tends to be (Ainasoja, 2008). 
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Fig. 68  Comparison of the active site cavities of 2-PS and CHS, the catalytic cysteine (red), the three 
positions that convert CHS into 2-PS (green) and the substitution which did not affect the product 
formation (blue) are highlighted modified from; Jez et al., (2000). 
Site-directed mutagenesis and X-ray crystallographic studies of AaPCS and AaOKS 
revealed that the chemically inert single residue 197 determines the polyketide chain length and 
the product specificity. Replacement of M207 in PCS with glycine transformed PCS into OKS. 
However, small-to-large substitutions in place of Gly207 in OKS resulted in loss of the 
octaketide-forming activity and production of shorter chain length polyketides. Structural 
comparison of AaPCS wild-type and the AaPCSM207G mutant revealed that, the conformations 
of the residues lining the active-site cavity are almost identical in the mutant but the mutant’s 
active site contains extra new buried pockets which extend into the normal active-site cavity 
(Fig. 69). This buried pocket was blocked in the wild-type PCS by the presence of the bulky 
Met207 at its entrance. Replacement of this bulky Met with the small Gly opens a gate to the 
buried pockets thereby expanding the polyketide elongation cavity.  
This is in contrast to the case of 2-PS in which the steric modulation of the active-site 
cavity by alteration of three chemically inert residues lining the active-site was supposed to play 
a critical role in controlling starter substrate selectivity and the number of malonyl-CoA 
condensations (Jez et al., 2000). STS homology models based on the CHS crystal structure 
showed no significant differences between these two enzymes. Despite of the absence of 
established clues for a “steric modulation” elucidation for the development of aldol cyclization 
specificity in STS enzymes, it had been broadly supposed that difference was achieved across 
folding of the tetraketide intermediate into a different conformation, which leads to aldol 
condensation. Recently, careful examination of in vitro enzyme reaction products of recombinant 
Pueraria lobata CHS and Arachis hypogaea STS revealed that both STS and CHS produce 
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minor amounts (1–5% of major product yields) of each other’s cyclization product in addition to 
the styrylpyrone side product formation by STS. This cross-reaction between STS and CHS is 
most likely produced by the conformational flexibility of the active-site of the two enzymes 
(Yamaguchi et al., 1999). 
 
Fig. 69  Schematic representation of the active site architecture of M. sativa CHS, G. hybrida 2PS, A. 
arborescens PCS and OKS, R. palmatum ALS and A. arborescens PCS M207G mutants (numbering in 
MsCHS). The ‘horizontally restricting’ G256L substitution controls the starter substrate selectivity, while 
the ‘downward expanding’ substitution of T197A (ALS) and T197G (OKS) open a gate to an additional 
buried pocket that extends into the ‘floor’ of the active site cavity. On the other hand, the residue T338 
(ALS) and V338 (OKS, PCS) located in proximity of the catalytic Cys164 at the ‘ceiling’ of the active 
site cavity guides the growing polyketide chain to extend into the buried pocket (Abe et al., 2006). 
Crystallographic comparison (of the crystal structures of P. sylvestris STS (Austin et al., 
2004) and A. hypogaea STS (Shomura et al., 2005) with MsCHS2 in addition to structure-guided 
mutagenic transformation of CHS into STS proved that, STS’s different cyclization specificity is 
occurred by a significant conformational backbone change (Fig. 70). That change occurs on a 
short buried loop between residues (132 - 136). These residues are located at the dimer interface 
between the two active sites. This movement is caused by various amino acid substitutions at 
buried positions adjoining to this loop (significantly the replacement of Val98 with a bulkier 
side-chain of Met amino acid) and results in a in an altered active site hydrogen-bonding network 
around the slightly repositioned Thr132 (numbering in MsCHS2). This active site residue 
(conserved in both CHS and STS) changes its bonding interaction with Glu192 (conserved in all 
type III PKSs) and based on this change, Thr132 side chain hydroxyl moiety will present within 
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the hydrogen bonding distance of a water molecule neighboring to the catalytic cysteine. Thr132 
in this area is supposed to play a crucial role in balancing competing cyclization specificities in 
CHS and STS (Austin et al., 2004). whereas Thr132 is a highly conserved in type III PKSs, the 
positional difference significantly affects the hydrogen bond network around the catalytic 
Cys164 the so-called ‘‘aldol-switch’’ thioesterase-like electronic hydrogen-bond network 
involving Ser338-H2O-Thr132-Glu192 is located adjacent to the catalytic Cys164 in the active-
site of STS which is not observed in the structure of CHS (Austin et al., 2004). A three 
dimensional comparison of the CHS and STS active sites lays doubt upon models that attribute 
these enzymes cyclization differences to alternative productive conformations of their shared 
linear tetraketide intermediate achieved by steric differences between the CHS and STS active 
site cavities. Crystallographic results suggest instead that, those active site changes obviously of 
an electronic rather than steric nature, favor an alternative cyclization mechanism within the 
context of a quite similarly folded tetraketide intermediate. This latter model is also consistent 
with the previously observed cross-reactivity of CHS and STS (Yamaguchi et al., 1999; Austin 
and Noel, 2003; Abe, 2010).  
 
Fig. 70  Active site of M. sativa CHS2 (silver) and P. sylvestris STS (green). Naringenin and resveratrol 
complexed with M. sativa CHS2 are shown in black and sky-blue respectively. Resveratrol in structure of 
a CHS mutant which is a functional mutant having the STS activity, is superimposed in A: to demonstrate 
that the products of both enzymes are attached in an almost identical position. B: Close-up look of the 
loops between 131–136 in STS and CHS. Close-up look of the hydrogen bond networks in C: CHS and 
D: STS. The hydrogen bonds and their distances are indicated with parentheses. The putative nucleophilic 
water molecule in STS and in CHS2 is shown by blue spheres (Abe, 2010). 
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5.3 Type III PKSs which accepts benzoyl-CoA substrate 
In comparison to CHS and STS which both use p-coumaroyl-CoA as the starter substrate, 
PKSs that use benzoyl-CoA as a starter unit is less well studied at the structural and mutational 
levels. Benzoyl-CoA-derived polyketides such as biphenyls and benzophenones which are the 
phytoalexins of the Maloideae (apple and pear) and Hypericaceae (St. John’s wort) are 
synthesized by biphenyl synthase (BIS) and benzophenone synthase (BPS) respectively. BIS and 
BPS are two members of the non-chalcone forming plant type III PKSs. They accept and prefer 
benzoyl-CoA as a starter substrate, form the same linear tetraketide intermediate after three 
malonyl-CoA condensations however, catalyze either intramolecular C6→C1 Claisen 
condensation (BPS) to give 2,4,6-trihydroxybenzophenone or intramolecular C2→C7 aldol 
condensation followed by decarboxylative elimination of the terminal carboxyl group (BIS) to 
produce 3,5-dihydroxybiphenyl (Fig. 71) (Liu et al., 2003; Liu et al., 2010).  
In addition to benzoyl-CoA as starter these two enzymes also accept 3-hydroxybenzoyl-
CoA forming 6-(3-hydroxy-phenyl)-4-hydroxy-2-pyrone after two condensations with malony-
CoA in case of BIS while BPS forms 2,3',4,6-tetrahydroxybenzophenone after three malonyl-
CoA extensions (Fig. 71). Interestingly, BIS also accepts 2-hydroxybenzoyl-CoA as a substrate 
and forms 4-hydroxycoumarin after single malonyl-CoA extension while neither HaBPS nor its 
mutants showed any activity with that substrate (Klundt et al., 2009; Liu et al., 2010). Since 
recently, GmBPS and HsBPS (Huang et al., 2012; Nualkaew et al., 2012) are the only reported 
BPSs that accept salicoyl-CoA and form small amounts of 4-hydroxycoumarin. BIS and BPS 
were first cloned from cell cultures of S. aucuparia and H. androsaemum respectively. They 
share 54% amino acid sequence identity (Liu et al., 2003; Liu et al., 2007; Beerhues and Liu, 
2009). Using site-directed mutagenesis (Klundt et al., 2009) constructed a large number of 
mutants based on the amino acids sequence comparison between HaBPS and different members 
of type III PKSs aiming to transform HaBPS into another polyketide synthase, like CHS, ACS 
and BAS but all of these trials were not successful. HaT135L is the only mutant that was able to 
drastically change the substrate and product specificities of HaBPS wild-type and transformed it 
into a functional phenylpyrone synthase (PPS). PPS was a new PKS variant that was not yet 
known as a naturally occurring enzyme function. Remarkably, the trials to replace Leu135 with 
other amino acids like isoleucine and alanine resulted in catalytically inactive proteins (Klundt et 
al., 2009). Thus, the position 135 in BPS turned out to be highly interesting and based on the 
above findings provoked the idea of screening different amino acids in this position. In the 
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current study all of the BPSs which were cloned from selected Hypericum species maintained the 
same amino acid residues along the active site cavity especially Thr135 (numbering from 
HsBPS) which is also conserved in most of the plant type III PKSs (Tab. 19). In RpBAS, the 
corresponding residue Thr132 is located within a loop region at the entrance of the coumaroyl 
binding pocket and the flexibility of this loop was supposed to be essential also for the activity of 
this enzyme (Shimokawa et al., 2010). 
 
Fig. 71  Reactions of BIS and BPS wild-type enzymes with different substrates. 
5.4 H. sampsonii benzophenone synthase T135K mutant 
Our challenge was to find out if there is any other amino acid that will be able to play the 
same role like leucine in this critical position or results in a new activity added to the wealth of 
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type III PKSs activities. Screening of the effects of the other 19 amino acids in position 135 of 
H. sampsonii BPS wild-type revealed that, only the HsT135K mutant, in which Thr was 
exchanged with Lys, dramatically changed the substrate and the product specificities 
transforming H. sampsonii BPS wild-type (HsBPS) into a functional 4-hydroxycoumarine 
synthase (HCS). Again, HCS is a new type III PKS variant that has not yet been detected in 
nature. The main and preferred starter substrate for the interesting enzyme mutant was 2-
hydroxybenzoyl (salicoyl)-CoA rather than benzoyl-CoA. Furthermore, the HsT135K mutant 
catalyzed only a single decarboxylative condensation with malonyl-CoA to form a linear 
diketide intermediate which then undergoes intramolecular cyclization by nucleophilic attack of 
the phenol group on the -CoA or cysteine-tethered C1 thioester followed by enolization, 
spontaneous lactonization and 4-hydroxycoumarin formation. So far, salicoyl-CoA has only been 
observed as a minor substrate for BPSs from Garcinia mangostana and H. sampsonii. 
Interestingly, these results illustrate that a single amino acid substitution in HsBPS impressively 
shifts the molecular selectivity of this enzyme, resulting in a novel PKS activity and further 
expansion of the biosynthetic repertoire of the type III PKS superfamily. This novel PKS activity 
reflects another step toward the modification of the biosynthetic activities of this group of 
enzymes and confirms their capability in creating a wide range of compounds.  
The HsT135K assays contained only 4-hydroxycoumarin and no substituted 
benzophenone derivative when started with salicoyl-CoA as a starter substrate. We had expected 
that the HsT135K mutant might also catalyze three malonyl-CoA condensations resulting in 
formation of an ortho-substituted benzophenone which undergoes water elimination, yielding 
1,3-dihydroxyxanthone. For comparison, 2'-O-ß-D-glucopyranosyl-2,4,5',6-
tetrahydroxybenzophenone (hypericophenonoside) was isolated from an H. annulatum 
methanolic extract and subjected to mild acid hydrolysis for sugar release which converted the 
resulting aglycone spontaneously into 1,3,7 trihydroxyxanthone (Fig. 72). Hypericophenonoside 
is considered as the second benzophenone-O-glycoside found in nature after the previous 
detection of 2,4',6-trihydroxy-4-methoxybenzophenone-2-O-glucoside. Isolation of these 
compounds supports the hypothesis that some xanthones might be formed in plants by 
dehydration of 2,2'-dihydroxybenzophenones and the intermediate precursors appear to be 
benzophenone O-glycosides ortho to the carbonyl function (Ferrari et al., 2000; Kitanov and 
Nedialkov, 2001). 
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Fig. 72  Hydrolysis and cyclization reactions of 2'-glycosylated benzophenones (Kitanov and Nedialkov, 
2001). 
A comparable case happened in case of SaBISs which also formed only 4-
hydroxycoumarin after a single malonyl-CoA condensation reaction and no ortho-substituted 
biphenyl was detected in the enzymatic reaction. The exclusive 4-hydroxycoumarin formation 
indicates that the hydroxyl group in the ortho position of salicoyl-CoA favors the early 
intramolecular cyclization and hinders further condensations with other malonyl-CoA molecules 
(Lin et al., 2013). 
The steady state kinetic analysis was carried out to determine the quantitative effect of 
the introduction of lysine in position 135. The results revealed that the HsT135K mutant showed 
a Km = 43.92 µM and a Kcat = 1.181 sec
-1
 for salicoyl-CoA (Tab. 16). On the other hand the 
previously reported 4-hydroxycoumarin forming SaBIS2 and SaBIS3 exhibited Km values of 2.3 
and 3.2 µM and Kcat values of 0.0293 and 0.037 sec
-1
, respectively (Tab. 16) (Liu et al., 2010). It 
is obvious that the affinity of HsT135K for salicoyl-CoA was 19- and 14-fold lower than that of 
SaBIS2 and BIS3 however, the mutant showed 40- and 32-fold higher turnover rates compared 
to the BISs respectively. Finally, a 2-fold higher catalytic efficiency (Kcat/Km) resulted for the 
HsT135K mutant compared to SaBIS2 and SaBIS3. These results indicate that the single amino 
acid substitution in the active site cavity of HsBPS mainly affects the catalytic process more than 
the substrate binding. Notably, the Km for malonyl-CoA of the HsT135K mutant equals 747 µM 
which is around 8 fold higher than that of the HsBPS wild-type enzyme (92.5 µM) (Huang et al., 
2012). Remarkably, HsBPS wild-type showed the highest malonyl-CoA Km value compared to 
other wild-type BPSs e.g. from H. androsaemum (Km 31.3 µM) and G. mangostana (Km 16.38 
µM) which on the other side points to subtle differences in the active site structures between 
BPSs from different Hypericum and Clusiaceae species. 
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Tab. 16  Steady state kinetic values for salicoyl-CoA substrate for HsT135K mutant compared to SaBIS2 
and SaBIS3 (Liu et al., 2010) 
Enzyme Km µM Kcat sec
-1
 Kcat/Km sec
-1 
M
-1
 
HsT135K 43.92 1.181 26889 
SaBIS2 2.3 0.0293 12716 
SaBIS3 3.2 0.037 11486 
Analogous situations were documented in two cases, a point mutation in position F215 in 
Scutellaria baicalensis CHS (SbCHS) (Abe et al., 2003)  and site-directed mutagenesis in M. 
sativa CHS (MsCHS) in position G256 (Jez et al., 2001). Concerning SbCHS point mutations in 
position F215 (F215W, F215Y, F215S, F215A, F215H and F215C) were constructed and tested 
for the resulting enzyme activities. When these mutations were compared to the former mutation 
studies done by (Jez et al., 2000) in the same position of MsCHS many differences in the 
activities of the mutants resulted. That indicates the presence of different active site structures in 
each species. For example, MsCHS F215W, F215Y and F215S mutations led to formation of 
increased levels of derailment products. Also the MsF215S mutant accepted non-physiological 
N-methylanthraniloyl-CoA as a starter to produce an unnatural tetraketide pyrone (Jez et al., 
2002) while in SbCHS, the point mutations considerably decreased chalcone formation and 
modified functional behavior of the enzyme to various levels. Interestingly, the steady state 
kinetic results of the SbCHS mutants showed a great variation especially in the affinity of the 
enzyme mutants to the starter and extender substrates. Such as SbF215A, SbF215Y, SbF215C, 
and SbF215S which showed 6.6, 35.6, 13 and 10.7 µM p-coumaroyl-CoA Km values respectively 
and 1099, 386, 247 and 117 µM  malonyl-CoA Km values respectively when compared to the 
wild-type SbCHS with 5.8 and 25.5 µM Km values for p-coumaroyl-CoA and malonyl-CoA 
respectively.  
Tab. 17  Scutellaria baicalensis CHS mutants and their p-coumaroyl-CoA and malonyl-CoA Km values 
(Abe et al., 2003) 
Enzyme p-coumaroyl-CoA Km (µM) Malonyl-CoA Km (µM) 
SbCHS 5.8 25.5 
SbF215A 6.6 1099 
SbF215Y 35.6 386 
SbF215C 13 247 
SbF215S 10.7 117 
Discussion 
 
130 
 
Those experiments led to 9 - 209-fold decrease in Kcat/Km values for p-coumaroyl-CoA 
and 7 - 2815-fold decreases in Kcat/Km values for malonyl-CoA compared with wild-type CHS 
(Tab. 17). The previous findings confirm the direct effect of point mutations on the catalytic 
efficiency of the enzyme with pronounced effect on malonyl-CoA. On the other hand, it was 
notable that the SbF215Y mutation resulted in almost complete loss of enzyme activity. In 
contrast, the MsF215Y mutant still saved chalcone-forming activity proposing delicate species-
difference of the active site structures between S. baicalensis and M. sativa (Jez et al., 2000; Abe 
et al., 2003). In MsCHS, replacement of Gly256 with valine resulted in 3 and 8 fold reduction in 
the Kcat values for p-coumaroyl-CoA and malonyl-CoA respectively. The MsG256L and 
MsG256F mutants showed the greatest variations in the steady-state kinetic parameters. The 
G256L mutant exhibited 75 and 9 fold decrease in the catalytic efficiency (Kcat/Km) with 
malonyl-CoA and p-coumaroyl-CoA respectively. Replacement of Gly256 with phenylalanine 
also decreased the catalytic efficiencies with p-coumaroyl-CoA and malonyl-CoA by 14 and 47 
fold respectively. These kinetic results illustrate that introduction of residues with bulky side 
chains at position 256 reduces the catalytic efficiency of each mutant enzyme compared to wild-
type MsCHS and even the greatest effect was observed for malonyl-CoA (Jez et al., 2001). 
Ultimately, the right and correct position of substrates at the active site allows the ‘catalytic’ 
residues to perform their maximal effect thereby connecting the assistance of binding 
interactions to catalysis. Therefore, it is tempting to speculate that with active site 
conformational changes due to introduced mutations for amino acids lining the active site 
malonyl-CoA may sample a range of conformations at the active site only some of which allow 
the right interaction with the catalytic residues and so lead to a successful decarboxylation 
reaction to take place (Jez et al., 2000).  
5.4.1 Biosynthesis and anticoagulant activity of 4-hydroxycoumarins  
The biosynthesis of 4-hydroxycoumarin is usually related to the effect of molds on trans-
2-coumaric acid-containing plants such as sweet clover (Melilotus albus, Fabaceae). Trans-2-
coumaric acid is stored as O-glucoside and hydrated after sugar release to yield 3-
hydroxymelilotic acid which then dehydrogenates to yield 3-oxomelilotic acid (Bye and King, 
1970). These acids are found as their -CoA thioesters. Spontaneous lactonization of 3-
oxomelilotic acid takes place to produce 4-hydroxycoumarin (Fig. 73). In the presence of 
formaldehyde produced from microbial degradation two molecules of 4-hydroxycoumarin can 
form dicoumarol none-enzymatically. Dicoumarol is a natural anticoagulant and acted as a 
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precursor for the synthetic anticoagulants such as warfarin, acenocoumarol and phenprocoumon 
(Fig. 74). Notably, some plant species such as Ferula communis (Apiaceae) contain 4-
hydroxycoumarin derivatives such as ferulenol (Fig. 74) without the molds fermentation effect. 
Ferulosis is a disease that results from ingestion of ferula plant. It causes hemorrhagic symptoms 
similar to those caused by sweet clover. Up to date the ferulenol biosynthetic pathway still 
unclear. Interestingly, precursor-feeding experiments in Gerbera jamesonii (Asteraceae) 
indicated that 4-hydroxy-5-methylcoumarin is synthesized via a pentaketide which is derived 
from one acetate and four malonates which strongly suggest the involvement of a type III PKS in 
its formation. (Inoue et al., 1989; Schröder, 2009; Liu et al., 2010). 
 
Fig. 73  Proposed biosynthetic pathway of 4-hydroxycoumarin by molds. 
 
Fig. 74  Structures of 4-hydroxycoumarin and some of its clinically used anticoagulant derivatives. 
Interesting are the biosynthesis models of 4-hydroxy-5-methylcoumarin proposed by 
(Schröder, 2009) especially the second one. In the first model he suggested that the biosynthesis 
of 4-hydroxy-5-methylcoumarin occurs via a pentaketide intermediate (Fig. 75, A) after a 
reduction step that results in the elimination of one of the oxygen functions during aromatization 
of the molecule. This reduction step is very fundamental to get the right product otherwise the 
derailment products will formed. The second model (Fig. 75, B) proposed that 4-hydroxy-5-
methylcoumarin may be synthesized by two reactions, the first reaction includes three 
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condensations followed by the reduction step which results in the formation of 6-
methylsalicylate. This reaction is not known from plants but also well-known from fungi by a 
type I PKS rather than a type III PKS (Dimroth et al., 1970).  
The second reaction would utilize 6-methylsalicoyl-CoA as substrate and perform only 
one condensation followed by the ring-closure to the pyrone ring of the 4-hydroxy-5-
methylcoumarin. The author supposed that the second step of this reaction requires a type III 
PKS which showed high activity with salicoyl-CoA and catalyzes a single malonyl-CoA 
extension to form 4-hydroxycoumarin and so this enzyme should accept 6-methylsalicoyl-CoA 
leading to formation of 4-hydroxy-5-methylcoumarin. It is a fascinating idea that a type III PKS 
might be involved in the biosynthesis of 4-hydroxy-5-methylcoumarin (Schröder, 2009).  
In the current study we have transformed a BPS into a 4-hydroxycoumarin synthase for 
which salicoyl-CoA is the best substrate. Therefore, it will be promising to figure out the activity 
of the HsT135K mutant with 6-methylsalicoyl-CoA as a substrate. In fact we synthesized and 
offered 2-methoxybenzoyl-NAC and 2-mercaptobenzoyl-NAC aiming to get methoxylated 
benzophenones or thiocoumarins respectively but unfortunately these precursors were accepted 
by neither the HaT135K mutant nor the wild-type BPS enzyme. HsT135K mutant also did not 
accept salicoyl-NAC. while HsBPS wild efficiently converted salicoyl and benzoyl-NACs to 4-
hydroxycoumarin and trihydroxybenzophenone respectively.  
Coumarins involve a huge array of biologically active compounds which have been used 
in traditional medicine for many years. They constitute a significant category of compounds with 
numerous pharmacological activities like anticancer, anti-HIV, anticoagulant, spasmolytic, 
antibacterial and antifungal activities. Antioxidant and antiproliferative activities are the most 
important and intensively investigated of the numerous coumarin activities (Kostova, 2005; Arif 
et al., 2009; Schröder, 2009; Kinza Aslam et al., 2010). Recently, a lot of light was shed on 
coumarins as they show a wide range of effects on tumors. Intensive work is going on to explore 
the role of these compounds in the treatment of cancer. Several studies revealed that coumarins 
stimulate the inhibitory effects on cell growth of various carcinoma cell lines and may be 
potential candidates for cancer therapy (Kostova, 2007). 4-Hydroxycoumarin (4HC) is the 
precursor of the anticoagulant dicoumarol and the model for the synthesis of warfarin (Fig. 74). 
The latter is one of the most prescribed oral anticoagulants worldwide and is the best choice for 
the long-term therapy and prevention of thromboembolic diseases such as deep vein thrombosis.  
Warfarin was a top 20 drug by prescription volume in the United States and had a global 
market value of $300 million in 2008. In Europe the most commonly used oral anticoagulants 
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are acenocoumarol and phenprocoumon. They share the 4HC skeleton but differ in 3-substitution 
on the pyrone ring. They can be chemically synthesized using 4-hydroxycoumarin as a direct 
precursor (Rost et al., 2004; Nicholas and Rettie, 2008; Lin et al., 2013). 4-Hydroxycoumarin 
derivatives can interfere with blood clotting due to the strong structural similarity of their 4-
hydroxycoumarin core to that of vitamin K. Any chemical modulations of the strictly conserved 
enolic 4-hydroxy group abolish the ability of these drugs to act as inhibitors of VKOR activity 
(Nicholas and Rettie, 2008). VKOR is a vitamin K epoxide reductase which converts vitamin K 
2,3-epoxide to vitamin K which is reduced to vitamin K hydroquinone which is an essential 
cofactor for posttranslational γ-carboxylation of several blood coagulation factors, such as II 
(prothrombin) VII, IX and X (Rost et al., 2004) (Fig. 76).  
 
Fig. 75  Models for 4-hydroxyl-5-methylcoumarin biosynthesis A: Biosynthesis via one reaction 
pentaketide, B: biosynthesis by two reactions modified from; Schröder, (2009). 
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Fig. 76  Mechanism of 4-hydroxycoumarin derivatives such as warfarin as oral anticoagulants 
modified from; Bhonoah, (2006). 
5.4.2 H.androsaemum benzophenone synthase T135K single and double mutations 
Interestingly, replacement of threonine in position 135 with lysine in the BPS of H. 
androsaemum (HaBPS) was also successful and completely changed the substrate and product 
specificities of HaBPS wild-type. The new mutant prefers salicoyl-CoA as a substrate catalyzing 
4HC formation but with much lower activity compared to the HsT135K variant. Many trials 
were done to improve the activity of the HaT135K single mutant. The only successful trial was 
the double mutation including position 135 with other different positions between HaBPS and 
HsBPS (HaE54D/T135K, HaV146A/T135K, HaC230G/T135K, HaS235A/T135K and 
HaV359L/T135K), except for position 360, which showed no over-expression in the host cells 
(Fig. 95, D). These results suggest the difference in the active site architecture between these two 
Hypericum BPSs (HaBPS and HsBPS). Determination of the steady state kinetic characters was 
calculated for one of these H. androsaemum lysine double mutants. The target was to find a 
mutant which is highly active with salicoyl-CoA and at the same time has a high affinity for 
malonyl-CoA. The HaV146A/T135K double mutant was selected due to its high activity with 
salicoyl-CoA. Unfourtionatly, its catalytic effeciency (Kcat/Km) was 4-fold lower than that of the 
HsT135K single mutant in addition to a 1.3-fold higher malony-CoA Km value compared to 
HsT135K mutant. Interestingly, carrying out the same mutation in the same position with two 
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other Hypericum species (HcBPS and HpaBPS) resulted in no over-expression in the host cells 
in case of HpaT135K mutant and the absence of soluble protein in case of HcT135K mutant as 
shown by SDS-PAGE analysis of these two mutants (Fig. 104, D and 101 D) respectively. These 
data propose minor species differences of the active site conformations between different 
Hypericum BPSs despite having the same amino acids lining the active site cavity. 
5.5 Effect of Leu and Ile instead of Thr135 in BPSs from different 
Hypericum species 
Leucine and isoleucine are another two amino acids that dramatically changed the 
substrate and product specificities of HsBPS. The replacement of Thr135 in HsBPS with Leu or 
Ile transformed HsBPS wild-type into phenylpyrone synthase (PPS). Leucine is the only amino 
acid which results in a dramatically different variant of HaBPS wild type. The functional 
behavior of the HaT135L mutant was rationalized by using homology modeling based on the 
crystal structure of chalcone synthase. HaBPS wild-type and the HaT135L mutant catalyze 
different reaction mechanisms which result in formation of different products (Fig. 77). The 
modeling explains the difference between them at the diketide and the triketide stages. Up to the 
diketide stage (Fig. 78) both HaBPS wild-type and the HaT135L mutant do not exhibit 
dissimilarities in the active site cavities which contain the reaction intermediates. However, at 
the triketide stage (Fig. 79) there were drastic changes in the guidance and the conformation of 
the polyketide intermediate. Structural differences in the active sites of wild-type HaBPS and the 
HaT135L mutant resulted in a change in the product specificity. The phenyl ring from benzoyl-
CoA in HaBPS wild-type projects into the elongation cavity where the acetyl moieties resulting 
from malonyl-CoA decarboxylation are added. This elongation cavity is open because of 
hydrogen bond formation between the hydroxyl group of Thr135 and the backbone amides of 
Gln165 and Gly166. In contrast, in the HaBPST135L mutant, leucine projects into the entrance 
space of the elongation cavity leading to steric hindrance. In addition, the absence of the 
hydroxyl group which was found in the polar Thr the hydrogen bonding with Gln165 and 
Gly166 was removed resulting in the formation of a new pocket. Favorable hydrophobic 
interactions between the lipophilic Leu135 side chain and the benzene ring of benzoyl-CoA 
result in a new orientation of substrate binding and elongation in the T135L mutant (Baker and 
Seah, 2012). The catalytic efficiency (Kcat/Km) for the mutant was nearly unchanged compared to 
the wild-type enzyme as an 8-fold Kcat decrease was offset by an 8-fold Km refinement.  
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When 3-hydroxybenzoyl-CoA is used as the starter substrate the HaBPS wild-type 
enzyme catalyzed condensations with three malonyl-CoAs to give a linear tetraketide 
intermediate which cyclized into 2,3',4,6-tetrahydroxybenzophenone. However, the HaT135L 
mutant was nearly inactive with 3-hydroxybenzoyl CoA as a starter substrate as the 3-hydroxyl 
group of the aroyl moiety of the triketide intermediate resides in the position that is occupied in 
the wild-type enzyme by the hydroxyl group of the Thr135 side chain. Consequently, the 3-
hydroxyl group of the triketide now forms hydrogen bonds with the backbone carbonyl and 
amide groups of Gly166. Thus, the 3-hydroxybenzoyl-primed triketide may be trapped in the 
new pocket of the active site cavity of the T135L mutant. It acts as an inhibitor explaining why 
the mutant enzyme is almost inactive with 3-hydroxybenzoyl-CoA as a starter substrate. Thus, 
the T135L substitution changes both the substrate and the product specificity of BPS (Klundt et 
al., 2009; Baker and Seah, 2012).  
The HsT135I and HsT135L mutants showed some deviation from the previous 
postulations based on the constructed model for HaBPS wild-type and its mutant. 1- Ile in 
position 135 in case of HaBPS gave catalytically inactive protein while it transformed HsBPS 
into PPS. As mentioned before, Ile is the amino acid occupying position 135 in the natural 
phenylpyrone synthase cloned recently in our group (Gaid, unpublished results). 2- These two 
mutants (HsT135I and HsT135L) prefer benzoyl-CoA as a starter substrate catalyzing two 
malonyl-CoA extensions and result in the formation of 6-phenyl-4-hydroxy-2-pyrone. 3-
Hydroxybenzoyl-CoA is the second best substrate for these two mutants as they form 6-(3-
hydroxyphenyl)-4-hydroxy-2-pyrone as a single product after two malonyl-CoA extensions. 
Notably, this substrate was a poor starter substrate for HaT135L mutant due to blocking the new 
pocket by the 3-hydroxybenzoyl-primed triketide intermediate which acts as inhibitor preventing 
further product formation (Fig. 79) (Klundt et al., 2009). 3- HsT135I and HsT135L mutants 
showed around 17 and 9% activity respectively, with salicoyl-CoA forming 4-hydroxycoumarin. 
4- These two mutants also accept anthraniloyl- and N-methylanthraniloyl-CoAs and form 4-
hydroxy-2(1H)-quinolone and 4-hydroxy-1-methyl-2(1H)-quinolone respectively. 
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Fig. 77  Reaction mechanisms of H. androsaemum BPS wild-type and the HaT135L mutant. The  active 
site structure differences between HaBPS wild-type and HaT135L mutant result in altered product 
specificities. 
 
Fig. 78  CHS-based homology model of the HaBPS active site cavity complexed with both the benzoyl-
primed diketide that is covalently bound to the catalytic cysteine 167 and malonyl-CoA that is used for 
the next chain elongation reaction. Amino acids of the initiation and elongation pockets are highlighted in 
pink and green, respectively. The catalytic triad is displayed in yellow (Cys167) and gray (His307 and 
Asn340) modified from; Klundt et al., (2009). 
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Fig. 79  CHS-based homology models of the active site cavities of wild-type HaBPS (a and c) and the 
HaT135L mutant (b, d). The benzoyl-primed (a, b) and 3-hydroxybenzoyl-primed triketides (c and d) are 
covalently attached to the catalytic cysteine 167. The wild-type enzyme catalyzes another acetyl addition 
to the intermediate triketides. In the mutant enzyme, however, the triketides may be redirected into a new 
pocket where no further chain elongation takes place (Klundt et al., 2009). 
5.6 Anthraniloyl and N-methylanthraniloyl-CoAs substrates  
Remarkably, HsBPS wild type showed around 7 and 12% activities with anthraniloyl and 
N-methylanthraniloyl-CoAs respectively. While the three mutants (HsT135K, Hst135I and 
HsT135L) showed 15, 20 and 43% activities with anthraniloyl-CoA and 6, 5, and 8% activities 
with N-methylanthraniloyl-CoA respectively. These findings are differing from R. palmatum 
benzalacetone synthase (RpBAS) and Aegle marmelos quinolone synthase (AmQNS) which 
showed highest activity with N-methylanthraniloyl-CoA (Abe et al., 2006; Resmi et al., 2013). 
RpBAS is a diketide-producing PKS and can efficiently catalyze condensation of N-
methylanthraniloyl-CoA (or anthraniloyl-CoA) with malonyl-CoA (or methylmalonyl-CoA) to 
produce 4-hydroxy-2(1H)-quinolone and the activity with N-methylanthraniloyl-CoA and 
anthraniloyl-CoA was 80% and 4% respectively (Abe et al., 2006). AmQNS accepts different 
starter substrates forming triketide and tetraketide lactones while N-methylanthraniloyl-CoA is 
the best substrate for this new type III PKSs member (Resmi et al., 2013). Transformation of 
AmQNS to CHS was carried out by (Resmi et al., 2013) via two amino acid substitutions 
S132T/A133S (numbering from MsCHS). It will be interesting to transform HsBPS into QNS 
especially since we already have HsT135S as a single mutant. Ultimately, leucine is present 
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naturally in RpBAS in position 132 (numbering from MsCHS). Notably, this active-site residue 
(Leu132) is located at the entrance of the coumaroyl binding pocket and it was supposed that it 
also plays a crucial role in the benzalacetone forming activity besides Ile214/Leu215 residues 
which are located at the junction between the active-site cavity and the CoA binding tunnel.  
 
Fig. 80  Active-site architecture comparisons of RpBAS A: wild-type, B: MsCHS, C: L132T and D: 
L132W mutants. Surface models illustrate the active sites. The coumarate that covalently binds to the 
active site Cys in BAS and the naringenin molecules are shown as black and green stick models 
respectively. The bottoms of the ‘coumaroyl binding pocket’ are highlighted in purple modified from; 
Shimokawa et al., (2010). 
The distinctive substitution of Thr132 (numbering in MsCHS2), which is highly 
conserved in most type III PKSs, with Leu causes steric contraction of the BAS active-site to 
form the diketide instead of the tetraketide intermediate. Only replacement of L132 with Thr 
(like MsCHS) restored the chalcone-forming activity in RpBAS. The homology models 
predicted that the L132T mutant restored the coumaroyl binding pocket in the active-site cavity 
(Fig. 80). It was previously proposed that Thr132 in CHS forms a hydrogen bond with the 
neighboring Glu192 and is thought to control the folding of the tetraketide intermediate so that 
the Claisen-type cyclization results in chalcone formation (Austin et al., 2004). These 
observations suggest that the L132T substitution in RpBAS opens a gate to the buried 
coumaroyl-binding pocket thereby increasing the polyketide chain elongation by up to three 
condensations with malonyl-CoA and leading to the formation of chalcone (Shimokawa et al., 
2010). Natural phenylpyrone derivatives were isolated from some Aloe species (Rebecca et al., 
2003;  ur   et al., 2004). Previously, psilotinin that is 4'-hydroxylated phenylpyrone was found in 
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Psilotum nudum (Whisk fern) which is the most primitive vascular plant (Mclnnes et al., 1965). 
Feeding experiments proposed that psilotinin results from condensation of single malonyl-CoA 
with coumaroyl-CoA followed by lactonization (Leete et al., 1982). Several type III PKSs such 
as CHS, STS and VPS were cloned from this species but nothing was reported about PPS 
activity despite of extensive work. Ultimately, The Kcat/Km values of the HsT135I and HsT135L 
mutants are 2.5 and 3.5-fold higher respectively compared to the HaT135L mutant from H. 
androsaemum (Klundt et al., 2009). However, they are more or less similar to those of the 
HsBPS wild-type (Huang et al., 2012). Both HsT135I and HsT135L showed 10 and 4 fold higher 
Km values for malonyl-CoA compared to HsBPS wild-type (Huang et al., 2012). Replacement of 
Thr135 with leucine or isoleucine in case of HcBPS and HpaBPS gave the same results like 
HsBPS mutants. They transformed HcBPS and HpaBPS into PPSs. All the previous results 
suggest the active site architectural differences between these Hypericum BPSs. Pyrone 
compounds such as 5,6-dihydro-4-hydroxy-6-phenylpyran-2-one and its derivatives like those 
which have thiophenyl and thiobenzyl side chains at C-3 (Fig. 81) are used as small nonpeptide 
protease inhibitors of the human immunodeficiency virus (HIV). Inhibition of HIV protease is an 
important target for antiviral therapy. It was reported that HIV which lacks this protease is non-
infectious (Tait et al., 1997).  
 
Fig. 81  Structures of 5,6-dihydro-4-hydroxy-6-phenylpyran-2-one derivatives, which block HIV 
protease. 
Generally, mutations of type III PKSs that have a single active site are characterized by 
unforeseen results. For example, transformation of PCS to OKS by single amino acid 
substitution in position M207G while large to small substitutions in place of Gly207 in OKS 
resulted in loss of the octaketide forming activity and production of shorter chain-length 
polyketides ranging from triketide to heptaketide as mentioned before (Abe, 2008). In addition to 
identifying new enzymes and biosynthetic pathways, the challenge now is how to use these 
results in industrial and medicinal fields. Considerable research works are now devoted to 
understanding type III PKSs and engineering this fascinating group of enzymes. The objective is 
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to develop new compounds with significant and distinct biological activities (U.Nair et al., 
2010). One of the most essential properties in the engineering of an enzyme for selective 
catalysis is changing the substrate specificity either by shifting the specificity towards novel 
substrates or expanding and narrowing substrate specificity. Type III PKSs are promiscuous 
enzymes accepting a wide range of starter substrates. Engineering of an enzyme to have a narrow 
substrate range is a challenge. Site-directed mutagenesis (SDM) plays a crucial role in this area. 
In the present study by using SDM a single amino acid substitution (HsT135K) switched the 
substrate specificity of HsBPS wild-type from benzoyl-CoA and 3-hydroxybenzoyl-CoA to 
salicoyl-CoA. 
 
Fig. 82 Proposed reaction mechanisms of HsBPS wild-type, HsT135L, HsT135I and HsT135K enzyme 
mutants. 
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Not only the substrate specificity changed but there was also a dramatically altered 
product specificity from tri and tetrahydroxybenzophenones after three malonyl-CoA extensions 
and Claisen condensation to 4-hydroxycoumarin after only one malonyl-CoA extension and 
spontaneous lactonization (Fig. 82). However, leucine or isoleucine in the same position result in 
formation of phenylpyrone after two malonyl-CoA extensions and lactonization, which is a 
drastic change in the product specificity as HsT135I and HsT135L, still accept benzoyl and 3-
hydroxybenzoyl-CoAs as substrates (Fig. 82). 
5.7 Amino acids which did not dramatically change the activity  
Other amino acids in position135 (Thr135) instead of threonine gave variable results. 
Aspartic acid, glutamine and proline showed no expression in the host cells as shown by SDS-
PAGE analysis (Fig. 23). It was reported that most of the expression problems are due to protein 
toxicity. No expression in the host cells is one of these problems which indicate that these 
proteins are too toxic to the host cells and results in cell death (Inc., 2009). Normally, in 
biological systems any specific protein is expressed only in a specific place or tissue in a specific 
period and in the required amount. That is named spatial, temporal and quantitative expression 
which is not harmful to the cell. Expression of recombinant proteins usually results in 
introduction of a strange protein in the host cell. This introduced protein is expressed in higher 
levels and in unwanted time. If this over-expressed recombinant protein is formed as a soluble 
one it will carry out certain functions which are not required by the host and may be destructive 
to the host cells. These effects could be observed as decreased growth rates and cell density and 
sometimes cell death. Recombinant proteins which result in the previous effects are called toxic 
proteins. Around 80% of all soluble proteins possess a particular degree of toxicity to their hosts. 
Nearly 10% of all proteins are extremely toxic to host cells. Insoluble proteins showed no 
toxicity to the host cell. It is tempting to speculate that a single amino acid substitution may 
results in a toxic protein which leads to cell death and so no expression could be detected (Inc., 
2009). Replacement of Thr135 in HsBPS wild-type with glutamic acid, argenine, tryptophane, 
tyrosine in addition to glycine decreased the activity so much compared to the wild-type HsBPS. 
These mutants resulted in formation of very low amounts of the products mainly phenylpyrone 
with benzoyl and 3-hydroxybenzoyl-CoAs and 4-hydroxycoumarin with 2-hydroxybenzoyl-
CoA. Recently, replacement of Leu132 in RpBAS with tryptophane blocked the entrance of the 
coumaroyl-binding pocket. The RpT132W mutant has a smaller cavity volume than the RpBAS 
wild-type, as expected from homology modeling (Fig. 80). This smaller volume of the active site 
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cavity of the RpL132W mutant cannot support the formation of bisnoryangonin (BNY) after two 
malonyl-CoA extensions but an increase in the formation of benzalacetone after one malonyl-
CoA extension. Tyrosine in the same position in RpBASL132 also increases the benzalacetone 
formation while the L132G mutant was similar to the wild-type RpBAS (Shimokawa et al., 
2010). Alanine instead of Thr135 in HsBPS results in the formation of nearly the same amounts 
of 2,4,6-trihydroxybenzophenone and 6-phenyl-4-hydroxy-2-pyrone from benzoyl-CoA. When 
3-hydroxybenzoyl-CoA is used as a substrate, the HsT135A mutant forms around 77% 6-(3-
hydroxy-phenyl)-4-hydroxy-2-pyrone and about 22% 2,3',4,6-tetrahydroxybenzophenone. Valine 
gave nearly the same result but with lower activity than alanine. The HsT135S mutant is the 
most similar one to the HsBPS wild-type albeit with the formation of higher amounts of the side 
products with both benzoyl and 3-hydroxybenzoyl-CoAs substrates. Cysteine and asparagine still 
form tri- and tetrahydroxybenzophenones but with much lower activities compared to the wild-
type. HsT135F and T135H mutants increased the activity with salicoyl-CoA and formed only 
smaller amounts of phenylpyrone with benzoyl and 3-hydroxybenzoyl-CoAs. No benzophenones 
were detected with these two mutants. Methionine showed good activity with benzoyl-CoA but 
mainly formed 6-phenyl-4-hydroxy-2-pyrone in addition to lower amounts of 2,4,6-
trihydroxybenzophenone. With 3-hydroxybenzoyl-CoA it forms only 6-(3-hydroxy-phenyl)-4-
hydroxy-2-pyrone and no 2,3',4,6-tetrahydroxy-benzophenone. Finally, it also forms higher 
amounts of 4-hydroxycoumarin when salicoyl-CoA was used as a substrate.  
Physiological product formation in type III PKS-catalyzed reactions needs a specific 
conformation of the polyketide intermediate which results in an effective cyclization reaction. 
After solving the X-ray crystal structure of MsCHS2 it was suggested that the active site 
(initiation/elongation/cyclization) cavity is considered as a structural model stabilizing a specific 
conformation of the linear tetraketide intermediate which permits the Claisen condensation to 
take place (Ferrer et al., 1999). However, derailment product (CTAL) or other lactone side 
products formed either in solution or in the enzyme active site via C5 keto-enolization which is 
followed by nucleophilic attack on the C1 keton by a hydroxyl group in solution or the cysteine 
thiolate (enzyme bound) as the leaving group results in CTAL. Any structural modification of 
the elongation/cyclization cavity of CHS will sway the ratio of Claisen-formed products against 
lactone products with physiological and nonphysiological substrates (Jez et al., 2001). 
Interestingly, most CHS mutagenesis experiments that showed increased formation of 
coumaroyltriacetic acid lactone (CTAL) proposed that the structural variations at different 
positions in the initiation/elongation/cyclization pockets results in conformational changes in the 
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formed tetraketide intermediate (Jez et al., 2000; Suh et al., 2000). For example, replacement of 
MsCHSThr197 with Leu results in the formation of only CTAL as a single product after three 
malonyl-CoA extension with p-coumaroyl-CoA (Jez et al., 2000). Ultimately, it was 
demonstrated that there is a direct relationship between the structural variations in the active site 
cavity and functional changes in the cyclization reaction (Jez et al., 2001). Briefly, the 3D 
structure of the active site in addition to the shape and size of the starter substrates are two 
important factors for the optimal stabilization of the tetraketide intermediate’s conformation that 
permits the Claisen condensation reaction to proceed effectively before side products formation 
(Jez et al., 2001). Remarkably, larger starter molecules prevent the polyketide intermediate from 
taking over the conformation required for the correct cyclization reaction. Comparable effects 
have been stated with 4-substituted analogues of p-coumaroyl-CoA and other aliphatic starter 
substrates (Zuurbier et al., 1998; Morita et al., 2000). 
5.8 Malonyl-CoA Km values of HsBPS and HaBPS enzymes 
Despite of the high similarity between HsBPS and HaBPS their malonyl-CoA Km values 
are very different. The malonyl-CoA Km value of HsBPS is around three fold higher than that of 
HaBPS 92.5 µM and 31.3 µM respectively (Liu et al., 2003; Huang et al., 2012). Only six amino 
acids are different between these two BPSs. So six single mutants were constructed for HaBPS 
wild-type towards HsBPS. Studying the effect of these positions, which are away from the active 
site, on the activity was performed using different starter substrates. Five mutants (HaE54D, 
HaV146A, HaC230G, HaV359L and HaN360S) are active where the sixth mutant (HaS235A) 
did not show any over-expression in the host cells as shown by SDS-PAGE analysis (Fig. 89, D). 
The five active mutants are more or less similar to the wild-type HaBPS in their activity with the 
tested starter substrates (benzoyl, 3-hydroxybenzoyl and 2-hydroxybenzoyl-CoAs) as shown in 
(Fig. 57). Steady state kinetic parameters of these five single HaBPS mutants were calculated to 
determine which amino acid would switch the Km value of malonyl-CoA. All of these five 
positions showed a direct effect on the affinities for both the starter and extender substrates with 
profound effect on malonyl-CoA. The Km values for these mutants varied by factor 2 and 1.5 for 
benzoyl-CoA and malonyl-CoA respectively. They also showed 3 - 4.9 and 2 - 4 fold increase in 
the malonyl-CoA and benzoyl-CoA Km values respectively compared to HaBPS wild-type. 
Notably, it was reported that residues which are not involved in the active site but influencing 
close to responsive areas of the three dimensional structure can modify enzyme specificities 
probably through modulating protein conformations (Ketterman et al., 2001). Mutational studies 
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of six Arg (non-active site) residues in Pueraria lobata CHS showed that some of these residues 
are essential for providing significant interactions to sustain the three dimensional structure of 
the enzyme. Some others showed significant effects on the enzyme activity. These residues are 
supposed to play important roles in placing the active site residues in the right catalytic positions. 
The previous findings demonstrate that residues away from the active site can have remarkable 
effects on the catalytic activity of the enzyme (Fukuma et al., 2007). At the same time 
replacement of Thr135 with Ile in H. sampsonii, H. calycinum, and H. perforatum ssp 
angustifolium resulted in three active mutants (HsT135I, HcT135I and HpaT135I) and 
transformed the wild-type BPSs of these Hypericum species into functional phenylpyrone 
synthases. While HaT135I mutant gave in active protein (Klundt et al., 2009).  
From the amino acid sequences alignment there are only six different amino acids 
between H. androsaemum and H. sampsonii BPSs. Thus provoked the idea of constructing six 
double mutants of HaT135I with the six different amino acids towards H.sampsonii. The target 
was to find which of these six positions will regain the activity of the HaT135I mutant. The six 
double mutants (HaE54D/T135I, HaV146A/T135I, HaC230G/T135I, HaS235A/T135I, 
HaV359L/T135I and HaN360S/T135I) were active with different substrates (benzoyl, 3-
hydroxybenzoyl and 2-hydroxybenzoyl-CoAs) resulting in the formation of 4-hydroxy-6-
phenylpyran-2-one, 4-hydroxy-6-(3-hydroxy)-phenylpyran-2-one and small amounts of 4-
hydroxycoumarin respectively (Fig. 60). Interestingly, the HaS235A single mutant showed no 
over-expression in the host cells while the HaS235A/T135I double mutant was active. These 
results suggest the presence of cooperation between these six non-active site residues and the 
conserved Thr135 amino acid. Ultimately, point mutations of amino acid residues which are not 
involved in the active site may change the tertiary structure of the enzyme either by modifying 
the mobility and positioning of a number of significant residues at different locations in the 
enzyme or changing the conformation of key side chains in the active site. These effects may 
drastically influence the enzyme activity (Dana et al., 2006). 
5.9 Comparative homology dimer model of HsBPS 
An updated comparative homology model was constructed to clarify many points 
obtained in the present study. The most important and interesting point is the dramatic functional 
variation of HsT135K mutant which completely changed the substrate and product specificity of 
H. sampsonii BPS wild-type. As previously shown in (Fig. 64) lysine residue has a long charged 
side chain which is in contact with the adjoining monomer and the dimer interface therefore, 
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lysine in position 135 not only acts as an active site residue but also extended to the other 
monomer and the dimer interface. This makes the explanation of the effect of this residue on the 
enzyme activity is not so easy and needs a crystal structure of the enzyme and the mutant to 
compare. The published model of H. androsaemum BPS (HaBPS) (Klundt et al., 2009) was 
monomeric for simplicity as all the former smaller mutations pointed directly into the active site. 
Therefore, this simple monomer model was sufficient to clarify the previous HaBPS mutations 
and so dimer stability or higher oligomers (tetramer) were neglected. Interestingly, after 
calculating the folding stability of the published model using FoldX (first turning all amino acids 
of the initial model into standard rotamers) the result indicated that Thr135Leu is only 
marginally destabilizing, in contrast to glycine, alanine, valine, isoleucine, asparagine and 
tyrosine which gave significantly more destabilized proteins which is in agreement with the 
experimental mutation results of H.androsaemum. Despite of the high sequence identity between 
the BPSs of the tested Hypericum species the different dimer interface results in different 
behavior of each enzyme. In case of H.sampsonii and based on the updated model the different 
dimer interface will result in a different orientation of the amino acids side chains and so a 
different behavior with different substrates. For example, 3-hydroxybenzoyl-CoA which is the 
second best substrate for HaBPS wild-type was not accepted by its leucine mutant HaT135L. In 
contrast, 3-hydroxybenzoyl-CoA still is the second best substrate for H.sampsonii, H .calycinum 
and H. perforatum ssp angustifolium BPSs wild types and their leucine mutants. Ultimately, six 
different positions ‘54, 146, 230, 235, 359, and 360’ between H. sampsonii and H. androsaemum 
are a way from the active site but they affect the enzyme activity as shown from the updated 
model.  
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6 Summary 
 Understanding the structure and function of type III polyketide synthases (PKSs) 
increased in the past years due to cloning and characterization of novel enzymes which 
expand the biosynthetic repertoire of this fascinating group of enzymes. Crystallographic 
studies and site-directed mutagenesis play an essential role in illustrating the active site 
structural details. Type III PKSs share a common three-dimensional fold and absolutely 
conserved catalytic triad Cys-His-Asn. Minor changes in the active site architecture in 
addition to steric modulation are responsible for the amazing functional diversity of this 
superfamily of enzymes.  
 Benzophenone synthase (BPS) is a relatively new member of type III PKSs cloned from 
some Hypericum species such as H. androsaemum, H. sampsonii, H. calycinum and H. 
perforatum ssp angustifolium. This enzyme is responsible for the formation of the C13 
skeleton of benzophenone derivatives and xanthones which are classes of phenolic 
natural products with interesting pharmacological activities. BPS catalyzes iterative 
condensation of benzoyl-CoA or 3-hydroxybenzoyl-CoA with three molecules of 
malonyl-CoA to form a linear tetraketide intermediate which undergoes C6 C1 Claisen 
condensation and aromatization to form tri and tetrahydroxybenzophenones respectively. 
Recently, H. androsaemum BPS was transformed into a functional phenylpyrone 
synthase (PPS) by single amino acid substitution in the active site i.e. replacement of 
Thr135 with Leu.  
 In the present study, various site-directed mutagenesis approaches were used to exchange 
Thr135 in H. sampsonii BPS (HsBPS) for the other 19 amino acids. Only three of these 
residues (lysine, isoleucine and leucine) dramatically changed the substrate and product 
specificities of HsBPS. Lysine in position 135 transformed HsBPS into a functional 4-
hydroxycoumarin synthase (HCS) a novel PKS variant. The preferred starter substrate for 
HCS is 2-hydroxybenzoyl (salicoyl)-CoA rather than benzoyl-CoA. Furthermore, there is 
only a single chain extension with malonyl-CoA which results in formation of 4-
hydroxycoumarin as a single product. 
 Leucine and isoleucine in the same position convert HsBPS into functional PPSs. The 
two mutants catalyze two malonyl-CoA extensions leading to formation of 6-phenyl-4-
hydroxy-2-pyrone. In contrast to the above H. androsaemum BPS-derived PPS both 
mutant enzymes showed relatively high activity with 3-hydroxybenzoyl-CoA forming 6-
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(3-hydroxyphenyl)-4-hydroxy-2-pyrone. They also accepted 2-hydroxybenzoyl-CoA 
forming small amounts of 4-hydroxycoumarin. 
 Three mutants containing proline, aspartic acid and glutamine in position 135 did not 
yield over-expression in E. coli. Glutamic acid, argenine, tryptophane, tyrosine and 
glycine strongly decreased the catalytic activity compared to the wild-type. Mutants with 
the other amino acids (alanine, valine, serine, cysteine, asparagine, methionine, 
phenylalanine and histidine) were more or less similar to the wild-type albeit with 
formation of higher amounts of the side products. 
 Testing the three mutants HsT135K, HsT135I and HsT135L with different starter 
substrates such as 2-aminobenzoyl (anthraniloyl)-CoA, 2-methoxybenzoyl- and 2-
mercaptobenzoyl-NACs which were chemically synthesized and N-methylanthraniloyl-
CoA revealed that anthraniloyl-CoA and N-methylanthraniloyl-CoA led to formation of 
4-hydroxy-2(1H)-quinolone and 4-hydroxy-1-methyl-2(1H)-quinolone respectively while 
2-methoxybenzoyl- and 2-mercaptobenzoyl-NACs were not converted.  
 Characterization of the three mutants revealed that the HsT135K mutant showed 40 and 
32 fold higher turnover rate (Kcat) when compared to Sorbus aucuparia BISs (Sa BIS2 
and SaBIS3) which can also form 4-hydroxycoumarin. The HsT135L and HsT135I 
mutants showed 3.5 and 2.5 fold higher catalytic efficiencies (Kcat/Km) respectively when 
compared to the T135L mutant of H. androsaemum BPS. However, the three HsBPS 
mutants showed 10, 8 and 4 fold higher Km values for malonyl-CoA than HsBPS wild-
type. The pH and temperature optima of the mutants were 7 and 30 C respectively. 
 Replacement of Thr135 with Lys in H. androsaemum BPS also generated HCS but with 
much lower catalytic activity in comparison to the HsT135K mutant.  
 HsBPS had an around 3 fold higher malonyl-CoA Km value than H. androsaemum BPS 
(HaBPS) although only six amino acids differ. To check for position-specific effects the 
six single mutants HaE54D, HaV146A, HaC230G, HaS235A, HaV359L and HaN360S 
were constructed, of which HaS235A failed to be over-expressed. Steady-state kinetic 
analysis of the five active mutants elucidated that all five positions directly affected the 
affinities for both starter and extender substrates. The Km values for malonyl-CoA and 
benzoyl-CoA were increased 3 - 4.9 and 2 - 4 times compared to wild-type. 
 Six double mutants (HaE54D/T135K, HaV146A/T135K, HaC230G/T135K, 
HaS235A/T135K, HaV359L/T135K and HaN360S/T135K) were constructed of which 
HaN360S/T135K failed to be over-expressed. The five residual double mutants showed 
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good activity with salicoyl-CoA and formed 4-hydroxycoumarin. As an example, steady 
state kinetic parameters were determind for HaV146A/T135K. Its catalytic efficiency 
(Kcat/Km) was 4 fold lower than that of HsT135K in addition to a 1.3 fold higher malonyl-
CoA Km value. 
 Isoleucine instead of Thr135 in HaBPS resulted previously in catalytically inactive 
proteins. The double mutants HaE54D/T135I, HaV146A/T135I, HaC230G/T135I, 
HaS235A/T135I, HaV359L/T135I and HaN360S/T135I were constructed to investigate 
the effect of these non-active-site amino acids on regaining activity. All these six double 
mutants showed good activity with benzoyl and 3-hydroxybenzoyl-CoAs and resulted in 
formation of 6-phenyl-4-hydroxy-2-pyrone and 6-(3-hydroxyphenyl)-4-hydroxy-2-
pyrone, respectively. 
 H. calycinum and H. perforatum ssp angustifolium BPSs also contain Thr135 with few 
different amino acids away from the active site. Replacement of Thr135 with Lys 
resulted in no over-expression in case of HpaT135K and no soluble protein in case of 
HcT135K. Leucine and isoleucine in the same position transformed both BPSs into PPSs 
which also exhibited good activities with 3-hydroxybenzoyl-CoA, forming 6-(3-hydroxy-
phenyl)-4-hydroxy-2-pyrone. 
 Finally, an updated homology model of HsBPS was constructed as a dimer based on the 
crystal structure of Medicago sativa chalcone synthase to rationalize the dramatic 
functional variation of HsT135K mutant. The modeling showed that lysine residue has a 
long charged side chain which is in contact with the adjoining monomer and the dimer 
interface. Lysine in position 135 does not only act as an active site residue but also 
extends to the other monomer and the dimer interface due to its long charged side chain. 
This makes the explanation of the effect of this residue on the enzyme activity not so 
easy and needs a crystal structure of the enzyme and the mutant to compare. 
 In addition, it showed that the loop from aa 138 to 144 is part of the dimer interface 
directly adjacent to the active site mutation in position 135. This effect of the adjoining 
dimer interface is even more pronounced in H. calycinum and H. perforatum ssp 
angustifolium BPSs where the active sites are identical but the dimer interfaces look 
different. Clarification in more detail needs an X-ray crystal structure as the current 
model cannot resolve such global conformational changes.  
 The following flow chart (Fig. 83) summarizes all Hypericum BPSs tested and all 
mutations constructed. 
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              Fig. 83  Flow chart of all Hypericum BPSs tested and all mutations constructed 
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8 Appendix 
 
  
----MAT---AMEEI R---KAQRAEGP--ATVL AI GTANPPNCVL QADYPDFYFRVTNS EHMTEL KEKFKRI CEKS MI RKRYMYL TEEI LMajority
10 20 30 40 50 60 70 80
----MAP---AMEYS T---QNGQGEGKKRAS VL AI GTTNPEHFI L QEDYPDFYFRNTNS EHMTEL KEKFKRI CVKS HI RKRHFYL TEEI L  80H.s BPS
----MAP---AMEYS T---QNGQGEGKKRAS VL AI GTTNPEHFI L QEDYPDFYFRNTNS EHMTDL KEKFKRI CVKS HI RKRHFYL TEEI L  80H.a BPS
----MAP---AMEYTT---QNGQGEGKKRAS VL AI GTTNPEHFI L QEEYPDFYFRNTNS EHMTDL KEKFKRI CVKS HI RKRHFYL TEEI L  80H.c BPS
----MAP---AMQYS S ---ENVQEDVKRRPS VL AI GTTNPEHFI L QEDYPDFYFRNTNS EHMTDL KEKFKRI CVKS HI RKRHFYL TEEI L  80H.pa BPS
----MVM----AKEL K---RPERADGL --AS I L AI GTANPS NFI EQS S YADYYFRVTNS EHMTDL KQKFNRI CEKS MI RKRHMFMTEEFL  77C.e PPS
----MVS ----VS EI R---KAQRAEGP--ATI L AI GTANPANCVEQS TYPDFYFKI TNS EHKTEL KEKFQRMCDKS MI KRRYMYL TEEI L  77M.s CHS
----MVT----VEEVR---KAQRAEGP--ATVMAI GTAVPPNCVDQATYPDYYFRI TNS EHKAEL KEKFQRMCDKS QI KKRYMYL NEEVL  77H.a CHS
----MVT----VEEVR---KAQRAEGP--ATVMAI GTAVPPNCVDQATYPDYYFRI TNS EHKAEL KEKFQRMCDKS QI KKRYMYL NEEVL  77H.s CHS
------MGGVDFEGFR---KL QRADGF--AS I L AI GTANPPNAVDQS TYPDFYFRI TGNEHNTEL KDKFKRI CERS AI KQRYMYL TEEI L  79P.s STS
----MAP---L VKNHG---EPQ----H--AKI L AI GTANPPNVYYQKDYPDFL FRVTKNEHRTDL REKFDRI CEKS RTRKRYL HL TEEI L  74S.a BIS
MGS YS S D---DVEVI R---EAGRAQGL --ATI L AI GTATPPNCVAQADYADYYFRVTKS EHMVDL KEKFKRI CEKTAI KKRYL AL TEDYL  82G.h 2PS
----MAS --VTVEQI R---KAQRAEGP--ATI L AI GTAVPANCFNQADFPDYYFRVTKS EHMTDL KKKFQRMCEKS TI KKRYL HL TEEHL  79H.l VPS
----MAT--EEMKKL --------------ATVMAI GTANPPNCYYQADFPDFYFRVTNS DHL I NL KQKFKRL CENS RI EKRYL HVTEEI L  70R.p BAS
----MES ----L KEMR---KAQKS EGP--AAI L AI GTATPDNVYI QADYPDYYFKI TKS EHMTEL KDKFKTL CEKS MI RKRHMCFS QEFL  77R.g ACS
----MVT----MEEI R---KAQRAEGL --ATI L AI S TATPPNCVI QADYPDYYFKI TNS EHMTEL KEKFRRL CEKS MI RKRHMCL TEEI L  77A.m QNS
----MATKS VAVEEMC---KAQKAGGP--ATI L AI GTAVPS NCYYQS EYPDFYFRVTKS DHL TDL KS KFKRMCDRS S I KKRYMHL TEEI L  81H.m STCS
-MTI KGS GS AAFEGTRL CPRVI KPDGP--ATI L AI GTS NPTNI FEQS TYPDFFFDVTNCNDKTEL KKKFQRI CDKS GI KKRHFHL TDEI L  87Hu.s PKS1
----MAD---VL QEI R---NS QKAS GP--ATVL AI GTAHPPTCYPQADYPDFYFRVCKS EHMTKL KKKMQFI CDRS GI RQRFMFHTEENL  78R.p ALS
-MS S L S NS L PL MEDVQGI RKAQKADGT--ATVMAI GTAHPPHI FPQDTYADVYFRATNS EHKVEL KKKFDHI CKKTMI GKRYFNYDEEFL  87A.a PCS
-MS S L S NAS HL MEDVQGI RKAQRADGT--ATVMAI GTAHPPHI FPQDTYADFYFRATNS EHKVEL KKKFDRI CKKTMI GKRYFNYDEEFL  87A.a OKS
KENPNI CTYMAP-S L DARQDI L VVEVPKL GKEAAVKAI KEWGQPKS KI THL VFCTTS GVDMPGADYQL TKL L GL NPS VKRVML YQQGCFAMajority
90 100 110 120 130 140 150 160
KENQGI ATYGAG-S L DARQRI L ETEVPKL GQEAAL KAI AEWGQPI S KI THVVFATTS GFMMPGADYVI TRL L GL NRTVRRVML YNQGCFA 169H.s BPS
KENQGI ATYGAG-S L DARQRI L ETEVPKL GQEAAL KAI AEWGQPI S KI THVVFATTS GFMMPGADYAI TRL L GL NRTVRRVML YNQGCFA 169H.a BPS
KENQGI ATYGAG-S L DARQRI L ETEVPKL GQEAAL KAI AEWGQPI S KI THVVFATTS GFMMPGADYAI TRL L GL NRTVRRVML YNQGCFA 169H.c BPS
KEKQGI ATYGAG-S L DARQRI L ETEVPKL GQEAAL KAI AEWGQPTS KI THVVFATTS GFMMPGADYAI TRL L GL NRTVRRVML YNQGCFA 169H.pa BPS
KKNPS I CAS MVP-S L DARQEML VVEVPKL GKEAAQKAI DEWGQPL S KI THL I FCTI S GI DMPGADYQL ARL L GL S AS VKRI ML YQNGCFA 166C.e PPS
KENPNVCEYMAP-S L DARQDMVVVEVPRL GKEAAVKAI KEWGQPKS KI THL I VCTTS GVDMPGADYQL TKL L GL RPYVKRYMMYQQGCFA 166M.s CHS
KENPNMCAYMAP-S L DARQDI VVVEVPKL GKEAAVKAI KEWGQPKS KI THL VFCTTS GVDMPGADYQL TKL L GL RPS VKRL MMYQQGCFA 166H.a CHS
KENPNMCAYMAP-S L DARQDI VVVEVPKL GKEAAVKAI KEWGQPKS KI THL VFCTTS GVDMPGADYQL TKL L GL RPS VKRL MMYQQGCFA 166H.s CHS
KKNPDVCAFVEVPS L DARQAML AMEVPRL AKEADEKAI QEWGQS KS GI THL I FCS TTTPDL PGADFEVAKL L GL HPS VKRVGVFQHGCFA 169P.s STS
KANPS I YTYGAP-S L DVRQDML NS EVPKL GQQAAL KAI KEWGQPI S KI THL I FCTAS CVDMPGADFQL VKL L GL NPS VTRTMI YEAGCYA 163S.a BIS
QENPTMCEFMAP-S L NARQDL VVTGVPML GKEAAVKAI DEWGL PKS KI THL I FCTTAGVDMPGADYQL VKL L GL S PS VKRYML YQQGCAA 171G.h 2PS
KQNPHL CEYNAP-S L NTRQDML VVEVPKL GKEAAI NAI KEWGQPKS KI THL I FCTGS S I DMPGADYQCAKL L GL RPS VKRVML YQL GCYA 168H.l VPS
KENPNI AAYEAT-S L NVRHKMQVKGVAEL GKEAAL KAI KEWGQPKS KI THL I VCCL AGVDMPGADYQL TKL L DL DPS VKRFMFYHL GCYA 159R.p BAS
KANPEVCKHMGK-S L NARQDI AVVETPRI GKEAAVKAI KEWGHPKS S I THL I FCTS AGVDMPGADYQL TRML GL NPS VKRMMI YQQGCYA 166R.g ACS
KANPNMCL HMGT-S L NARQDI S L VEVPKL GKEAATKAI KEWGQPKS KI THL I FCTS AGVDMPGADYQL TRL L GL S PEVKRMMI YQQGCYA 166A.m QNS
KENPNMCS FAAP-S I DGRQDI VVKEI PKL AKEAAS KAI KEWGQPES NI THL VFCTTS GVDMPGCDYQL TRL L GL RPS I KRL MMYQQGCHA 170H.m STCS
RKNPS I CKFKEA-S L DPRQDI AVL EVPKL AKEAAI S AI KQWGQPKS KI THL VFATTS GVDMPGADFQL AKL L GL RPTVKRVML YQQGCYA 176Hu.s PKS1
GKNPGMCTFDGP-S L NARQDML I MEVPKL GAEAAEKAI KEWGQDKS RI THL I FCTTTS NDMPGADYQFATL FGL NPGVS RTMVYQQGCFA 167R.p ALS
KKYPNI TS YDEP-S L NDRQDI CVPGVPAL GTEAAVKAI EEWGRPKS EI THL VFCTS CGVDMPS ADFQCAKL L GL HANVNKYCI YMQGCYA 176A.a PCS
KKYPNI TS FDEP-S L NDRQDI CVPGVPAL GAEAAVKAI AEWGRPKS EI THL VFCTS CGVDMPS ADFQCAKL L GL RTNVNKYCVYMQGCYA 176A.a OKS
GGTVL RL AKDL AENNKGARVL VVCS EI TAVTFRGPS ETHL DS L VGQAL FGDGAAAL I VGADPDPS V-ERPL FEI VS AS QTI VPDS EGAI TMajority
170 180 190 200 210 220 230 240 250
GGTAL RVAKDL AENNEGARVL VVCAENTAMTFHAPNES HL DVI VGQAMFS DGAAAL I I GACPDVAS GERAVFNI L S AS QTI VPGS DGAI T  259H.s BPS
GGTAL RVAKDL AENNEGARVL VVCAENTAMTFHAPNES HL DVI VGQAMFS DGAAAL I I GAGPDVAAGERAVFNI L S AS QTI VPGS DGAI T  259H.a BPS
GGTAL RVAKDL AENNEGARVL VVCAENTAMTFHAPNES HL DVI VGQAMFS DGAAAL I I GAGPDAAS GERAVFNI L S AS QTI VPGS DGAI T  259H.c BPS
GGTAL RVAKDL AENNANARVL VVCAENTAMTFHAPNES HL DVI VGQAMFS DGAAAL I I GAEPNPWS GERAVFNI L S AS QTI VPGS DGAI T  259H.pa BPS
GGTVL RL AKDMAENNKGARVL VVCAEI I GL TFRGPS EKHL DDL VCQAL FADGAAS MVI GADPVPEV-EKPL FEVFS AGQTFI PETNGAI T  255C.e PPS
GGTVL RL AKDL AENNKGARVL VVCS EVTAVTFRGPS DTHL DS L VGQAL FGDGAAAL I VGS DPVPEI -EKPI FEMVWTAQTI APDS EGAI D 255M.s CHS
GGTVL RL AKDL AENNKGARVL VVCS EI TAVTFRGPTDTHL DS L VGQAL FGDGAAAI I I GS DPI PEV-EKPL FEL VS AAQTI L PDS EGAI D 255H.a CHS
GGTVL RL AKDL AENNKGARVL VVCS EI TAVTFRGPTDTHL DS L VGQAL FGDGAAAI I I GS DPI PEV-EKPL FEL VS AAQTI L PDS EGAI D 255H.s CHS
GGTVL RMAKDL AENNRGARVL VI CS ETTAVTFRGPS ETHL DS L VGQAL FGDGACAL I VGADPI PQV-EKACFEI VWTAQTVVPNS EGAI G 258P.s STS
GATVL RL AKDFAENNEGARVL VVCAEI TTVFFHGL TDTHL DI L VGQAL FADGAS AVI VGANPEPKI -ERPL FEI VACRQTI I PNS EHGVV 252S.a BIS
GGTVL RL AKDL AENNKGS RVL I VCS EI TAI L FHGPNENHL DS L VAQAL FGDGAAAL I VGS GPHL AV-ERPI FEI VS TDQTI L PDTEKAMK 260G.h 2PS
GGKVL RI AKDI AENNKGARVL I VCS EI TACI FRGPS EKHL DCL VGQS L FGDGAS S VI VGADPDAS VGERPI FEL VS AAQTI L PNS DGAI A 258H.l VPS
GGTVL RL AKDI AENNKGARVL I VCS EMTTTCFRGPS ETHL DS MI GQAI L GDGAAAVI VGADPDL TV-ERPI FEL VS TAQTI VPES HGAI E  248R.p BAS
GGTVL RL AKDL AENNKGS RVL VVCS EL TAPTFRGPS PDAVDS L VGQAL FADGAAAL VVGADPDTS V-ERAL YYI VS AS QML L PDS DGAI E  255R.g ACS
GATVL RL AKDL TENNKGS RVL I VCS ENTVPTFRGPS DTHI DS L VGQAL FADGAAAL I VGADPDAS I -ERPL YHI VS AS QTL L PDS DGAI E  255A.m QNS
GGTGL RL AKDL AENNKGARVL VVCS EMTVI NFRGPS EAHMDS L VGQS L FGDGAS AVI VGS DPDL S T-EHPL YQI MS AS QI I VADS EGVI D 259H.m STCS
GATVL RVAKDL AENNKGARVL VACS EVTAVTFRAPS ETHL DGL VGS AL FGDGAAAL I VGS DPVPQE-EKPL FEI HWAGEAVL PDS DGAI N 265Hu.s PKS1
GGTVL RL VKDI AENNKGARVL VVCS EI VAFAFRGPHEDHI DS L I GQL L FGDGAAAL VVGTDI DES V-ERPI FQI MS ATQATI PNS L HTMA 256R.p ALS
GGTVMRYAKDL AENNRGARVL VVCAEL TI MML RAPNETHL DNAI GI S L FGDGAAAL I I GS DPI I GV-EKPMFEI VCTKQTVI PNTEDVI H 265A.a PCS
GGTVMRYAKDL AENNRGARVL VVCAEL TI I GL RGPNES HL DNAI GNS L FGDGAAAL I VGS DPI I GV-EKPMFEI VCAKQTVI PNS EDVI H 265A.a OKS
2  235 
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Fig. 84  Alignment of the amino acid sequences of plant type III PKSs. The catalytic triad Cys-His-
Asn is colored in red. The residues lining the active-site which are important for the functional 
diversity of type III PKSs are highlighted in blue and orange colors. The green color represents the 
different amino acid residues between H. sampsonii, H .androsaemum, H. calycinum, and H. 
perforatum ssp angustifolium BPSs (numbering in H. sampsonii BPS). Abbreviations are summarized 
in (Tab. 18). 
  
GHL REAGL TFHL KKDVPGL I S DNI EKVL VEAFS PL GI S ------DWNS L FWI AHPGGPAI L DQVEAKL GL KPEKL RATRHVL S EYGNMS SMajority
260 270 280 290 300 310 320 330 340
AHFYEMGMS YFL KEDVI PL FRDNI AAVMEEAFS PL GVS ------DWNS L FYS I HPGGRGI I DGVAGNL GI KDENL VATRHVL GEYGNMGS  343H.s BPS
AHFYEMGMS YFL KEDVI PL FRDNI AAVMEEAFS PL GVS ------DWNS L FYS I HPGGRGI I DGVAGNL GI KDENL VATRHVL GEYGNMGS  343H.a BPS
AHFYEMGMS YFL KEDVI PL FRDNI AAVMEEAFS PL GVS ------DWNS L FYS I HPGGRGI I DGVAGNL GI KDENL VATRHVL GEYGNMGS  343H.c BPS
AHFYEMGMS YFL KEDVI PL FRDNI ADVMKEAFS PL GVS ------DWNS L FYS I HPGGRGI I DGVAGNL GI KDENL VATRHVL GEYGNMGS  343H.pa BPS
ARL L QAGL L VNL HRDVPKFFS ENI EKCL HDAFGPL GI S ------DWNS I FWI AHPGGAGI L DNVERKL AL KPEKL RATRHVL S EYGNI S S  339C.e PPS
GHL REAGL TFHL L KDVPGI VS KNI TKAL VEAFEPL GI S ------DYNS I FWI AHPGGPAI L DQVEQKL AL KPEKMNATREVL S EYGNMS S  339M.s CHS
GHL REVGL TFHL L KDVPGL I S KNVEKS L TEAFKPL GI S ------DWNS L FWI AHPGGPAI L DQVEAKL S L KPEKL RATRHVL S EYGNMS S  339H.a CHS
GHL REVGL TFHL L KDVPGL I S KNVEKS L TEAFKPL GI S ------DWNS L FWI AHPGGPAI L DQVEAKL S L KPEKL RATRHVL S EYGNMS S  339H.s CHS
GKVREVGL TFQL KGAVPDL I S ANI ENCMVEAFS QFKI S ------DWNKL FWVVHPGGPAI L DRVEAKL NL DPTKL I PTRHVMS EYGNMS S  342P.s STS
ANI REMGFTYYL S GEVPKFVGGNVVDFL TKTFEKVDGKNK----DWNS L FFS VHPGGPAI VDQVEEQL GL KEGKL RATRHVL S EYGNMGA 338S.a BIS
L HL REGGL TFQL HRDVPL MVAKNI ENAAEKAL S PL GI T------DWNS VFWMVHPGGRAI L DQVERKL NL KEDKL RAS RHVL S EYGNL I S  344G.h 2PS
GHVTEAGL TFHL L RDVPGL I S QNI EKS L I EAFTPI GI N------DWNNI FWI AHPGGPAI L DEI EAKL EL KKEKMKAS REML S EYGNMS C 342H.l VPS
GHL L ES GL S FHL YKTVPTL I S NNI KTCL S DAFTPL NI S ------DWNS L FWI AHPGGPAI L DQVTAKVGL EKEKL KVTRQVL KDYGNMS S  332R.p BAS
GHI REEGL TVHL KKDVPAL FS ANI DTPL VEAFRPL GI S ------DWNS I FWI AHPGGPAI L DQI EVKL GL KEDKL RAS KHVMS EYGNMS S  339R.g ACS
GHI REAGL TVHL KKDVPAFFS ANI EKS L VDAFTPI GI S ------DWNS I FWI AHPGGPAI L DQVEEKL GL RKDKL KAS RHVMS EFGNMS S  339A.m QNS
GHL RQEGL TFHL RKDVPS L VS DNI ENTL VEAFTPI L MDS I DS I I DWNS I FWI AHPGGPAI L NQVQAKVGL KEEKL RVS RHI L S EYGNMS S  349H.m STCS
GHL REAGL I FHL L KDVPGL I S KNI DKVL AEPL EYVHFP------S YNDMFWAVHPGGPAI L DQI EAKL GL S TDKMQAS RDVL AS YGNMS S  349Hu.s PKS1
L HL TEAGL TFHL S KEVPKVVS DNMEEL ML EAFKPL GI T------DWNS I FWQVHPGGRAI L DKI EEKL EL TKDKMRDS RYI L S EYGNL TS  340R.p ALS
L HL RETGMMFYL S KGS PMTI S NNVEACL I DVFKS VGI TPPE---DWNS L FWI PHPGGRAI L DQVEAKL KL RPEKFRAARTVL WDYGNMVS  352A.a PCS
L HMREAGL MFYMS KDS PETI S NNVEACL VDVFKS VGMTPPE---DWNS L FWI PHPGGRAI L DQVEAKL KL RPEKFRATRTVL WDCGNMVS  352A.a OKS
ACVL FI L DEMRKKS KEEGKS TTGEGL EWGVL FGFGPGL TVETVVL RS VPI L -------Majority
350 360 370 380 390
ACVMFI L DEL RKS S KVNGKPTTGDGKEFGCL I GL GPGL TVEAVVL QS VPI L QMAPA                                   399H.s BPS
ACVMFI L DEL RKS S KL S GKPTTGDGKEFGCL I GL GPGL TVEAVVL QS VPI L Q                                       395H.a BPS
ACVMFI L DEL RRS S KL NGKPTTGDGKEFGCL I GL GPGL TVEAVVL QGVPI L Q.                                       396H.c BPS
ACVMFI L DEL RRS S KL NGKPTTGDGKEFGCL I GL GPGL TVEAVVL QS VPI L Q.                                       396H.pa BPS
ACVFFI L DETRKS S I KNGL GTTGGGL EWGAL FGFGPGL TVDTVVL RS VAI .                                         390C.e PPS
ACVL FI L DEMRKKS TQNGL KTTGEGL EWGVL FGFGPGL TI ETVVL RS VAI                                          389M.s CHS
ACVL FI L DEMRRKS KEDGL KTTGEGI EWGVL FGFGPGL TVETVVL HS VAI NMVT                                      393H.a CHS
ACVL FI L DEMRRKS KEDGL KTTGEGI EWGVL FGFGPGL TVETVVL HS L AI NMVTV                                    394H.s CHS
ACFHFI L DQTRKAS L ENGFS TTGEGL EMGVL FGFG-GL TI ETVVL KS VPI Q                                        392P.s STS
PS VHFI L DDMRKKS I EEGKS TTGEGL EWGVVI GI GPGL TVETAVL RS ES I PCM                                      391S.a BIS
ACVL FI I DEVRKRS MAEGKS TTGEGL DCGVL FGFGPGMTVETVVL RS VRVTAAVANGN                                 402G.h 2PS
AS VFFI VDEMRKQS S KEGKS TTGDGL EWGAL FGFGPGL TVETVVL HS VPTNV                                       394H.l VPS
ATVFFI MDEMRKKS L ENGQATTGEGL EWGVL FGFGPGI TVETVVL RS VPVI S                                        384R.p BAS
S CVL FVL DEMRNKS L QDGKS TTGEGL DWGVL FGFGPGL TVETVVL RS VPVEA                                       391R.g ACS
ACVL FI L DEMRKTCL EEGKATTGEGL DWGVL FGFGPGL TVETVVL RS VPI EA                                       391A.m QNS
ACVFFI MDEMRKRS VEEGKGTTGEGL EWGVL FGFGPGFTVETI VL HS VPI                                          399H.m STCS
AS VL FVL DQI RKNS EEL HL PTTGEGFEWGFVI GFGPGL TVETL L L RS I NI MTI                                       402Hu.s PKS1
ACVL FVMDEMRKRS FREGKQTTGDGYEWGVAI GL GPGL TVETVVL RS VPI PM                                       392R.p ALS
AS VGYI L DEMRRKS AAKGL ETYGEGL EWGVL L GFGPGI TVETI L L HS L PL MMS S L S N                                  409A.a PCS
ACVL YI L DEMRRKS ADEGL ETYGEGL EWGVL L GFGPGMTVETI L L HS L PL M                                        403A.a OKS
2  307 340 342 
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     Tab. 18  Specification of PKSs used in the alignment illustrated in (Fig. 84). 
Abbreviation Name accession numbers 
H.s BPS Hypericum sampsonii BPS JQ670939 
H.a BPS  Hypericum androsaemum BPS AAL79808 
H.c BPS Hypericum calycinum BPS  
H.pa BPS Hypericum perforatum spp angustifolium BPS  
C.e PPS Centaurium erythraea PPS  
P.s STS Pinus sylvestris STS AAB24341 
M.s CHS Medicago sativa CHS2 P30074 
H.s CHS Hypericum sampsonii CHS JQ670940 
H.a CHS Hypericum androsaemum CHS AAG30295 
S.a BIS Sorbus aucuparia BIS ABB89212 
R.g ACS Ruta graveolens ACS  CAC14058 
A.m QNS Aegle. Marmelos QNS JX679860 
G.h 2PS Gerbera hybrida 2-PS P48391 
H.l VPS  Humulus lupulus VPS BAA29039 
R.p BAS  Rheum palmatum BAS AAK82824 
Hu.s PKS1 Huperzia. serrata  PKS1 DQ979827 
R.p ALS Rheum palmatum ALS AY517486 
A.a PCS Aloe arborescens PCS AY823626 
A.a OKS Aloe arborescens OKS AY567707 
 
  
Appendix 
170 
 
Tab. 19  Amino acid residues lining the active sites of CHS from Medicago sativa and BPSs from  H. 
sampsonii, H. androsaemum, H. calycinum, and H. perforatum ssp angustifolium. 
M. sativa CHS Hypericum BPSs M. sativa CHS Hypericum BPSs 
Initiation Pocket Elongation Pocket 
Leucine 214 Methionine 217 Threonine 132 Threonine 135 
Isoleucine 254 Isoleucine 258 Serine 133 Serine 136 
Glycine 256 Alanine 260 Threonine 194 Threonine 197 
Phenylalanine 265 Tyrosine 269 Valine 196 Methionine 199 
Catalytic Triad Threonine 197 Threonine 200 
Cysteine 164 Cysteine 167 Glycine 216 Serine 219 
Histidine 303 Histidine 307 Leucine 263 Methionine 267 
Aspragine 336 Aspragine 340 Serine 338 Glycine 342 
 
 
                   Fig. 85  Structures of the enzymatic products obtained in the present study. 
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                                  Fig. 86  Structures of the amino acids tested in HsBPS. 
    A    B            C 
 
 
 
 
                                                                                                         
 
Fig. 87  Agarose gel electrophoresis of, the SDM-PCR amplification product of HaBPS lysine single 
mutant (A), the enzyme mutant after KpnI digestion (B), L: DNA Ladder Mix (Thermo Scientific). 
SDS-PAGE demonstrating production in E.col and purification of the HaT135K mutant (C). 
M: protein marker, 1: pre-induction, 2: post-induction, 3: soluble protein, 4: affinity-purified protein. 
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Fig. 88  HPLC chromatograms of assays of HaBPS wild-type and HaT135K with, a, b: benzoyl-CoA, 
c, d: 3-hydroxybenzoyl-CoA, e, f: 2-hydroxybenzoyl-CoA.  
1: 2,4,6-trihydroxybenzophenone. 2: 6-phenyl-4-hydroxy-2-pyrone,  
3: 2,3',4,6-tetrahydroxybenzophenone, 4: 6- (3-hydroxy-phenyl)-4-hydroxy-2-pyron,  
5: 4-hydroxycoumarin. 
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Fig. 89  A: Agarose gel electrophoresis of the SDM-PCR amplification products of HaBPS single 
mutants, 54: HaE54D, 146: HaV146A, 230: HaC230G, 235: HaS235A, 359: HaV359L, 360: 
HaN360S, B: Agarose gel electrophoresis of the HaBPS single mutants after KpnI digestion, L: DNA 
Ladder Mix (Thermo Scientific). C: SDS-PAGE demonstrating the purification of His6-HaBPS wild-
type and mutants, wild: HaBPS wild-type, 54: HaE54D, 146: HaV146A, 230: HaC230G, 359: 
HaV359L, 360: HaN360S. D: SDS-PAGE for HaS235A.  
M:  protein marker, 1: pre-induction, 2: post-induction, 3: soluble protein, 4: affinity-purified protein. 
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Fig. 90  a: Dependence of HaE54D activity on benzoyl-CoA concentration. 
             b: Determination of the Km value for benzoyl-CoA via Lineweaver-Burk plot. 
             c: Dependence of HaE54D activity on malonyl-CoA concentration. 
             d: Determination of Km value for malonyl-CoA via Lineweaver-Burk plot. 
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Fig. 91  a: Dependence of HaV146A activity on benzoyl-CoA concentration.  
             b: Determination of Km value for benzoyl-CoA via Lineweaver-Burk plot. 
             c: Dependence of HaV146A activity on malonyl-CoA concentration. 
             d: Determination of Km value for malonyl-CoA via Lineweaver-Burk plot. 
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Fig. 92  a: Dependence of HaC230G activity on benzoyl-CoA concentration.  
             b: Determination of Km value for benzoyl-CoA via Lineweaver-Burk plot. 
             c: Dependence of HaC230G activity on malonyl-CoA concentration. 
             d: Determination of Km value for malonyl-CoA via Lineweaver-Burk plot. 
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Fig. 93  a: Dependence of HaV359L activity on benzoyl-CoA concentration.  
             b: Determination of Km value for benzoyl-CoA via Lineweaver-Burk plot. 
             c: Dependence of HaV359L activity on malonyl-CoA concentration. 
             d: Determination of Km value for malonyl-CoA via Lineweaver-Burk plot. 
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Fig. 94  a: Dependence of HaN360S activity on benzoyl-CoA concentration. 
             b: Determination of Km value for benzoyl-CoA via Lineweaver-Burk plot. 
             c: Dependence of HaN360S activity on malonyl-CoA concentration. 
             d: Determination of Km value for malonyl-CoA via Lineweaver-Burk plot. 
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Fig. 95  A: Agarose gel electrophoresis of SDM-PCR amplification products of HaBPS lysine double 
mutants, 54K: HaE54D/T135K, 146K: HaV146A/T135K, 230K: HaC230G/T135K, 235K: 
HaS235A/T135K, 359K: HaV359L/T135K 360K: HaN360S/T135K, B: Agarose gel electrophoresis 
of the enzyme mutants after KpnI digestion, L: DNA Ladder Mix (Thermo Scientific). C: SDS-PAGE 
of affinity-purified proteins, wild: HaBPS, 54K: HaE54D/T135K, 146K: HaV146A/T135K, 230K: 
HaC230G/T135K, 235K: HaS235A/T135K, 359K: HaV359L/T135K, D: SDS-PAGE of Ha 
N360S/T135K double mutant.  
M: protein marker, 1: pre-induction, 2: post-induction, 3: soluble protein, 4: affinity-purified protein. 
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Fig. 96  HPLC chromatograms of assays of HaBPS lysine double mutants with salicoyl-CoA a: 
HaE54D/T135K, b: HaV146A /T135K, c: HaC230G/T135K, d: HaS235A/T135K,  
e: HaV359L/T135K. 
5: 4-hydroxycoumarin. 
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Fig. 97  Agarose gel electrophoresis of, A: SDM-PCR amplification products of isoleucine double 
mutants, B: the mutants after KpnI digestion, L: DNA Ladder Mix (Thermo Scientific). C: SDS-PAGE 
of affinity-purified proteins, 360A: Ha N360S/T135A, 54I: HaE54D/T135I, 146I: HaV146A/T135I, 
230I: HaC230G/T135, 235I: HaS235A/T135I, 359I: HaV359L/T135I, 360I: HaN360S/T135I.  
M: protein marker, 1: pre-induction, 2: post-induction, 3: soluble protein, 4: affinity-purified protein. 
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Fig. 98  HPLC chromatograms of assays of isoleucine double mutants with benzoyl-CoA a: 
HaE54D/T135I, b: HaV146A/T135I, c: HaC230G/T135I, d: HaS235A/T135I, e: HaV359L/T135I, 
f: HaN360S/T135I double mutants. 
2: 6-phenyl-4-hydroxy-2-pyrone. 
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Fig. 99  HPLC chromatograms of assays of isoleucine double mutants with 3-hydroxybenzoyl-CoA, a: 
HaE54D/T135I, b: HaV146A/T135I, c: HaC230G/T135I, d: HaS235A/T135I, e: HaV359L/T135I,  
f: HaN360S/T135I double mutants. 
4: 6- (3-hydroxy-phenyl)-4-hydroxy-2-pyron. 
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Fig. 100  HPLC chromatograms of assays of HaN360S/T135A with, a: benzoyl-CoA.  
b: 3-hydroxybenzoyl-CoA.c: 2-hydroxybenzoyl-CoA. 
1: 2,4,6-trihydroxybenzophenone. 2: 6-phenyl-4-hydroxy-2-pyrone, *: unidentified peak.  
3: 2,3',4,6-tetrahydroxybenzophenone, 4: 6-(3-hydroxy-phenyl)-4-hydroxy-2-pyrone,  
5: 4-hydroxycoumarin. 
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Fig. 101  Agarose gel electrophoresis of, A: SDM-PCR amplification products of HcBPS mutants, B: 
the enzyme mutants after KpnI digestion, L: DNA Ladder Mix (Thermo Scientific), C: SDS-PAGE 
demonstrating His6- HcT135L and HcT135I mutants, D: SDS-PAGE demonstrating His6-HcT135K 
mutant. 
M: protein marker, 1: pre-induction, 2: post-induction, 3: soluble protein, 4: affinity-purified protein. 
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Benzoyl-CoA 3-Hydroxybenzoyl-CoA 2-Hydroxybenzoyl-CoA 
   
Fig. 102  HPLC chromatograms of assays of HcBPS wild-type with, a: benzoyl-CoA.  
b: 3-hydroxybenzoyl-CoA. c: 2-hydroxybenzoyl-CoA.  
1: 2,4,6-trihydroxybenzophenone, 2: 6-phenyl-4-hydroxy-2-pyrone,  
3: 2,3',4,6-tetrahydroxybenzophenone, 4: 6-(3-hydroxy-phenyl)-4-hydroxy-2-pyrone. 
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Fig. 103  HPLC chromatograms of assays of HcT135L and HcT135I mutants with a, c: benzoyl-CoA. 
b, d: 3-hydroxybenzoyl-CoA. 
 2: 6-phenyl-4-hydroxy-2-pyrone, 4: 6-(3-hydroxy-phenyl)-4-hydroxy-2-pyrone. 
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Fig. 104  Agarose gel electrophoresis of, A: SDM PCR amplification products of HpaBPS mutants, B: 
the mutants after KpnI digestion, L: DNA Ladder Mix (Thermo Scientific). C: SDS-PAGE 
demonstrating HpaT135L and HpaT135I enzyme mutants, D: SDS-PAGE illustrating HpaT135K 
mutants.  
M: protein marker, 1: pre-induction, 2: post-induction, 3: soluble protein, 4: affinity-purified protein. 
  
  1        2      3     4       M    1      2      3     4      M       1        2        3       4     M    
kDa 
 
 
 
55 
40 
 
35 
 
 
 
kDa 
 
 
 
 
55 
40 
 
35 
 
 
   Hpa  
T135I 
   Hpa 
T135L 
   Hpa 
T135K 
          L        HpaT135L    HpaT135I  HpaT135K         L      HpaT135 L   HpaT135I  HpaT135K 
4.2 kb 
Appendix 
189 
 
   
Fig. 105  HPLC chromatograms of assays of HpaBPS wild-type with, a: benzoyl-CoA. b: 3-
hydroxybenzoyl-CoA. C: 2-hydroxybenzoyl-CoA.  
1: 2,4,6-trihydroxybenzophenone.2: 6-phenyl-4-hydroxy-2-pyrone,  
3: 2,3',4,6-tetrahydroxybenzophenone, 4: 6-(3-hydroxy-phenyl)-4-hydroxy-2-pyrone. 
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Fig. 106  HPLC chromatograms of assays of HpaT135L and HpaT135I mutants with a, c: benzoyl-
CoA. b, d: 3-hydroxybenzoyl-CoA. 
2: 6-phenyl-4-hydroxy-2-pyrone, 4: 6-(3-hydroxy-phenyl)-4-hydroxy-2-pyrone. 
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Fig. 107  Mass spectra of 2-methoxybenzoyl-N-hydroxysuccinimide ester. 
 
 
Fig. 108  Mass spectra of 2-mercaptobenzoyl-N-hydroxysuccinimide ester. 
 
